<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003988.pub2" GROUP_ID="FERTILREG" ID="448801111316123474" MERGED_FROM="" MODIFIED="2015-03-06 10:53:39 +0000" MODIFIED_BY="Anja Helmerhorst" NOTES="&lt;p&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.2.9&lt;br&gt;Exported from Review Manager 4.2.8&lt;/p&gt;" NOTES_MODIFIED="2015-03-06 11:50:49 +0100" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="0036" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="12.0">
<COVER_SHEET MODIFIED="2015-03-06 10:53:39 +0000" MODIFIED_BY="Anja Helmerhorst">
<TITLE MODIFIED="2015-02-22 13:32:20 +0100" MODIFIED_BY="[Empty name]">Combined hormonal versus nonhormonal versus progestin-only contraception in lactation</TITLE>
<CONTACT MODIFIED="2015-03-06 10:53:39 +0000" MODIFIED_BY="Anja Helmerhorst"><PERSON ID="3B53A95682E26AA20114382D371E0DCB" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Laureen</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Lopez</LAST_NAME><EMAIL_1>llopez@fhi360.org</EMAIL_1><ADDRESS><DEPARTMENT>Clinical and Epidemiological Sciences</DEPARTMENT><ORGANISATION>FHI 360</ORGANISATION><ADDRESS_1>359 Blackwell St, Suite 200</ADDRESS_1><CITY>Durham</CITY><ZIP>27701</ZIP><REGION>North Carolina</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 919 5447040 ext: 11443</PHONE_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2015-03-06 10:53:39 +0000" MODIFIED_BY="Anja Helmerhorst"><PERSON ID="3B53A95682E26AA20114382D371E0DCB" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Laureen</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Lopez</LAST_NAME><EMAIL_1>llopez@fhi360.org</EMAIL_1><ADDRESS><DEPARTMENT>Clinical and Epidemiological Sciences</DEPARTMENT><ORGANISATION>FHI 360</ORGANISATION><ADDRESS_1>359 Blackwell St, Suite 200</ADDRESS_1><CITY>Durham</CITY><ZIP>27701</ZIP><REGION>North Carolina</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 919 5447040 ext: 11443</PHONE_1></ADDRESS></PERSON><PERSON ID="z1406121005222148080961083296413" ROLE="AUTHOR"><FIRST_NAME>Thomas</FIRST_NAME><MIDDLE_INITIALS>W</MIDDLE_INITIALS><LAST_NAME>Grey</LAST_NAME><POSITION>Research Associate</POSITION><EMAIL_1>tgrey@fhi360.org</EMAIL_1><ADDRESS><DEPARTMENT>Social and Behavioral Health Sciences</DEPARTMENT><ORGANISATION>FHI 360</ORGANISATION><ADDRESS_1>359 Blackwell St, Suite 200</ADDRESS_1><CITY>Durham</CITY><ZIP>27701</ZIP><REGION>North Carolina</REGION><COUNTRY CODE="US">USA</COUNTRY></ADDRESS></PERSON><PERSON ID="z1210031240434726625105534575156" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Alison</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Stuebe</LAST_NAME><POSITION>Associate Professor</POSITION><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynecology</DEPARTMENT><ORGANISATION>University of North Carolina School of Medicine</ORGANISATION><ADDRESS_1>3010 Old Clinic Building</ADDRESS_1><ADDRESS_2>CB 7516</ADDRESS_2><CITY>Chapel Hill</CITY><ZIP>27599</ZIP><REGION>North Carolina</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>919-966-1601</PHONE_1><FAX_1>919-966-6377</FAX_1></ADDRESS></PERSON><PERSON ID="4505019582E26AA200DA2AF3B33ECEBE" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Mario</FIRST_NAME><LAST_NAME>Chen</LAST_NAME><POSITION>Associate Director</POSITION><EMAIL_1>mchen@fhi360.org</EMAIL_1><ADDRESS><DEPARTMENT>Biostatistics</DEPARTMENT><ORGANISATION>FHI 360</ORGANISATION><ADDRESS_1>359 Blackwell St, Suite 200</ADDRESS_1><CITY>Durham</CITY><ZIP>27701</ZIP><REGION>North Carolina</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 919 5447040 ext: 11399</PHONE_1><FAX_1>+1 919 5447261</FAX_1></ADDRESS></PERSON><PERSON ID="13662" ROLE="AUTHOR"><FIRST_NAME>Sarah</FIRST_NAME><MIDDLE_INITIALS>T</MIDDLE_INITIALS><LAST_NAME>Truitt</LAST_NAME><EMAIL_1>struitt@scf.cc</EMAIL_1><EMAIL_2>sarahttruitt@gmail.com</EMAIL_2><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynecology</DEPARTMENT><ORGANISATION>Alaska Native Medical Center</ORGANISATION><ADDRESS_1>4320 Diplomacy Drive</ADDRESS_1><CITY>Anchorage</CITY><REGION>Alaska</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 907 7295088</PHONE_1></ADDRESS></PERSON><PERSON ID="13632" ROLE="AUTHOR"><FIRST_NAME>Maria</FIRST_NAME><MIDDLE_INITIALS>F</MIDDLE_INITIALS><LAST_NAME>Gallo</LAST_NAME><SUFFIX>PhD</SUFFIX><POSITION>Assistant Professor</POSITION><EMAIL_1>mgallo@cph.osu.edu</EMAIL_1><EMAIL_2>fjr4@cdc.gov</EMAIL_2><ADDRESS><DEPARTMENT>Division of Epidemiology</DEPARTMENT><ORGANISATION>The Ohio State University</ORGANISATION><CITY>Columbus</CITY><REGION>Ohio</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 919 3080144</PHONE_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2015-03-06 11:46:00 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Minor update: 5/6/08&lt;/p&gt;&lt;p&gt;New studies sought but none found: 4/5/05&lt;/p&gt;&lt;p&gt;Feedback added: 2/1/04&lt;/p&gt;&lt;p&gt;Response to feedback added: 3/5/04&lt;/p&gt;" NOTES_MODIFIED="2015-03-06 11:46:00 +0100" NOTES_MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="2" MONTH="3" YEAR="2015"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="2" MONTH="3" YEAR="2015"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="1" MONTH="3" YEAR="2017"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2003"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2003"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2015"/>
</DATES>
<WHATS_NEW MODIFIED="2015-03-06 11:50:49 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;The search was updated in April 2005.  No new trials were found. Some references were updated. The text was updated to reflect current Cochrane style issues. A plain language summary was provided in lieu of the original Synopsis.&lt;/p&gt;" NOTES_MODIFIED="2015-03-06 11:50:49 +0100" NOTES_MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2015-03-06 11:50:49 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="2" MONTH="3" YEAR="2015"/>
<DESCRIPTION>
<P>Searches updated</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2015-02-25 19:14:44 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="4" MONTH="8" YEAR="2014"/>
<DESCRIPTION>
<P>Summaries of evidence quality (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>) and outcomes (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>) and a sensitivity analysis (<LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>) added</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-02-25 19:14:44 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="31" MONTH="7" YEAR="2014"/>
<DESCRIPTION>
<P>7 trials (<LINK REF="STD-Heikkil_x00e4_-1982" TYPE="STUDY">Heikkilä 1982</LINK>; <LINK REF="STD-Shaamash-2005" TYPE="STUDY">Shaamash 2005</LINK>; <LINK REF="STD-Brito-2009" TYPE="STUDY">Brito 2009</LINK>; <LINK REF="STD-Gurtcheff-2011" TYPE="STUDY">Gurtcheff 2011</LINK>; <LINK REF="STD-Espey-2012" TYPE="STUDY">Espey 2012</LINK>; <LINK REF="STD-Dutta-2013" TYPE="STUDY">Dutta 2013</LINK>; <LINK REF="STD-Stuart-2014" TYPE="STUDY">Stuart 2014</LINK>) and 1 ongoing trial (<LINK REF="STD-Turok-2014" TYPE="STUDY">Turok 2014</LINK>) added</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2015-02-25 19:16:08 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="14" MONTH="7" YEAR="2014"/>
<DESCRIPTION>
<P>
<LINK TAG="CRIT_OUTCOMES" TYPE="SECTION">Types of outcome measures</LINK> separated into primary (effect on lactation) and secondary (contraceptive efficacy). Trials must report a primary outcome; <LINK REF="STD-Were-1997" TYPE="STUDY">Were 1997</LINK> determined to be no longer eligible (<LINK TAG="EXCLUDED_STUDIES_DESCR" TYPE="SECTION">Excluded studies</LINK>)</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2015-03-05 15:38:17 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-03-05 15:38:17 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="17" MONTH="12" YEAR="2012"/>
<DESCRIPTION>
<P>Study added to 'awaiting classification' (Espey 2012).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-03-05 15:25:23 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="2" MONTH="11" YEAR="2010"/>
<DESCRIPTION>
<P>Searches were updated for MEDLINE, CENTRAL, and POPLINE. New searches were added for ClinicalTrials.gov and ICTRP. No new trials met the inclusion criteria.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-03-05 15:25:23 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="7" MONTH="5" YEAR="2008"/>
<DESCRIPTION>
<P>Searches were updated; no new trials were found.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2015-03-05 15:37:47 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="3" MONTH="10" YEAR="2005"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2015-03-02 17:51:15 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES MODIFIED="2015-03-02 17:51:15 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2014-08-07 16:42:33 +0200" MODIFIED_BY="[Empty name]">
<NAME>National Institute of Child Health and Human Development</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION>
<P>2002 through 2014: Support for conducting the review and updates at FHI 360</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2015-03-02 17:51:15 +0100" MODIFIED_BY="[Empty name]">
<NAME>US Agency for International Development</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION>
<P>2002 through 2010: Support for conducting the review and updates at FHI 360<BR/>2014: This report is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of The Evidence Project, cooperative agreement no. AID-OAA-A-13-00087. The findings and conclusions are the sole responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government.<BR/>
<BR/>
</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2015-03-05 15:39:26 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2015-03-03 21:47:00 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2015-03-02 21:26:38 +0100" MODIFIED_BY="[Empty name]">Hormonal and nonhormonal birth control during breastfeeding</TITLE>
<SUMMARY_BODY MODIFIED="2015-03-03 21:47:00 +0100" MODIFIED_BY="[Empty name]">
<P>Birth control for women who are breastfeeding is important worldwide. Delaying the next pregnancy improves the health of women and children. Each year, millions of women decide whether to use birth control after having a baby. The decision includes the birth control type and when to start using it. Researchers and health care providers debate these issues. Some worry that hormones could affect the breast milk and therefore the baby's growth. Ideally, the birth control would not affect the type or amount of breast milk or the baby's growth. Identifying the best time to start birth control is also important. When monthly cycles return is uncertain, and the woman could get pregnant again.</P>
<P>Combined birth control methods contain the hormones estrogen and progestin. Other types of birth control contain only progestin or no hormones. We looked at whether combined birth control or methods with only progestin affect breastfeeding more than other methods. We ran computer searches for randomized trials of birth control used during breastfeeding until 2 March 2015. These trials compared hormonal methods to other hormonal methods or to placebo ('dummy' method). We also looked at reference lists to find trials. For the initial review, we wrote to researchers to find other studies.</P>
<P>We included 11 studies with a total of 1482 women. These trials looked at many methods: pills, an implant, the injectable 'Depo,' and a hormonal intrauterine device (IUD). Some older reports did not have much data. Most trials showed no major difference due to hormonal birth control use. Two of eight trials noted less breastfeeding among women using hormonal birth control. One was a combined pill with few results and the other a hormonal IUD. In one study, the implant group infants gained more weight than those in the no-method group but less weight than infants in the 'Depo' group. Two trials noted that a combined pill had a negative effect on breast milk volume or content. One report did not have much data. The other showed lower volume for combined pill users than for women taking pills with only progestin.</P>
<P>We found little information on any specific birth control method, with usually two studies per method. Results were not consistent across all trials. The data were of moderate quality overall. The results of better quality showed little effect on breastfeeding or infant growth.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2015-03-05 15:39:09 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2015-03-03 21:36:35 +0100" MODIFIED_BY="[Empty name]">
<P>Postpartum contraception improves the health of mothers and children by lengthening birth intervals. For lactating women, contraception choices are limited by concerns about hormonal effects on milk quality and quantity and passage of hormones to the infant. Ideally, the contraceptive chosen should not interfere with lactation or infant growth. Timing of contraception initiation is also important. Immediately postpartum, most women have contact with a health professional, but many do not return for follow-up contraceptive counseling. However, immediate initiation of hormonal methods may disrupt the onset of milk production.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2015-03-03 21:36:14 +0100" MODIFIED_BY="[Empty name]">
<P>To determine the effects of hormonal contraceptives on lactation and infant growth</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2015-03-02 22:34:28 +0100" MODIFIED_BY="[Empty name]">
<P>We searched for eligible trials until 2 March 2015. Sources included the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, POPLINE, Web of Science, LILACS, ClinicalTrials.gov, and ICTRP. We also examined review articles and contacted investigators.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2015-03-02 21:37:54 +0100" MODIFIED_BY="[Empty name]">
<P>We sought randomized controlled trials in any language that compared hormonal contraception versus another form of hormonal contraception, nonhormonal contraception, or placebo during lactation. Hormonal contraception includes combined or progestin-only oral contraceptives, injectable contraceptives, implants, and intrauterine devices.</P>
<P>Trials had to have one of our primary outcomes: breast milk quantity or biochemical composition; lactation initiation, maintenance, or duration; infant growth; or timing of contraception initiation and effect on lactation. Secondary outcomes included contraceptive efficacy while breastfeeding and birth interval.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2015-03-02 17:02:31 +0100" MODIFIED_BY="[Empty name]">
<P>For continuous variables, we calculated the mean difference (MD) with 95% confidence interval (CI). For dichotomous outcomes, we computed the Mantel-Haenszel odds ratio (OR) with 95% CI. Due to differing interventions and outcome measures, we did not aggregate the data in a meta-analysis.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2015-03-05 15:39:09 +0100" MODIFIED_BY="[Empty name]">
<P>In 2014, we added seven trials for a new total of 11. Five reports were published before 1985 and six from 2005 to 2014. They included 1482 women. Four trials examined combined oral contraceptives (COCs), and three studied a levonorgestrel-releasing intrauterine system (LNG-IUS). We found two trials of progestin-only pills (POPs) and two of the etonogestrel-releasing implant. Older studies often lacked quantified results. Most trials did not report significant differences between the study arms in breastfeeding duration, breast milk composition, or infant growth. Exceptions were seen mainly in older studies with limited information.</P>
<P>For breastfeeding duration, two of eight trials indicated a negative effect on lactation. A COC study reported a negative effect on lactation duration compared to placebo but did not quantify results. Another trial showed a lower percentage of the LNG-IUS group breastfeeding at 75 days versus the nonhormonal IUD group (reported P &lt; 0.05) but no significant difference at one year.</P>
<P>For breast milk volume, two older studies indicated lower volume for the COC group versus the placebo group. One trial did not quantify results. The other showed lower means (mL) for the COC group, e.g. at 16 weeks (MD -24.00, 95% CI -34.53 to -13.47) and at 24 weeks (MD -24.90, 95% CI -36.01 to -13.79). Another four trials did not report any significant difference between the study groups in milk volume or composition with two POPs, a COC, or the etonogestrel implant.</P>
<P>Seven trials studied infant growth; one showed greater weight gain (grams) for the etonogestrel implant versus no method for six weeks (MD 426.00, 95% CI 58.94 to 793.06) but less compared with depot medroxyprogesterone acetate (DMPA) from 6 to 12 weeks (MD -271.00, 95% CI -355.10 to -186.90). The others studied POPs, COCs versus POPs, or an LNG-IUS.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2015-03-03 21:42:00 +0100" MODIFIED_BY="[Empty name]">
<P>Results were not consistent across the 11 trials. The evidence was limited for any particular hormonal method. The quality of evidence was moderate overall and low for three of four placebo-controlled trials of COCs or POPs. The sensitivity analysis included six trials with moderate quality evidence and sufficient outcome data. Five trials indicated no significant difference between groups in breastfeeding duration (etonogestrel implant insertion times, COC versus POP, and LNG-IUS). For breast milk volume or composition, a COC study showed a negative effect, while an implant trial showed no significant difference. Of four trials that assessed infant growth, three indicated no significant difference between groups. One showed greater weight gain in the etonogestrel implant group versus no method but less versus DMPA.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2015-03-05 15:39:26 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2015-03-04 15:30:01 +0100" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2015-03-03 21:49:22 +0100" MODIFIED_BY="[Empty name]">
<P>Contraception for women who are breastfeeding is a public health issue of global importance. According to early Demographic and Health Surveys (DHS), nearly two-thirds of women in their first postpartum year have an unmet need for family planning (<LINK REF="REF-WHO-2013" TYPE="REFERENCE">WHO 2013</LINK>). More recent DHS indicate that unmet need for modern contraceptive methods is 32% among married women in general, and one-third to one-half of unmarried women have an unmet need for such methods (<LINK REF="REF-Westhoff-2012" TYPE="REFERENCE">Westhoff 2012</LINK>). Each year more than 100 million women make decisions about beginning or resuming contraception after childbirth (<LINK REF="REF-Tsui-1997" TYPE="REFERENCE">Tsui 1997</LINK>). These decisions include the choice of contraceptive method and the time at which to begin use. For women who are breastfeeding, the choice and timing of hormonal contraception may influence both lactation and infant growth.</P>
<P>Breastfeeding has well-established health benefits. It provides the infant with complete nutrition up to six months, a safe food source, and immunological defense against infectious diseases (<LINK REF="REF-USAID-2009" TYPE="REFERENCE">USAID 2009</LINK>; <LINK REF="REF-AAP-2012" TYPE="REFERENCE">AAP 2012</LINK>). Breastfeeding has economic benefits from conserving funds that would be spent on milk substitutes (<LINK REF="REF-AAP-2012" TYPE="REFERENCE">AAP 2012</LINK>). Lactation is associated with reducing a woman's risk of type 2 diabetes and ovarian and breast cancer (<LINK REF="REF-Ip-2007" TYPE="REFERENCE">Ip 2007</LINK>). Infants exclusively breastfed for the first six months appear to have better health outcomes than those partially breastfed as of three or four months of age (<LINK REF="REF-Kramer-2012" TYPE="REFERENCE">Kramer 2012</LINK>).</P>
<P>Breastfeeding influences the need for and timing of postpartum contraception. An interval of anovulation occurs after delivery, and the length of time until ovulation resumes depends on breastfeeding patterns, biological variation, nutrition, geography, culture, and socioeconomic factors (<LINK REF="REF-Knijff-2000" TYPE="REFERENCE">Knijff 2000</LINK>). Lactation itself can be an effective form of temporary contraception, known as the lactational amenorrhea method (LAM) (<LINK REF="REF-Van-der-Wijden-2003" TYPE="REFERENCE">Van der Wijden 2003</LINK>). For LAM to be effective, the woman must fully (or nearly fully) breastfeed, have no menstrual bleeding, and be within six months of delivery (<LINK REF="REF-Kennedy-2011" TYPE="REFERENCE">Kennedy 2011</LINK>; <LINK REF="REF-K4-Health-2014" TYPE="REFERENCE">K4 Health 2014</LINK>). Return of menstruation and ovulation can be unpredictable in breastfeeding women. Therefore, the timing of contraception initiation is important. Ideally, the contraceptive method chosen should not interfere with lactation.</P>
</CONDITION>
<INTERVENTION MODIFIED="2015-03-03 21:51:35 +0100" MODIFIED_BY="[Empty name]">
<P>Contraception after childbirth improves the health of mothers and infants by lengthening birth intervals. Women are more likely to report births or pregnancies as unintended when they occur within an interval of 24 months or less (<LINK REF="REF-Tsui-1997" TYPE="REFERENCE">Tsui 1997</LINK>). Preventing such unintended pregnancies reduces health risks and helps avoid associated financial and psychological costs. A longer birth interval of 18 to 27 months decreases the risk of major maternal complications including death, third-trimester bleeding, puerperal endometritis, and anemia (<LINK REF="REF-Conde_x002d_Agudelo-2000" TYPE="REFERENCE">Conde-Agudelo 2000</LINK>; <LINK REF="REF-WHO-2005" TYPE="REFERENCE">WHO 2005</LINK>). To reduce risk for poor maternal and infant health outcomes, the World Health Organization has recommended waiting 24 months before attempting the next pregnancy (<LINK REF="REF-WHO-2005" TYPE="REFERENCE">WHO 2005</LINK>).</P>
<P>Hormonal contraception includes combined methods that contain both estrogen and progestin as well as progestin-only methods. Combined hormonal contraceptives include combined oral contraceptives (COCs), combined injectables, and the combined vaginal ring and transdermal patch. Progestin-only methods include progestin-only pills (POPs), the injectable depot medroxyprogesterone acetate (DMPA), levonorgestrel and etonogestrel implants, and the levonorgestrel intrauterine system. A progesterone vaginal ring was developed for use during lactation and is available in some Latin American countries (<LINK REF="REF-RamaRao-2013" TYPE="REFERENCE">RamaRao 2013</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2015-03-03 21:59:47 +0100" MODIFIED_BY="[Empty name]">
<P>Hormonal contraceptives, especially those containing estrogen, may impair lactation through their effect on prolactin, the hormone responsible for production of milk. During pregnancy, prolactin levels rise and they peak at delivery. However, during pregnancy, both estrogen and progesterone block the effect of prolactin on the breasts. After delivery, levels of both estrogen and progesterone drop markedly, and, without their inhibitory effects, prolactin initiates milk production. Infant suckling stimulates more prolactin, which then sustains milk production. Breast engorgement and full milk secretion start three to four days after delivery, when estrogen and progesterone have sufficiently cleared from the maternal circulation (<LINK REF="REF-Speroff-2004" TYPE="REFERENCE">Speroff 2004</LINK>; <LINK REF="REF-Pang-2007" TYPE="REFERENCE">Pang 2007</LINK>).</P>
<P>Choices of contraception may be limited for lactating women because of concerns about potential negative hormonal effects on quality and quantity of milk, passage of hormones to the infant, and infant growth and development. Some studies have found negative effects on lactation from COCs but not from progestin-only contraception (<LINK REF="REF-Kapp-2010a" TYPE="REFERENCE">Kapp 2010a</LINK>; <LINK REF="REF-Kapp-2010b" TYPE="REFERENCE">Kapp 2010b</LINK>; <LINK REF="REF-Kennedy-2011" TYPE="REFERENCE">Kennedy 2011</LINK>). However, those studies had various ways of measuring effects on milk production, yielded inconsistent results, and generally did not show negative effects on infants. Theoretical concerns about milk production focus on the early postpartum period, i.e. the onset of lactogenesis (<LINK REF="REF-CDC-2011" TYPE="REFERENCE">CDC 2011</LINK>; <LINK REF="STD-Gurtcheff-2011" TYPE="STUDY">Gurtcheff 2011</LINK>). Gonadal steroids may also impact milk supply in established lactation, as suggested by evidence of slower growth among children who continue to breastfeed when their mothers conceive another pregnancy (<LINK REF="REF-Bohler-1996" TYPE="REFERENCE">Bohler 1996</LINK>). To determine whether hormonal contraception affects milk production, studies ideally would quantify the rate of exclusive or full breastfeeding, as well as the supplementation that infants receive, among women using different contraceptive methods. In the setting of mixed feeding, comparisons of infant growth are difficult to interpret because mothers can compensate for differences in milk supply by formula supplementation.<BR/>
</P>
<P>Due to concerns about the effect on lactation, combined hormonal contraceptives are considered category 4 for breastfeeding women up to six weeks postpartum and category 3 for six weeks to six months (<LINK REF="REF-WHO-2009" TYPE="REFERENCE">WHO 2009</LINK>; <LINK REF="REF-CDC-2011" TYPE="REFERENCE">CDC 2011</LINK>). Category 3 means that the theoretical or proven risks usually outweigh the advantages of using the method. The method is not usually recommended unless more appropriate methods are unavailable or unacceptable (<LINK REF="REF-WHO-2009" TYPE="REFERENCE">WHO 2009</LINK>). Most progestin-only methods are considered category 3 for less than six weeks postpartum (<LINK REF="REF-WHO-2009" TYPE="REFERENCE">WHO 2009</LINK>). For the first month postpartum in the United States, they are considered category 2, i.e. the advantages of using the method generally outweigh the risks (<LINK REF="REF-CDC-2011" TYPE="REFERENCE">CDC 2011</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2015-03-04 15:30:01 +0100" MODIFIED_BY="[Empty name]">
<P>Despite potential adverse effects of COCs on lactation, many women prefer this method (<LINK REF="REF-Erwin-1994" TYPE="REFERENCE">Erwin 1994</LINK>). Combined oral contraceptives have many benefits, including familiarity with the method, effectiveness, safety, reversibility, excellent cycle control, a decrease in menstrual cramps and pain, decreased days of bleeding and amount of blood loss, and other noncontraceptive benefits. Other hormonal methods, including the progestin-only pill, may not offer all of these advantages (<LINK REF="REF-Raymond-2011" TYPE="REFERENCE">Raymond 2011</LINK>). Progestin-only pill use is estimated at only 0.4% in the United States, according to an analysis of data from the National Survey of Family Growth (<LINK REF="REF-Hall-2012" TYPE="REFERENCE">Hall 2012</LINK>). The percentage may be much higher for breastfeeding women, but the sample size was very small for postpartum women. Some women quit breastfeeding early so they can start the COC (<LINK REF="REF-Erwin-1994" TYPE="REFERENCE">Erwin 1994</LINK>).</P>
<P>Examining the impact of long-acting reversible contraception (LARC) on lactation is also important. The levonorgestrel-releasing intrauterine system (LNG-IUS) and the etonogestrel-releasing implant (ETG implant) provide highly effective birth control; both are progesterone-only methods.</P>
<P>Clinical recommendations must be evidence-based if women are to make informed choices concerning contraception while breastfeeding. This updated review examined the effects of combined hormonal contraceptives and progestin-only contraceptives on lactation and infant growth.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2015-03-04 15:30:11 +0100" MODIFIED_BY="[Empty name]">
<P>To determine the effects of hormonal contraceptives on lactation and infant growth</P>
</OBJECTIVES>
<METHODS MODIFIED="2015-03-05 15:33:31 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2015-03-04 16:58:09 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2015-03-02 18:07:28 +0100" MODIFIED_BY="[Empty name]">
<P>All randomized controlled trials (RCTs) reported in any language that compared hormonal contraception during lactation versus other hormonal contraception, nonhormonal contraception, or placebo.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2015-03-04 15:39:35 +0100" MODIFIED_BY="[Empty name]">
<P>Breastfeeding women of any age or parity who desired contraception</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2015-03-04 16:58:09 +0100" MODIFIED_BY="[Empty name]">
<P>Any form of hormonal contraception compared with another form of hormonal contraception, nonhormonal contraception, or placebo. Combined hormonal contraceptives include oral or injectable methods, vaginal rings and transdermal patches. Progestin-only contraceptives include oral and injectable methods, subdermal implants, and hormonal intrauterine devices.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2015-03-04 15:40:50 +0100" MODIFIED_BY="[Empty name]">
<P>For the 2015 update, we separated the original list of outcomes into primary and secondary outcomes. Trials must have reported on at least one of the primary outcomes, which focus on the effect of the hormonal contraceptive on lactation.</P>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2015-03-02 18:13:56 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Quantity of milk</LI>
<LI>Biochemical analysis of milk composition</LI>
<LI>Initiation, maintenance and duration of lactation (any or fully breastfeeding)</LI>
<LI>Infant growth</LI>
<LI>Timing of contraception initiation and its effects on lactation</LI>
</UL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2015-03-02 18:14:00 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Efficacy of contraceptive method while breastfeeding (pregnancy)</LI>
<LI>Birth interval</LI>
</UL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2015-03-02 22:35:00 +0100" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2015-03-02 22:35:00 +0100" MODIFIED_BY="[Empty name]">
<P>We searched for eligible RCTs until 2 March 2015. Sources included the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, POPLINE, Web of Science, and LILACS. We also searched for recent trials via ClinicalTrials.gov and the search portal of the International Clinical Trials Registry Platform (ICTRP). Search strategies are shown in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>. The initial review and the 2005 and 2008 updates also included EMBASE (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2015-03-02 18:14:38 +0100" MODIFIED_BY="[Empty name]">
<P>For the initial review, we began with review articles. We also examined reference lists of relevant articles and book chapters to seek publications comparing different forms of contraception in breastfeeding women and their effects on lactation. We contacted other investigators in the field to find publications that might have been missed, including unpublished reports. For the 2015 update, we also examined reference lists of reviews and relevant articles for other trials.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2015-03-05 15:33:31 +0100" MODIFIED_BY="[Empty name]">
<P>
<U>2003</U>: For the initial review, the authors read titles and abstracts from the searches to assess whether trials appeared to meet the inclusion criteria. We retrieved the full text when necessary. The authors verified that included references were satisfactory and reviewed others that could have met the inclusion criteria. They resolved disagreements by consensus. They sought additional information from investigators of the original included trials. Two investigators responded to questions about randomization methods and blinding (<LINK REF="STD-Miller-1970" TYPE="STUDY">Miller 1970</LINK>; <LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK>).</P>
<P>
<U>2005 to 2010</U>: The authors reviewed titles and abstracts from the database searches to determine whether trials appeared to be eligible. We retrieved the full text when necessary to determine whether the trial met the inclusion criteria.</P>
<P>
<U>2014</U>: We describe below the data collection and analysis methods used in the current version of this review.</P>
<STUDY_SELECTION MODIFIED="2014-07-15 16:16:04 +0200" MODIFIED_BY="[Empty name]">
<P>We assessed for inclusion all titles and abstracts identified during the literature searches with no language limitation.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2015-03-04 15:44:54 +0100" MODIFIED_BY="[Empty name]">
<P>Two authors independently abstracted the data. One author entered the data into Review Manager (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>), and a second author verified the accuracy. We resolved discrepancies through discussion. In <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>, we focused on primary and secondary outcomes for this review, which may not include all outcomes from each study.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2015-03-02 18:22:00 +0100" MODIFIED_BY="[Empty name]">
<P>We examined studies for methodological quality, according to recommended principles (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We considered factors such as study design, methods used to generate the randomization sequence, allocation concealment, blinding, and losses to follow-up and to early discontinuation. We also examined the methods used for outcome assessment.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2015-03-02 17:41:40 +0100" MODIFIED_BY="[Empty name]">
<P>For continuous variables, we computed the mean difference (MD) with 95% confidence interval (CI) using a fixed-effect model. RevMan uses the inverse variance approach. For dichotomous outcomes, we calculated the Mantel-Haenszel odds ratio (OR) with 95% CI using a fixed-effect model. When multivariate analysis was conducted, we presented the results as reported by the trial investigators.</P>
</EFFECT_MEASURES>
<MISSING_DATA MODIFIED="2015-03-04 15:47:10 +0100" MODIFIED_BY="[Empty name]">
<P>We wrote to investigators to request missing data, such as sample sizes for analysis and actual numbers for outcomes presented in figures. However, we limited our requests to studies less than 10 years old, unless a report was produced within the past five years. Investigators are unlikely to have access to data from 10 years ago.</P>
</MISSING_DATA>
<DATA_SYNTHESIS MODIFIED="2015-03-04 15:50:27 +0100" MODIFIED_BY="[Empty name]">
<P>To assess evidence quality and to address confidence in the effect estimates, we applied principles from GRADE (Grades of Recommendation, Assessment, Development and Evaluation) (<LINK REF="REF-Balshem-2011" TYPE="REFERENCE">Balshem 2011</LINK>; <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). When meta-analysis is not viable because of varied interventions, a Summary of findings table is not feasible. In this review, experimental and comparison interventions differed across the included trials. Outcomes assessed also varied, e.g. breast milk composition, reports of breastfeeding, or change in infant weight. Because of the heterogeneity of interventions and outcomes, we did not conduct a formal GRADE assessment with an evidence profile and Summary of findings table (<LINK REF="REF-Guyatt-2011" TYPE="REFERENCE">Guyatt 2011</LINK>).</P>
<P>Our quality assessment was based on the quality of evidence from the individual studies, which could be rated as high, moderate, low, or very low. We considered the evidence from RCTs to be of high quality initially, then downgraded it for each of the following: (1) no information on randomization sequence generation or allocation concealment, or one was clearly inadequate; (2) no blinding; (3) follow-up less than 8 weeks for infant growth or less than 12 weeks for breastfeeding; (4) losses greater than 20%; and (5) information missing on both blinding and losses.</P>
</DATA_SYNTHESIS>
<SENSITIVITY_ANALYSIS MODIFIED="2015-03-05 15:33:31 +0100" MODIFIED_BY="[Empty name]">
<P>We examined a subgroup of trials that provided evidence of moderate or high quality and reported sufficient outcome data. Most of the older trials did not quantify results, limiting the interpretation of effect. Even recent trials might not have reported sufficient detail for interpreting the outcome data presented.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2015-03-05 15:39:10 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2015-03-04 16:54:25 +0100" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2015-03-04 16:48:25 +0100" MODIFIED_BY="[Empty name]">
<P>The initial search in 2003 identified 50 articles as potentially eligible for inclusion. Seven were included and 43 were excluded, as indicated below. Searches in 2005, 2008, and 2010 did not yield any eligible studies.</P>
<P>In 2014, we identified a study that was eligible but was not include earlier. Therefore, we ran searches starting from September 2001. This revised search, completed in 2015, produced 215 unduplicated references (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>). Duplicates removed totaled 109 (93 identified electronically and 16 by hand). With four citations identified from other sources, we had 219 unduplicated references. We reviewed the full text of 14 items (9 primary and 5 secondary). From recent clinical trial listings, we obtained 15 unduplicated trials. We located a conference abstract for a completed trial, which we included, and we listed another trial in <LINK TAG="ONGOING_STUDIES" TYPE="SECTION">Ongoing studies</LINK>. In this review, we included seven new primary reports plus two secondary articles. We excluded two new primary reports plus one secondary article. We also discarded two more secondary articles related to an included trial; the abstracts indicated they did not meet our criteria.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2015-03-04 16:49:36 +0100" MODIFIED_BY="[Empty name]">
<P>A total of 11 trials met our inclusion criteria. The seven trials added in 2014 included three recent reports (<LINK REF="STD-Gurtcheff-2011" TYPE="STUDY">Gurtcheff 2011</LINK>; <LINK REF="STD-Espey-2012" TYPE="STUDY">Espey 2012</LINK>; <LINK REF="STD-Dutta-2013" TYPE="STUDY">Dutta 2013</LINK>), a recent abstract (<LINK REF="STD-Stuart-2014" TYPE="STUDY">Stuart 2014</LINK>), and three older reports missed during earlier searches (<LINK REF="STD-Heikkil_x00e4_-1982" TYPE="STUDY">Heikkilä 1982</LINK>; <LINK REF="STD-Shaamash-2005" TYPE="STUDY">Shaamash 2005</LINK>; <LINK REF="STD-Brito-2009" TYPE="STUDY">Brito 2009</LINK>).</P>
<P>The 11 trials included a total of 1482 women. Sample sizes ranged from 20 to 320 with a median of 80. Only four provided information on sample size calculations. Outcomes of focus were breastfeeding (<LINK REF="STD-Shaamash-2005" TYPE="STUDY">Shaamash 2005</LINK>; <LINK REF="STD-Gurtcheff-2011" TYPE="STUDY">Gurtcheff 2011</LINK>; <LINK REF="STD-Espey-2012" TYPE="STUDY">Espey 2012</LINK>) and infant growth (<LINK REF="STD-Shaamash-2005" TYPE="STUDY">Shaamash 2005</LINK>); one was designed to assess change in the woman's weight (<LINK REF="STD-Brito-2009" TYPE="STUDY">Brito 2009</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Contraceptive methods examined</HEADING>
<P>Seven trials studied just progestin-only methods.</P>
<UL>
<LI>Two compared progestin-only pills (POPs) versus placebo (<LINK REF="STD-Giner-Velazquez-1976" TYPE="STUDY">Giner Velazquez 1976</LINK>; <LINK REF="STD-Dutta-2013" TYPE="STUDY">Dutta 2013</LINK>).</LI>
<LI>Three studied a progestin-only intrauterine systems (IUS); two compared a hormonal IUS versus a nonhormonal IUD (<LINK REF="STD-Heikkil_x00e4_-1982" TYPE="STUDY">Heikkilä 1982</LINK>; <LINK REF="STD-Shaamash-2005" TYPE="STUDY">Shaamash 2005</LINK>), and one examined different insertion times for the same hormonal IUS (<LINK REF="STD-Stuart-2014" TYPE="STUDY">Stuart 2014</LINK>).</LI>
<LI>Two focused on a progestin-only implant; one compared the implant versus no contraceptive for the first six weeks followed by a progestin-only injectable (<LINK REF="STD-Brito-2009" TYPE="STUDY">Brito 2009</LINK>), and the other examined different insertion times for the same implant (<LINK REF="STD-Gurtcheff-2011" TYPE="STUDY">Gurtcheff 2011</LINK>).</LI>
</UL>
<P>Four trials examined COCs.</P>
<UL>
<LI>Two studied a COC versus placebo (<LINK REF="STD-Semm-1966" TYPE="STUDY">Semm 1966</LINK>; <LINK REF="STD-Miller-1970" TYPE="STUDY">Miller 1970</LINK>).</LI>
<LI>Two compared a COC versus a POP (<LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK>; <LINK REF="STD-Espey-2012" TYPE="STUDY">Espey 2012</LINK>).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcomes assessed</HEADING>
<UL>
<LI>For breast milk, two studies examined quantity (<LINK REF="STD-Semm-1966" TYPE="STUDY">Semm 1966</LINK>; <LINK REF="STD-Miller-1970" TYPE="STUDY">Miller 1970</LINK>) and four reported on quantity and composition (<LINK REF="STD-Giner-Velazquez-1976" TYPE="STUDY">Giner Velazquez 1976</LINK>; <LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK>; <LINK REF="STD-Gurtcheff-2011" TYPE="STUDY">Gurtcheff 2011</LINK>; <LINK REF="STD-Dutta-2013" TYPE="STUDY">Dutta 2013</LINK>).</LI>
<LI>Seven trials assessed any or full (exclusive) breastfeeding (<LINK REF="STD-Miller-1970" TYPE="STUDY">Miller 1970</LINK>; <LINK REF="STD-Heikkil_x00e4_-1982" TYPE="STUDY">Heikkilä 1982</LINK>; <LINK REF="STD-Shaamash-2005" TYPE="STUDY">Shaamash 2005</LINK>; <LINK REF="STD-Brito-2009" TYPE="STUDY">Brito 2009</LINK>; <LINK REF="STD-Gurtcheff-2011" TYPE="STUDY">Gurtcheff 2011</LINK>; <LINK REF="STD-Espey-2012" TYPE="STUDY">Espey 2012</LINK>; <LINK REF="STD-Stuart-2014" TYPE="STUDY">Stuart 2014</LINK>).</LI>
<LI>Seven studies reported infant growth (<LINK REF="STD-Giner-Velazquez-1976" TYPE="STUDY">Giner Velazquez 1976</LINK>; <LINK REF="STD-Heikkil_x00e4_-1982" TYPE="STUDY">Heikkilä 1982</LINK>; <LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK>; <LINK REF="STD-Shaamash-2005" TYPE="STUDY">Shaamash 2005</LINK>; <LINK REF="STD-Brito-2009" TYPE="STUDY">Brito 2009</LINK>; <LINK REF="STD-Espey-2012" TYPE="STUDY">Espey 2012</LINK>; <LINK REF="STD-Dutta-2013" TYPE="STUDY">Dutta 2013</LINK>).</LI>
</UL>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2015-03-04 16:54:25 +0100" MODIFIED_BY="[Empty name]">
<P>The initial review excluded 43 reports. Currently, we list articles as 'excluded' if the full text was needed to determine eligibility; otherwise, we 'discard' the abstract. Of the original 43 studies, 14 did not require full-text review. We removed those 14 studies from 'excluded' to shorten the list, and listed them for reference in this update (<LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>). Most of the remaining articles had been excluded because communication with investigators indicated the trials were not RCTs, or because the method of participant allocation was unclear. In addition, <LINK REF="STD-Drury-1986" TYPE="STUDY">Drury 1986</LINK> and <LINK REF="STD-Gellen-1984" TYPE="STUDY">Gellen 1984</LINK> were subgroup analyses that examined similar outcomes from <LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK> and were dropped from consideration.</P>
<P>In 2014, we divided the outcomes into primary and secondary and required one of the primary outcome measures. An earlier included trial was no longer eligible (<LINK REF="STD-Were-1997" TYPE="STUDY">Were 1997</LINK>). The study had no outcomes addressing lactation; no pregnancy occurred in either group. We excluded three additional trials (<LINK REF="STD-Rodrigues-da-Cunha-2001" TYPE="STUDY">Rodrigues da Cunha 2001</LINK>; <LINK REF="STD-Chen-2011" TYPE="STUDY">Chen 2011</LINK>; <LINK REF="STD-Shaaban-2013" TYPE="STUDY">Shaaban 2013</LINK>) for design issues or for lack of our primary outcomes (<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2015-03-04 17:03:34 +0100" MODIFIED_BY="[Empty name]">
<P>The included trials span a publication period of nearly 50 years; earlier reports typically have more reporting limitations than later ones. The quality of evidence is discussed below and is summarized later (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). In addition, <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> presents the risk of bias for each study, and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK> summarizes the risk of bias for all included trials.</P>
<P>Four of the recent trials mentioned some type of computer-generated sequence (<LINK REF="STD-Shaamash-2005" TYPE="STUDY">Shaamash 2005</LINK>; <LINK REF="STD-Brito-2009" TYPE="STUDY">Brito 2009</LINK>; <LINK REF="STD-Gurtcheff-2011" TYPE="STUDY">Gurtcheff 2011</LINK>; <LINK REF="STD-Espey-2012" TYPE="STUDY">Espey 2012</LINK>), as did one earlier report (<LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK>). Four of the five early trials and a recent preliminary report did not specify the method used to generate the random sequence (<LINK REF="STD-Semm-1966" TYPE="STUDY">Semm 1966</LINK>; <LINK REF="STD-Miller-1970" TYPE="STUDY">Miller 1970</LINK>; <LINK REF="STD-Giner-Velazquez-1976" TYPE="STUDY">Giner Velazquez 1976</LINK>; <LINK REF="STD-Heikkil_x00e4_-1982" TYPE="STUDY">Heikkilä 1982</LINK>; <LINK REF="STD-Dutta-2013" TYPE="STUDY">Dutta 2013</LINK>). Additionally, <LINK REF="STD-Miller-1970" TYPE="STUDY">Miller 1970</LINK> stratified the 'randomization' by gender of the infant and showed a disparity in baseline characteristics (primiparas) unlikely to result from a random process. <LINK REF="STD-Heikkil_x00e4_-1982" TYPE="STUDY">Heikkilä 1982</LINK> also appeared to have an imbalance by parity, but the difference reportedly was not significant.</P>
<ALLOCATION MODIFIED="2015-03-02 18:26:36 +0100" MODIFIED_BY="[Empty name]">
<P>Reporting of allocation concealment varied. One trial used pharmacy-blinded pill packages (<LINK REF="STD-Espey-2012" TYPE="STUDY">Espey 2012</LINK>). Two used sealed, sequentially numbered, opaque envelopes (<LINK REF="STD-Shaamash-2005" TYPE="STUDY">Shaamash 2005</LINK>; <LINK REF="STD-Gurtcheff-2011" TYPE="STUDY">Gurtcheff 2011</LINK>). We determined through communication with an investigator that another also used sealed, opaque envelopes (<LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK>). The remaining trials did not report the method of allocation concealment.</P>
</ALLOCATION>
<BLINDING MODIFIED="2015-03-04 16:59:46 +0100" MODIFIED_BY="[Empty name]">
<P>Four trials of oral contraceptives (OCs) had placebos; two used identically labeled placebos (<LINK REF="STD-Semm-1966" TYPE="STUDY">Semm 1966</LINK>; <LINK REF="STD-Miller-1970" TYPE="STUDY">Miller 1970</LINK>). <LINK REF="STD-Miller-1970" TYPE="STUDY">Miller 1970</LINK> and <LINK REF="STD-Giner-Velazquez-1976" TYPE="STUDY">Giner Velazquez 1976</LINK> mentioned double-blinding but did not describe the specifics. Written communication from <LINK REF="STD-Miller-1970" TYPE="STUDY">Miller 1970</LINK> indicated that participants and clinicians were kept unaware of participant treatment assignments. <LINK REF="STD-Dutta-2013" TYPE="STUDY">Dutta 2013</LINK> did not mention blinding.</P>
<P>Two trials compared combined and progestin-only oral contraceptives. <LINK REF="STD-Espey-2012" TYPE="STUDY">Espey 2012</LINK> used pharmacy-blinded pill packages. Written correspondence from an investigator in <LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK> (Tankeyoon) indicated that participants and clinicians were kept unaware of treatment assignments.</P>
<P>The two implant studies were not blinded. <LINK REF="STD-Brito-2009" TYPE="STUDY">Brito 2009</LINK> was identified as an open trial of different contraceptive methods. <LINK REF="STD-Gurtcheff-2011" TYPE="STUDY">Gurtcheff 2011</LINK> noted that blinding was not feasible because implants were inserted at different time points.</P>
<P>Of the three LNG-IUS studies, <LINK REF="STD-Heikkil_x00e4_-1982" TYPE="STUDY">Heikkilä 1982</LINK> noted that participants were unaware of which IUD was inserted, <LINK REF="STD-Stuart-2014" TYPE="STUDY">Stuart 2014</LINK> was listed as open label, and <LINK REF="STD-Shaamash-2005" TYPE="STUDY">Shaamash 2005</LINK> did not mention blinding.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2015-03-04 17:03:34 +0100" MODIFIED_BY="[Empty name]">
<P>Four trials did not mention any losses to follow-up, exclusions, or discontinuations (<LINK REF="STD-Semm-1966" TYPE="STUDY">Semm 1966</LINK>; <LINK REF="STD-Giner-Velazquez-1976" TYPE="STUDY">Giner Velazquez 1976</LINK>; <LINK REF="STD-Shaamash-2005" TYPE="STUDY">Shaamash 2005</LINK>; <LINK REF="STD-Dutta-2013" TYPE="STUDY">Dutta 2013</LINK>). <LINK REF="STD-Heikkil_x00e4_-1982" TYPE="STUDY">Heikkilä 1982</LINK> had no loss to follow-up. Three trials had losses less than 20% (<LINK REF="STD-Miller-1970" TYPE="STUDY">Miller 1970</LINK>; <LINK REF="STD-Brito-2009" TYPE="STUDY">Brito 2009</LINK>; <LINK REF="STD-Gurtcheff-2011" TYPE="STUDY">Gurtcheff 2011</LINK>).</P>
<P>Losses were greater than 20% in two trials (<LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK>; <LINK REF="STD-Espey-2012" TYPE="STUDY">Espey 2012</LINK>). In <LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK>, the disposition of participants in the randomized arms was unclear. One table indicated that 50 participants in each arm completed the study, yet tables with outcome data showed data for 57 and 58 participants in the study arms at 24 weeks (trial completion) (<LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK>). Losses at 16 weeks were 22% for the COC group and 14% for the POP group. At 24 weeks, from 32% to 34% of participants in each randomized arm were not included in the analysis. The investigators stated that participants who discontinued or were lost to follow-up were analyzed via noncompeting risk life-table procedures, and at least one participant was excluded after randomization.</P>
</EXCLUSIONS>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2015-03-05 15:39:10 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Progestin-only pills (POPs) versus placebo</HEADING>
<P>These two studies did not provide sufficient data for analysis. The older trial did not provide actual values for the outcomes and the newer trial report did not have sample sizes for analysis or information on losses. Both studies noted no significant differences between the study groups in breast milk volume and composition and in infant growth.</P>
<UL>
<LI>
<LINK REF="STD-Giner-Velazquez-1976" TYPE="STUDY">Giner Velazquez 1976</LINK> (n = 20) compared a POP containing norethindrone 350 &#956;g versus a placebo for 14 days, starting 48 hours postpartum. Results were presented in figures without actual numbers. The investigators reported no significant differences between the study groups in milk volume and composition, nor in infant growth.</LI>
</UL>
<UL>
<LI>In <LINK REF="STD-Dutta-2013" TYPE="STUDY">Dutta 2013</LINK> (n = 400), a POP containing desogestrel 75 &#956;g was compared with placebo, starting six weeks postpartum. This 'preliminary report' stated the intervention was provided for six months. Results were presented in tables without time frames for assessments or specific sample sizes for analysis. The groups were not significantly different for amount or composition of breast milk nor for percent of infants with 'normal growth' (weight, length, and head circumference) (reported P <U>&gt;</U> 0.15). Pregnancy was 0.5% in the POP group and 4% for the placebo group (reported P = 0.018).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Progestin-only IUS versus nonhormonal IUD or different insertion times</HEADING>
<P>Two studies compared a levonorgestrel-releasing intrauterine system (LNG-IUS) versus a nonhormonal intrauterine device (IUD). Neither provided sample sizes for analysis; results are presented as reported by the investigators.</P>
<UL>
<LI>
<LINK REF="STD-Heikkil_x00e4_-1982" TYPE="STUDY">Heikkilä 1982</LINK> (n = 80) compared an LNG-IUS (30 &#956;g) versus the Nova T IUD. Insertion was done at six weeks postpartum with a range from 29 to 56 days. Sample sizes were lacking in most tables.</LI>
<UL>
<LI>The source of breastfeeding data was unclear (record or recall); one analysis date (75 days after insertion) did not correspond to clinic visit times (3, 6, and 12 months after insertion). The investigators did not mention whether women were asked to record days of breastfeeding as they did for bleeding and spotting. The percentage of women breastfeeding at 75 days was lower in the LNG-IUS group than in the Nova T group (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). However, the groups did not differ significantly in mean days of breastfeeding during the study (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>).</LI>
<LI>Women were asked to have their infants weighed and measured monthly and to record those numbers on a special card; results were shown in figures without actual numbers. Reportedly, infant growth did not differ between the two study groups.</LI>
<LI>A secondary article noted that no pregnancies occurred during the study.</LI>
</UL>
</UL>
<UL>
<LI>
<LINK REF="STD-Shaamash-2005" TYPE="STUDY">Shaamash 2005</LINK> (n = 320) compared the LNG-IUS (20 &#956;g) versus the CuT 308A IUD. The article did not provide sample sizes for analysis or information on losses. Means and standard deviations (SDs) or standard errors (SEs) are presented as available for the 6- and 12-month assessments. The groups did not differ significantly for mean infant weight or length or in the Kaplan-Meier rates for full breastfeeding or continued use of the IUS or IUD (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK> to <LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>). Sample size for the study was based on detecting differences in breastfeeding rate and infant weight gain. No pregnancy occurred in either group.</LI>
<LI>In <LINK REF="STD-Stuart-2014" TYPE="STUDY">Stuart 2014</LINK> (n = 35), the LNG-IUS was inserted either within 48 hours of delivery or four to eight weeks after delivery. The trial was stopped early because expulsion rates met a priori stopping rules. Only 35 women were randomized; 190 had been planned. At the six-month study visit, the groups were not significantly different for any breastfeeding, but the sample size was much smaller than was intended (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Progestin-only implant versus no method or delayed method</HEADING>
<P>Two studies examined the etonogestrel-releasing (ETG) implant. <LINK REF="STD-Brito-2009" TYPE="STUDY">Brito 2009</LINK> compared the implant versus no contraceptive for the first six weeks, then DMPA initiated at postpartum week six. In <LINK REF="STD-Gurtcheff-2011" TYPE="STUDY">Gurtcheff 2011</LINK>, both groups received the ETG implant, either by early insertion (one to three days postpartum) or standard insertion (four to eight weeks postpartum).</P>
<UL>
<LI>In <LINK REF="STD-Brito-2009" TYPE="STUDY">Brito 2009</LINK> (n = 40), the sample size calculation was based on the women's weight change and a metabolic measure, which are not outcomes for our review. Women with a body mass index &#8805; 30 kg/m<SUP>2</SUP> were excluded from the trial, potentially affecting generalizability. The study groups did not differ significantly in proportions of women fully breastfeeding at 6 or 12 weeks postpartum (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>). None of the participants completely ceased breastfeeding during the study. Those who were not fully breastfeeding had started supplemental feeding. For infant weight, mean change (grams) by six weeks was greater in the ETG implant group than in the no-contraceptive group (MD 426.00, 95% CI 58.94 to 793.06; <LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>). The wide CI indicates imprecision in the estimate; the standard deviations were large. Mean change between 6 and 12 weeks was lower for the ETG implant group than for the group that received DMPA (MD -271.00, 95% CI -355.10 to -186.90; <LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>). The report did not provide the actual infant weights.</LI>
</UL>
<UL>
<LI>For <LINK REF="STD-Gurtcheff-2011" TYPE="STUDY">Gurtcheff 2011</LINK> (n = 69), the main outcomes were lactation failure and time to lactogenesis stage II (copious milk secretion). Sample size was based on establishing non-inferiority in those outcomes. Non-inferiority margins were a 15% increase in lactation failure and an additional eight hours to lactogenesis II in the early insertion group, as assessed through the 95% CI. Study groups were not significantly different for lactation failure (<LINK REF="CMP-006.01" TYPE="ANALYSIS">Analysis 6.1</LINK>), mean time to lactogenesis (<LINK REF="CMP-006.02" TYPE="ANALYSIS">Analysis 6.2</LINK>), or mean creamatocrit of breast milk at six weeks (<LINK REF="CMP-006.03" TYPE="ANALYSIS">Analysis 6.3</LINK>). See <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> for explanations of these outcomes. However, our results differed from the non-inferiority results for time to lactogenesis; our 95% CI exceeded the prespecified margin of an additional eight hours (MD -0.90, 95% CI -9.90 to 8.10). For breastfeeding (full or any), the investigator provided the actual numbers for analysis. Early and standard insertion groups did not differ significantly for full breastfeeding (<LINK REF="CMP-006.04" TYPE="ANALYSIS">Analysis 6.4</LINK>) or for any breastfeeding (<LINK REF="CMP-006.05" TYPE="ANALYSIS">Analysis 6.5</LINK>) at any time point. About half of study participants were fully breastfeeding at two weeks.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Combined oral contraceptive versus placebo</HEADING>
<P>Findings from <LINK REF="STD-Miller-1970" TYPE="STUDY">Miller 1970</LINK> and <LINK REF="STD-Semm-1966" TYPE="STUDY">Semm 1966</LINK> were conflicting. Results were presented in figures without actual numbers. Neither trial quantified the outcomes, making interpretation difficult.</P>
<UL>
<LI>
<LINK REF="STD-Miller-1970" TYPE="STUDY">Miller 1970</LINK> (n = 50) examined a COC containing norethindrone 1 mg plus mestranol 80 &#956;g versus placebo. The investigators noted inhibitory effects on milk volume and lactation duration from COC use. They indirectly measured milk volume by assessing the subjective need for supplemental infant feeds and infant weight as a proxy for milk adequacy. Only general estimates were given for the effects of the COC on lactation duration.</LI>
</UL>
<UL>
<LI>
<LINK REF="STD-Semm-1966" TYPE="STUDY">Semm 1966</LINK> (n = 100) compared a COC containing lynestrenol 2.5 mg plus mestranol 75 &#956;g versus placebo. The investigators found no differences in milk volume or lactation initiation during the first 10 days postpartum. Hormone doses were larger than those in currently marketed COCs; therefore generalizability is limited.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Combined versus progestin-only oral contraceptives</HEADING>
<P>The two studies in this group included an older multisite trial of OCs containing different progestins (<LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK>) and a recent trial that compared OCs containing the same progestin (<LINK REF="STD-Espey-2012" TYPE="STUDY">Espey 2012</LINK>). The report of <LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK> provided data on milk volume, but did not have sufficient data to analyze infant growth in this review. Also, data on milk composition were presented by center, not for the full trial. <LINK REF="STD-Espey-2012" TYPE="STUDY">Espey 2012</LINK> examined infant growth and breastfeeding continuation.</P>
<UL>
<LI>
<LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK> (n = 171) compared a COC containing levonorgestrel 150 &#956;g plus ethinyl estradiol 30 &#956;g versus a POP containing norgestrel 75 &#956;g. Breast milk volume was determined by pump expression using standardized procedures. The participants breastfed their infants in the morning, waited two hours, and pumped milk while simultaneously nursing from the other breast for 20 minutes. The process was repeated two hours later, using the opposite breast for pumping. The 'average' amount was then presented. Mean milk volume (mL) was lower for the COC group than for the POP group at 9 weeks (MD -17.80, 95% CI -28.80 to -6.80), 16 weeks (MD -24.00, 95% CI -34.53 to -13.47), and 24 weeks (MD -24.90, 95% CI -36.01 to -13.79) (<LINK REF="CMP-007.01" TYPE="ANALYSIS">Analysis 7.1</LINK>). Declines began after study initiation at six weeks postpartum and continued throughout the trial. From week 6 through week 24, average milk volume for COC users declined by 42% versus 12% among POP users. The randomized groups were not significantly different in infant weight change; sample sizes were not available for analysis (<LINK REF="CMP-007.02" TYPE="ANALYSIS">Analysis 7.2</LINK>). Biochemical composition of breast milk was presented by center, not for the total sample. Differences within centers were small and inconsistent. Increases in milk lipid among combined contraceptive users in one center are of unknown clinical significance.</LI>
</UL>
<UL>
<LI>
<LINK REF="STD-Espey-2012" TYPE="STUDY">Espey 2012</LINK> (n = 197) compared a COC containing norethindrone 1 mg plus ethinyl estradiol 35 &#956;g versus a POP containing norethindrone 350 &#956;g. The trial was powered to assess differences in continuation of breastfeeding. The investigator provided means and standard deviations for actual change and percentage change in infant weight and length. The study groups did not differ significantly for mean change in infant weight (<LINK REF="CMP-008.01" TYPE="ANALYSIS">Analysis 8.1</LINK>) or in infant length (<LINK REF="CMP-008.02" TYPE="ANALYSIS">Analysis 8.2</LINK>) from week two to week eight. The groups did not differ significantly at two or eight weeks for supplementing with formula. Results for the Cox proportional hazard regression indicate that the intervention group was not statistically associated with breastfeeding discontinuation (<LINK REF="CMP-008.03" TYPE="ANALYSIS">Analysis 8.3</LINK>). The regression included the covariates of OC history and breastfeeding history due to baseline differences. However, formula supplementation and concerns about milk supply were associated with breastfeeding discontinuation (reported P = 0.033 and 0.005, respectively). No pregnancies were reported by eight weeks.</LI>
</UL>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2015-03-05 15:39:26 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2015-03-05 15:39:23 +0100" MODIFIED_BY="[Empty name]">
<P>Most trials did not show or report significant differences between study arms in breastfeeding duration, breast milk composition, or infant growth (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>). The few exceptions were seen mainly in older studies with limited reporting.</P>
<UL>
<LI>Breastfeeding continuation was studied in eight trials. One older study noted a negative effect of a combined oral contraceptive (COC) on lactation duration but did not quantify results. An early trial of a levonorgestrel-releasing intrauterine system (LNG-IUS) showed a lower percentage of the LNG-IUS group breastfeeding at 75 days but no significant difference at one year. The other five trials indicated no significant differences between the study arms. Of those five, two studied insertion times for the etonogestrel-releasing (ETG) implant, one compared a COC versus a progestin-only pill (POP), and two examined the LNG-IUS. Of the latter, one compared the LNG-IUS versus a nonhormonal intrauterine device (IUD); the other compared insertion times and was stopped early because of expulsion rates.</LI>
<LI>Milk volume or composition was examined in six trials. Two older studies indicated conflicting effects of a COC on milk volume, but neither quantified results. Another older trial showed lower volume for the COC versus POP group. Two placebo-controlled trials reported no significant effect of a POP on breast milk volume or composition, although one did not quantify results, and the other did not provide sample sizes for analysis. An ETG implant study showed no significant effect of early versus standard insertion.</LI>
<LI>Infant growth was assessed in seven trials. One showed greater infant weight gain for the ETG implant group than for the no-method group during the first six weeks. The implant group had less weight gain from 6 to 12 weeks when compared to those given depot medroxyprogesterone acetate (DMPA). The other six studied POPs only, COCs versus POPs, or the LNG-IUS, and indicated no significant differences between groups. Trial reports did not present the amount of supplemental feeding provided to the infants.</LI>
<LI>Pregnancy was self-reported. One trial showed a lower percentage in the POP group. Three had no pregnancy in either group; they examined an LNG-IUS or a COC and POP.</LI>
</UL>
<SUBSECTION>
<HEADING LEVEL="2">Sensitivity analysis</HEADING>
<P>This analysis was restricted to six studies that provided sufficient data and moderate-quality evidence (<LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>). Two examined the LNG-IUS, with one comparing it with a nonhormonal IUD and one examining insertion times. Two trials studied insertion times for the ETG implant, and two examined a COC versus a POP. Five of the six trials were published since 2005.</P>
<UL>
<LI>Lactation duration: The five trials that examined breastfeeding duration indicated no significant differences between the study groups.</LI>
<LI>Breast milk volume or composition: One study showed a negative effect of the COC versus a POP on milk volume (mL expressed) through 24 weeks postpartum (mean difference (MD) -24.90, 95% confidence interval (CI) -36.01 to -13.79), and a recent implant trial showed no significant difference between insertion times.</LI>
<LI>Infant growth: Three trials indicated no significant differences in weight or length. One trial showed greater weight gain in the ETG implant group compared with the no-method group at six weeks (MD 426.00, 95% CI 58.94 to 793.06) but less gain compared with the DMPA group at 12 weeks (MD -271.00, 95% CI -355.10 to -186.90).</LI>
</UL>
</SUBSECTION>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2015-03-04 18:47:47 +0100" MODIFIED_BY="[Empty name]">
<P>Most studies assessed breastfeeding duration (full or any) or breast milk volume or composition as well as infant growth. Four examined self-reported pregnancy. Time frames for contraceptive initiation in the experimental group varied: one to three days after delivery in five trials (implant, LNG-IUS, and OCs); two weeks postpartum in two trials (OCs); and approximately six weeks postpartum in four trials (OCs or IUS). Follow-up ranged from 10 days (oldest trial) to one year (more recent studies).</P>
<P>Studies were conducted in Asia, Europe, North Africa, and the Americas. Five trials published before 1985 included a multicenter trial conducted in Hungary and Thailand and four other trials from Finland, Germany, Mexico, and the United States. Six newer trials, published from 2005 to 2014, were conducted in Brazil, Egypt, India, and the United States (three studies).</P>
<P>Inclusion and exclusion criteria varied among trials. Most studies were limited to healthy women with birth at 37 weeks gestation or later. Some trials included any woman intending to initiate breastfeeding, whereas others were limited to women who planned to breastfeed exclusively (<LINK REF="STD-Brito-2009" TYPE="STUDY">Brito 2009</LINK>) or for a minimum duration (<LINK REF="STD-Miller-1970" TYPE="STUDY">Miller 1970</LINK>; <LINK REF="STD-Stuart-2014" TYPE="STUDY">Stuart 2014</LINK>), had previously breastfed successfully (<LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK>), or were exclusively breastfeeding at the time of randomization (<LINK REF="STD-Shaamash-2005" TYPE="STUDY">Shaamash 2005</LINK>).<BR/>
</P>
<P>The evidence was limited for any particular hormonal method. Four trials examined COCs: two versus placebo and two versus a POP. Three of the four studies were at least 30 years old and had limited reporting. Older studies used hormonal preparations and doses that may be applicable to contemporary practice. Seven trials focused on progestin-only methods. Two studied a POP versus placebo; the recent one was a preliminary report. Two trials compared ETG implant insertion times. Three examined an LNG-IUS (one had an older IUS); two compared the LNG-IUS versus a nonhormonal IUD, and one compared insertion times. We did not find any RCTs of a vaginal ring or a transdermal patch among lactating women. A trial of emergency contraception as a backup for the lactational amenorrhea method did not include data on our primary outcomes (<LINK REF="STD-Shaaban-2013" TYPE="STUDY">Shaaban 2013</LINK>).</P>
<P>This review examined infant growth rather than development or other health outcomes. Two included trials assessed infant health issues at 12 months. In <LINK REF="STD-Heikkil_x00e4_-1982" TYPE="STUDY">Heikkilä 1982</LINK>, the LNG-IUS and Nova T groups did not differ significantly for incidence of otitis media and respiratory infection as reported by the mothers. <LINK REF="STD-Shaamash-2005" TYPE="STUDY">Shaamash 2005</LINK> assessed 19 infant development items, grouped as gross motor, vision and fine motor, hearing and language, self-help skills, and social skills (<LINK REF="REF-WHO-1986" TYPE="REFERENCE">WHO 1986</LINK>). No significant difference was noted between the LNG-IUS and CuT 380A groups in time to pass any test. An earlier non-randomized study of progestin-only methods used the same 19 items (<LINK REF="REF-WHO-1994" TYPE="REFERENCE">WHO 1994</LINK>). The investigators found a few differences that were mainly site-specific but no consistent trends. The progestin-only methods apparently had no negative effect on infant development. A systematic review of mainly observational studies came to the same conclusion (<LINK REF="REF-Kapp-2010a" TYPE="REFERENCE">Kapp 2010a</LINK>). In a review of combined oral contraceptives, the limited evidence indicated no adverse health outcomes in infants (<LINK REF="REF-Kapp-2010b" TYPE="REFERENCE">Kapp 2010b</LINK>).</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2015-03-02 21:40:14 +0100" MODIFIED_BY="[Empty name]">
<P>The quality of reporting varied over time. The earlier publications often provided little detail on methodology and provided insufficient data on results. Standards for publishing trials were developed in the late 1990s, and the CONSORT statement was widely adopted in 2010 (<LINK REF="REF-Schulz-2010" TYPE="REFERENCE">Schulz 2010</LINK>). We summarized the quality of evidence from the individual trials (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). Overall, the quality was considered moderate. The lower-quality evidence, often due to limited reporting, came from three of the four placebo-controlled trials of oral contraceptives.</P>
<P>Half of the trials provided inadequate information on randomization and allocation concealment. Two trials had high losses to follow-up (<LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK>; <LINK REF="STD-Espey-2012" TYPE="STUDY">Espey 2012</LINK>). Loss to follow-up greater than 20% threatens trial validity (<LINK REF="REF-Strauss-2005" TYPE="REFERENCE">Strauss 2005</LINK>). Two trials with moderate-quality evidence provided insufficient or inconsistent data (<LINK REF="STD-Miller-1970" TYPE="STUDY">Miller 1970</LINK>; <LINK REF="STD-Heikkil_x00e4_-1982" TYPE="STUDY">Heikkilä 1982</LINK>). One trial was terminated early because expulsion rates met a priori stopping rules (<LINK REF="STD-Stuart-2014" TYPE="STUDY">Stuart 2014</LINK>). The resulting sample size was much smaller than was planned, so the trial was underpowered to detect differences between groups in breastfeeding outcomes.</P>
</QUALITY_OF_EVIDENCE>
<AGREEMENT MODIFIED="2015-03-05 15:39:26 +0100" MODIFIED_BY="[Empty name]">
<P>Two systematic reviews of hormonal contraceptives and lactation included studies of various designs (<LINK REF="REF-Kapp-2010a" TYPE="REFERENCE">Kapp 2010a</LINK>; <LINK REF="REF-Kapp-2010b" TYPE="REFERENCE">Kapp 2010b</LINK>). Progestin-only methods did not appear to negatively affect lactation (<LINK REF="REF-Kapp-2010a" TYPE="REFERENCE">Kapp 2010a</LINK>). The evidence was limited and inconsistent for COCs and breastfeeding (<LINK REF="REF-Kapp-2010b" TYPE="REFERENCE">Kapp 2010b</LINK>). For infant growth and health, the evidence for progestin-only methods was consistent though limited but did not appear to show an adverse effect. The evidence for COCs was considered inadequate at the time for assessing the effect on infant health. Another systematic review found limited evidence regarding medroxyprogesterone use and breastfeeding at less than six weeks postpartum (<LINK REF="REF-Brownell-2012" TYPE="REFERENCE">Brownell 2012</LINK>). Only three studies of limited quality were eligible and none adjusted for potential confounding. A non-randomized study of hormonal contraceptives and lactation examined a COC, the LNG-IUS, the etonogestrel implant, and a nonhormonal IUD (CuT 380A) initiated at 42 days postpartum (<LINK REF="REF-Bahamondes-2013" TYPE="REFERENCE">Bahamondes 2013</LINK>). Participants had previously breastfed and were willing to breastfeed exclusively and on demand for the study duration. The investigators reported no significant differences between the study groups from 42 days to 63 days postpartum in infant milk intake, infant weight or height, or breastfeeding (also assessed at six months).</P>
<P>We did not review the evidence for venous thromboembolism (VTE) risk, which was a factor in developing medical eligibility criteria for hormonal contraceptive use by postpartum women (<LINK REF="REF-WHO-2009" TYPE="REFERENCE">WHO 2009</LINK>; <LINK REF="REF-CDC-2011" TYPE="REFERENCE">CDC 2011</LINK>). Physiological risk of VTE is high in the postpartum period, especially for the first three weeks, and declines by six weeks' postpartum (<LINK REF="REF-WHO-2010" TYPE="REFERENCE">WHO 2010</LINK>). However, direct evidence is lacking for risk of VTE with combined hormonal contraception.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2015-03-02 21:40:19 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2015-03-02 17:52:01 +0100" MODIFIED_BY="[Empty name]">
<P>We found limited information on any particular hormonal method and lactation. The six trials of higher quality examined the levonorgestrel-releasing IUS, the etonogestrel-releasing implant, and two COCs versus progestin-only pills. Of those six trials, an older one showed a negative effect of the COC on breast milk volume. A later study within those six indicated greater infant weight gain with the implant versus no contraceptive but less gain compared with the injectable DMPA. Volume of supplementation was not assessed.</P>
<P>As noted earlier, because of concerns about the effect on lactation, combined hormonal contraceptives are considered category 4 for breastfeeding women up to six weeks postpartum, and category 3 for six weeks to six months (<LINK REF="REF-WHO-2009" TYPE="REFERENCE">WHO 2009</LINK>; <LINK REF="REF-CDC-2011" TYPE="REFERENCE">CDC 2011</LINK>). Category 3 means that the risks outweigh the advantages. Progestin-only methods are considered category 3 for less than six weeks' postpartum in global guidelines (<LINK REF="REF-WHO-2009" TYPE="REFERENCE">WHO 2009</LINK>), and category 2 for the first month postpartum in the USA (<LINK REF="REF-CDC-2010" TYPE="REFERENCE">CDC 2010</LINK>). The latter means that the advantages generally outweigh the risks.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2015-03-02 21:40:19 +0100" MODIFIED_BY="[Empty name]">
<P>The body of evidence regarding the effects of hormonal contraceptives on lactation has grown considerably. Six RCTs were published after a 20-year gap. The 11 trials in this review examined a range of contraceptive methods; consequently, evidence was limited for any specific method. Most early studies focused on oral contraceptives, often compared with placebo. Most of the later trials examined the levonorgestrel-releasing intrauterine system or the etonogestrel-releasing implant, with several comparing insertion times. The overall quality of evidence was moderate. Five of the six newer trials provided moderate-quality data, as did one older multisite trial.</P>
<P>Further research on progestin-only methods and lactation would be beneficial, especially because some are long-acting methods. The field could benefit from additional research into the effects of initiation time on lactation and infant health. To more accurately assess those outcomes, future research should assess the mother's breastfeeding intention, duration of full and any breastfeeding, and amount of supplemental feeding.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2014-07-14 20:24:13 +0200" MODIFIED_BY="[Empty name]">
<P>Carol Manion of FHI 360 assisted with the original literature searches.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2015-02-25 23:11:51 +0100" MODIFIED_BY="[Empty name]">
<P>Lopez LM, Grey TW, Stuebe AM, Chen M, Truitt ST, Gallo MF: none.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2015-03-04 18:26:31 +0100" MODIFIED_BY="[Empty name]">
<P>
<U>2014 revision</U>
<BR/>LM Lopez conducted the searches and primary data extraction, incorporated the six trials, and revised the review. TW Grey conducted the secondary data extraction for study characteristics and outcomes. M Chen contributed to the methodology and to statistical interpretation, and examined the quality assessment data. AM Stuebe contributed research expertise in lactation to the background and discussion sections. ST Truitt contributed clinical expertise in lactation to the interpretation of results. MF Gallo commented on the overall presentation and interpretation of results.</P>
<P>
<U>2005, 2008, and 2010 updates</U>
<BR/>LM Lopez wrote the plain language summary, reviewed the search results, and edited the text for Cochrane style.</P>
<P>
<U>2003 initial review</U>
<BR/>Sarah T Truitt conceived and designed the review, performed initial database searches and retrieval of papers, wrote the protocol, and wrote to study authors for additional information.<BR/>Anna B Fraser (formerly of St John's Clinic, Springfield, Montana) screened search results and retrieved papers, edited the protocol, and wrote the review.<BR/>Maria F Gallo designed the database searches, screened search results and retrieved papers, and edited the protocol and the review.<BR/>David A Grimes (formerly of FHI 360) supervised the review, provided advice, edited the review, screened retrieved papers, and wrote to study authors for additional information.<BR/>Kenneth F Schulz (from FHI 360) provided advice, interpreted data, and contributed statistical expertise.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2015-03-05 15:15:09 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2015-03-05 15:15:09 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2015-02-25 21:51:07 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="MIX" ID="STD-Brito-2009" MODIFIED="2015-02-25 21:48:55 +0100" MODIFIED_BY="[Empty name]" NAME="Brito 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-02-25 21:48:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brito MB, Ferriani RA, Meijers JC, Garcia AA, Quintana SM, Silva de Sa MF, et al</AU>
<TI>Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: a randomized controlled trial</TI>
<SO>Thrombosis Research</SO>
<YR>2012</YR>
<VL>130</VL>
<NO>3</NO>
<PG>355-60</PG>
<IDENTIFIERS MODIFIED="2014-07-22 19:13:35 +0200" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE MODIFIED="2014-07-22 19:14:12 +0200" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Brito, Milena Bastos&lt;br&gt;Ferriani, Rui Alberto&lt;br&gt;Quintana, Silvana Maria&lt;br&gt;Yazlle, Marta Edna Holanda Diogenes&lt;br&gt;Silva de Sa, Marcos Felipe&lt;br&gt;Vieira, Carolina Sales&lt;br&gt;Randomized Controlled Trial&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;United States&lt;br&gt;Contraception. 2009 Dec;80(6):519-26. doi: 10.1016/j.contraception.2009.05.124. Epub 2009 Jul 10.&lt;/p&gt;" NOTES_MODIFIED="2014-07-22 19:14:12 +0200" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Brito MB, Ferriani RA, Quintana SM, Yazlle ME, Silva de Sa MF, Vieira CS</AU>
<TI>Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study</TI>
<SO>Contraception</SO>
<YR>2009</YR>
<VL>80</VL>
<NO>6</NO>
<PG>519-26</PG>
<IDENTIFIERS MODIFIED="2014-07-22 19:14:12 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-07-22 19:14:12 +0200" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="NCT00828542"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Dutta-2013" MODIFIED="2015-02-25 21:49:18 +0100" MODIFIED_BY="[Empty name]" NAME="Dutta 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-02-25 21:49:18 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Dutta DK, Dutta I</AU>
<TI>Desogestrel mini pill: is this safe in lactating mother?</TI>
<SO>Journal of the Indian Medical Association</SO>
<YR>2013</YR>
<VL>111</VL>
<NO>8</NO>
<PG>553-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Espey-2012" MODIFIED="2014-07-21 16:28:56 +0200" MODIFIED_BY="[Empty name]" NAME="Espey 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-07-09 18:24:54 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Espey E, Ogburn T, Leeman L, Singh R, Ostrom K, Schrader R</AU>
<TI>Effect of progestin compared with combined oral contraceptive pills on lactation: a randomized controlled trial</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2012</YR>
<VL>119</VL>
<NO>1</NO>
<PG>5-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Giner-Velazquez-1976" MODIFIED="2014-07-23 14:37:06 +0200" MODIFIED_BY="[Empty name]" NAME="Giner Velazquez 1976" YEAR="">
<REFERENCE MODIFIED="2014-07-23 14:35:25 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Giner Velázquez J, Córtes Gallegos V, Sotelo López A, Bondani A</AU>
<TI>Effects of the daily administration of 0.350 mg of norethindrone on breastfeeding and milk composition</TI>
<TO>Efecto de la administracion oral diaria de 0.350 mg de noretindrona en la lactancia y en la composicion de la leche</TO>
<SO>Ginecologia y Obstetricia de Mexico</SO>
<YR>1976</YR>
<VL>40</VL>
<NO>237</NO>
<PG>31-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Gurtcheff-2011" MODIFIED="2014-07-23 19:45:00 +0200" MODIFIED_BY="[Empty name]" NAME="Gurtcheff 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-07-10 15:38:45 +0200" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Gurtcheff, Shawn E&lt;br&gt;Turok, David K&lt;br&gt;Stoddard, Greg&lt;br&gt;Murphy, Patricia A&lt;br&gt;Gibson, Mark&lt;br&gt;Jones, Kirtly P&lt;br&gt;C06-RR11234/RR/NCRR NIH HHS/United States&lt;br&gt;UL1-RR025764/RR/NCRR NIH HHS/United States&lt;br&gt;Randomized Controlled Trial&lt;br&gt;Research Support, N.I.H., Extramural&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;United States&lt;br&gt;Obstet Gynecol. 2011 May;117(5):1114-21. doi: 10.1097/AOG.0b013e3182165ee8.&lt;/p&gt;" NOTES_MODIFIED="2014-07-10 15:38:45 +0200" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gurtcheff SE, Turok DK, Stoddard G, Murphy PA, Gibson M, Jones KP</AU>
<TI>Lactogenesis after early postpartum use of the contraceptive implant: a randomized controlled trial</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2011</YR>
<VL>117</VL>
<NO>5</NO>
<PG>1114-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Heikkil_x00e4_-1982" MODIFIED="2014-08-06 16:04:07 +0200" MODIFIED_BY="[Empty name]" NAME="Heikkilä 1982" YEAR="1982">
<REFERENCE MODIFIED="2014-08-06 16:03:56 +0200" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Heikkilä M, Luukkainen T</AU>
<TI>Duration of breast-feeding and development of children after insertion of a levonorgestrel-releasing intrauterine contraceptive device</TI>
<SO>Contraception</SO>
<YR>1982</YR>
<VL>25</VL>
<NO>3</NO>
<PG>279-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-08-06 16:04:07 +0200" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Heikkila, M&lt;br&gt;eng&lt;br&gt;Clinical Trial&lt;br&gt;Randomized Controlled Trial&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;1982/06/01&lt;br&gt;Contraception. 1982 Jun;25(6):561-72.&lt;/p&gt;" NOTES_MODIFIED="2014-08-06 16:04:07 +0200" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Heikkilä M</AU>
<TI>Puerperal insertion of a copper-releasing and a levonorgestrel-releasing intrauterine contraceptive device</TI>
<SO>Contraception</SO>
<YR>1982</YR>
<VL>25</VL>
<NO>6</NO>
<PG>561-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miller-1970" MODIFIED="2014-07-14 20:35:42 +0200" MODIFIED_BY="[Empty name]" NAME="Miller 1970" YEAR="">
<REFERENCE MODIFIED="2014-07-14 20:35:42 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miller GH, Hughes LR</AU>
<TI>Lactation and genital involution effects of a new low-dose oral contraceptive on breast-feeding mothers and their infants</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>1970</YR>
<VL>35</VL>
<NO>1</NO>
<PG>44-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Semm-1966" MODIFIED="2014-07-14 20:31:32 +0200" MODIFIED_BY="[Empty name]" NAME="Semm 1966" YEAR="">
<REFERENCE MODIFIED="2014-07-14 20:31:32 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Semm K, Dittmar FW</AU>
<TI>Post partum ovulation: inhibition and milk yield</TI>
<SO>Current Therapeutic Research</SO>
<YR>1966</YR>
<VL>8</VL>
<NO>2</NO>
<PG>48-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shaamash-2005" MODIFIED="2014-07-09 18:37:00 +0200" MODIFIED_BY="[Empty name]" NAME="Shaamash 2005" YEAR="2005">
<REFERENCE MODIFIED="2014-07-09 18:37:00 +0200" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Shaamash, Ayman H&lt;br&gt;Sayed, Gamal H&lt;br&gt;Hussien, Mostafa M&lt;br&gt;Shaaban, Mamdouh M&lt;br&gt;Comparative Study&lt;br&gt;Randomized Controlled Trial&lt;br&gt;United States&lt;br&gt;Contraception. 2005 Nov;72(5):346-51. Epub 2005 Jul 6.&lt;/p&gt;" NOTES_MODIFIED="2014-07-09 18:37:00 +0200" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shaamash AH, Sayed GH, Hussien MM, Shaaban MM</AU>
<TI>A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development</TI>
<SO>Contraception</SO>
<YR>2005</YR>
<VL>72</VL>
<NO>5</NO>
<PG>346-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Stuart-2014" MODIFIED="2015-02-25 21:51:07 +0100" MODIFIED_BY="[Empty name]" NAME="Stuart 2014" YEAR="2014">
<REFERENCE MODIFIED="2014-09-03 23:08:56 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Stuart G</AU>
<TI>Postpartum levonorgestrel-releasing intrauterine system and breastfeeding (PPIUD1)</TI>
<SO>http://clinicaltrials.gov/show/NCT01555931</SO>
<YR>(accessed 13 August 2014)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-02-25 21:51:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Stuart GS, Lesko C, Stuebe A, Bryant A</AU>
<TI>Breastfeeding and postpartum insertion of the levonorgestrel intrauterine system: a randomized trial</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2014</YR>
<VL>123</VL>
<NO>Suppl 1</NO>
<PG>15S</PG>
<IDENTIFIERS MODIFIED="2015-02-25 21:51:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-WHO-1984" MODIFIED="2015-02-25 21:50:37 +0100" MODIFIED_BY="[Empty name]" NAME="WHO 1984" YEAR="">
<REFERENCE MODIFIED="2015-02-25 21:50:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sas M, Gellen JJ, Dusitsin N, Tankeyoon M, Chalapati S, Crawford MA, et al</AU>
<TI>An investigation on the influence of steroidal contraceptives on milk lipid and fatty acids in Hungary and Thailand. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on Oral Contraceptives</TI>
<SO>Contraception</SO>
<YR>1986</YR>
<VL>33</VL>
<NO>2</NO>
<PG>159-78</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-02-25 21:50:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Tankeyoon M, Dusitain N, Chalapati S, Koetsawang S, Saibiang S, Sas M, et al</AU>
<TI>Effects of hormonal contraceptives on milk volume and infant growth. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on Oral Contraceptives</TI>
<SO>Contraception</SO>
<YR>1984</YR>
<VL>30</VL>
<NO>6</NO>
<PG>505-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-07-14 20:33:49 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>World Health Organization (WHO) Task Force on Oral Contraceptives</AU>
<TI>Effects of hormonal contraceptives on breast milk composition and infant growth</TI>
<SO>Studies in Family Planning</SO>
<YR>1988</YR>
<VL>19</VL>
<NO>6</NO>
<PG>361-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2015-03-05 15:15:09 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Abdel_x002d_Aleem-1996" NAME="Abdel-Aleem 1996" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abdel-Aleem H, Abol-Oyoun EM, Shaaban MM, el-Saeed M, Shoukry M, Makhlouf A, et al</AU>
<TI>The use of nomegestrol acetate subdermal contraceptive implant, Uniplant, during lactation</TI>
<SO>Contraception</SO>
<YR>1996</YR>
<VL>54</VL>
<PG>281-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barsivala-1973" NAME="Barsivala 1973" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barsivala VM, Virkar KD</AU>
<TI>The effect of oral contraceptives on concentrations of various components of human milk</TI>
<SO>Contraception</SO>
<YR>1973</YR>
<VL>7</VL>
<PG>307-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bassol-2002" NAME="Bassol 2002" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bassol S, Nava-Hernandez MP, Hernandez-Morales C, Trujillo-Macias AM, Lopez-Lozano MR, Recio R</AU>
<TI>Effects of levonorgestrel implant upon TSH and LH levels in male infants during lactation</TI>
<SO>International Journal of Gynaecology and Obstetrics</SO>
<YR>2002</YR>
<VL>76</VL>
<PG>273-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Betrabet-1987" MODIFIED="2015-02-25 21:50:54 +0100" MODIFIED_BY="[Empty name]" NAME="Betrabet 1987" YEAR="">
<REFERENCE MODIFIED="2015-02-25 21:50:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Betrabet SS, Shikary ZK, Toddywalla VS, Toddywalla SP, Patel D, Saxena BN</AU>
<TI>ICMR Task Force Study on Hormonal Contraception: transfer of norethisterone (NET) and levonorgestrel (LNG) from a single tablet into the infant's circulation through the mother's milk</TI>
<SO>Contraception</SO>
<YR>1987</YR>
<VL>35</VL>
<PG>517-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bhatia-1987" MODIFIED="2010-10-29 22:26:15 +0200" MODIFIED_BY="Laureen M Lopez" NAME="Bhatia 1987" YEAR="">
<REFERENCE MODIFIED="2010-10-29 22:26:15 +0200" MODIFIED_BY="Laureen M Lopez" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bhatia S, Becker S, Kim YJ</AU>
<TI>The effect of oral contraceptive acceptance on fertility in the postpartum period</TI>
<SO>International Journal of Gynaecology and Obstetrics</SO>
<YR>1987</YR>
<VL>25</VL>
<NO>Suppl</NO>
<PG>1-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Borglin-1971" NAME="Borglin 1971" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Borglin Nils-B, Sandholm Lars-E</AU>
<TI>Effect of oral contraceptives on lactation</TI>
<SO>Fertility and Sterility</SO>
<YR>1971</YR>
<VL>22</VL>
<PG>39-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2011" MODIFIED="2014-07-10 19:31:27 +0200" MODIFIED_BY="[Empty name]" NAME="Chen 2011" YEAR="2009">
<REFERENCE MODIFIED="2014-07-10 19:31:27 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen BA, Hayes JL, Hohmann HL, Perriera LK, Reeves MF, Creinin MD</AU>
<TI>A randomized trial of postplacental compared to delayed insertion of the levonorgestrel-releasing intrauterine device after vaginal delivery (abstract)</TI>
<SO>Contraception</SO>
<YR>2009</YR>
<VL>80</VL>
<NO>2</NO>
<PG>205</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="NCT00476021"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-07-10 19:31:27 +0200" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Chen, Beatrice A&lt;br&gt;Reeves, Matthew F&lt;br&gt;Creinin, Mitchell D&lt;br&gt;Schwarz, E Bimla&lt;br&gt;1 UL1RR024153/RR/NCRR NIH HHS/United States&lt;br&gt;UL1 RR024153/RR/NCRR NIH HHS/United States&lt;br&gt;UL1 RR024153-01/RR/NCRR NIH HHS/United States&lt;br&gt;Randomized Controlled Trial&lt;br&gt;Research Support, N.I.H., Extramural&lt;br&gt;United States&lt;br&gt;Contraception. 2011 Nov;84(5):499-504. doi: 10.1016/j.contraception.2011.01.022. Epub 2011 Apr 16.&lt;/p&gt;" NOTES_MODIFIED="2014-07-10 19:31:27 +0200" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Chen BA, Reeves MF, Creinin MD, Schwarz EB</AU>
<TI>Postplacental or delayed levonorgestrel intrauterine device insertion and breast-feeding duration</TI>
<SO>Contraception</SO>
<YR>2011</YR>
<VL>84</VL>
<NO>5</NO>
<PG>499-504</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-07-10 19:31:27 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen BA, Reeves MF, Hayes JL, Hohmann HL, Perriera LK, Creinin MD</AU>
<TI>Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2010</YR>
<VL>116</VL>
<NO>5</NO>
<PG>1079-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Croxatto-1982" MODIFIED="2015-02-25 21:51:21 +0100" MODIFIED_BY="[Empty name]" NAME="Croxatto 1982" YEAR="">
<REFERENCE MODIFIED="2015-02-25 21:51:21 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Croxatto HB, Diaz S, Peralta O, Juez G, Casado ME, Salvatierra AM, et al</AU>
<TI>Fertility regulation in nursing women: II. Comparative performance of progesterone implants versus placebo and copper T</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1982</YR>
<VL>144</VL>
<PG>201-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Croxatto-1983" MODIFIED="2015-03-05 15:15:09 +0100" MODIFIED_BY="[Empty name]" NAME="Croxatto 1983" YEAR="">
<REFERENCE MODIFIED="2015-03-05 15:15:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Croxatto HB, Diaz S, Peralta O, Juez G, Herreros C, Casado ME, et al</AU>
<TI>Fertility regulation in nursing women: IV. Long-term influence of a low-dose combined oral contraceptive initiated at day 30 postpartum upon lactation and infant growth</TI>
<SO>Contraception</SO>
<YR>1983</YR>
<VL>27</VL>
<PG>13-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Diaz-1983" MODIFIED="2015-02-25 21:51:58 +0100" MODIFIED_BY="[Empty name]" NAME="Diaz 1983" YEAR="">
<REFERENCE MODIFIED="2015-02-25 21:51:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Diaz S, Peralta O, Juez G, Herreros C, Casado ME, Salvatierra AM, et al</AU>
<TI>Fertility regulation in nursing women: III. Short-term influence of low-dose combined oral contraceptive upon lactation and infant growth</TI>
<SO>Contraception</SO>
<YR>1983</YR>
<VL>27</VL>
<PG>1-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Diaz-1985" MODIFIED="2015-02-25 21:52:07 +0100" MODIFIED_BY="[Empty name]" NAME="Diaz 1985" YEAR="">
<REFERENCE MODIFIED="2015-02-25 21:52:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Diaz S, Herreros C, Juez G, Casado ME, Salvatierra AM, Miranda P, et al</AU>
<TI>Fertility regulation in nursing women: VII. Influence of Norplant levonorgestrel implants upon lactation and infant growth</TI>
<SO>Contraception</SO>
<YR>1985</YR>
<VL>32</VL>
<PG>53-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Diaz-1997" MODIFIED="2015-02-25 21:52:22 +0100" MODIFIED_BY="[Empty name]" NAME="Diaz 1997" YEAR="">
<REFERENCE MODIFIED="2015-02-25 21:52:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Diaz S, Zepeda A, Maturana X, Reyes MV, Miranda P, Casado ME, et al</AU>
<TI>Fertility regulation in nursing women: IX. Contraceptive performance, duration of lactation, infant growth, and bleeding patterns during use of progesterone vaginal rings, progestin-only pills, Norplant implants, and Copper T 380-A intrauterine devices</TI>
<SO>Contraception</SO>
<YR>1997</YR>
<VL>56</VL>
<PG>223-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Drury-1986" NAME="Drury 1986" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Drury PJ, Crawford MA, Ayeni O, Pinol A</AU>
<TI>Fatty acids in human milk and steroidal contraceptives in Hungary and Thailand</TI>
<SO>Progress in Lipid Research</SO>
<YR>1986</YR>
<VL>25</VL>
<PG>229-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gellen-1984" NAME="Gellen 1984" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gellen JJ, Sas M</AU>
<TI>Lactation and contraception: effect of low dose oral contraceptives on infant's growth during lactation</TI>
<SO>Orvosi Hetilap</SO>
<YR>1984</YR>
<VL>125</VL>
<PG>193-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gupta-1974" NAME="Gupta 1974" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gupta AN, Mathur VS, Garg SK</AU>
<TI>Effect of oral contraceptives on quantity and quality of milk secretion in human beings</TI>
<SO>Indian Journal of Medical Research</SO>
<YR>1974</YR>
<VL>62</VL>
<PG>964-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hefnawi-1970" NAME="Hefnawi 1970" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Hefnawi F, Fawzi G, Badrawi MH, Kader MM, Bahgat MH</AU>
<TI>Attempts to select a suitable hormonal contraceptive during lactation</TI>
<SO>The VI World Congress of Ob-Gyn; New York (NY)</SO>
<YR>1970</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kader-1969" MODIFIED="2015-02-25 21:52:33 +0100" MODIFIED_BY="[Empty name]" NAME="Kader 1969" YEAR="">
<REFERENCE MODIFIED="2015-02-25 21:52:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kader MM, Hay AA, El-Safouri S, Aziz MT, El-Din JS, Kamal I, et al</AU>
<TI>Clinical, biochemical, and experimental studies on lactation: III. Biochemical changes induced in human milk by gestagens</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1969</YR>
<VL>105</VL>
<PG>978-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kader-1975" NAME="Kader 1975" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kader M, Aziz MT, Bahgat MR, Talaat K, Osman A, Osman M</AU>
<TI>Effect of two long acting injectable progestogens on lactation in the human</TI>
<SO>Acta Biologica et Medica Germanica</SO>
<YR>1975</YR>
<VL>34</VL>
<PG>1199-204</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kaern-1967" NAME="Kaern 1967" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kaern T</AU>
<TI>Effect of an oral contraceptive immediately post partum on initiation of lactation</TI>
<SO>British Medical Journal</SO>
<YR>1967</YR>
<VL>3</VL>
<PG>644-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kamal-1969a" MODIFIED="2015-02-25 21:52:42 +0100" MODIFIED_BY="[Empty name]" NAME="Kamal 1969a" YEAR="">
<REFERENCE MODIFIED="2015-02-25 21:52:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kamal I, Hefnawi F, Ghoneim M, Talaat M, Younis N, Tagui A, et al</AU>
<TI>Clinical, biochemical, and experimental studies on lactation: II. Clinical effects of gestagens on lactation</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1969</YR>
<VL>105</VL>
<PG>324-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kamal-1969b" MODIFIED="2015-02-25 21:52:53 +0100" MODIFIED_BY="[Empty name]" NAME="Kamal 1969b" YEAR="">
<REFERENCE MODIFIED="2015-02-25 21:52:53 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kamal I, Hefnawi F, Ghoneim M, Talaat M, Younis N, Tagui A, et al</AU>
<TI>Clinical, biochemical, and experimental studies on lactation: I. Lactation pattern in Egyptian women</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1969</YR>
<VL>105</VL>
<PG>314-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kamal-1970" MODIFIED="2015-02-25 21:53:01 +0100" MODIFIED_BY="[Empty name]" NAME="Kamal 1970" YEAR="">
<REFERENCE MODIFIED="2015-02-25 21:53:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kamal I, Hefnawi F, Ghoneim M, Abdallah M, Razek SA</AU>
<TI>Clinical, biochemical, and experimental studies on lactation: V. Clinical effects of steroids on the initiation of lactation</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1970</YR>
<VL>108</VL>
<PG>655-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karim-1971" MODIFIED="2015-02-25 21:53:11 +0100" MODIFIED_BY="[Empty name]" NAME="Karim 1971" YEAR="">
<REFERENCE MODIFIED="2015-02-25 21:53:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karim M, Ammar R, Mahgoub SE, Ganzoury BE, Fikri F, Abdou I</AU>
<TI>Injected progestogen and lactation</TI>
<SO>British Medical Journal</SO>
<YR>1971</YR>
<VL>1</VL>
<PG>200-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Koetsawang-1972a" NAME="Koetsawang 1972a" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Koetsawang S, Bhiraleus P, Chiemprajert T</AU>
<TI>Effects of oral contraceptives on lactation</TI>
<SO>Fertility and Sterility</SO>
<YR>1972</YR>
<VL>23</VL>
<PG>24-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Koetsawang-1972b" NAME="Koetsawang 1972b" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Koetsawang S, Chiemprajert T, Kochananda P</AU>
<TI>The effects of injectable contraceptives on lactation</TI>
<SO>Clinical Proceedings I.P.P.F. Southeast Asia and Oceania Medical and Scientific Congress; Sydney (Australia)</SO>
<YR>1972;1</YR>
<PG>84-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Peralta-1983" MODIFIED="2015-02-25 21:53:19 +0100" MODIFIED_BY="[Empty name]" NAME="Peralta 1983" YEAR="">
<REFERENCE MODIFIED="2015-02-25 21:53:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peralta O, Diaz S, Juez G, Herreros C, Casado ME, Salvatierra AM, et al</AU>
<TI>Fertility regulation in nursing women: V. Long-term influence of a low-dose combined oral contraceptive initiated at day 90 postpartum upon lactation and infant growth</TI>
<SO>Contraception</SO>
<YR>1983</YR>
<VL>27</VL>
<PG>27-38</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rodrigues-da-Cunha-2001" MODIFIED="2014-07-31 17:18:06 +0200" MODIFIED_BY="[Empty name]" NAME="Rodrigues da Cunha 2001" YEAR="2001">
<REFERENCE MODIFIED="2014-07-31 17:18:06 +0200" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Rodrigues da Cunha, A C&lt;br&gt;Dorea, J G&lt;br&gt;Cantuaria, A A&lt;br&gt;Clinical Trial&lt;br&gt;Controlled Clinical Trial&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;United States&lt;br&gt;Contraception. 2001 Jan;63(1):37-9.&lt;/p&gt;" NOTES_MODIFIED="2014-07-31 17:18:06 +0200" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rodrigues da Cunha AC, Dorea JG, Cantuaria AA</AU>
<TI>Intrauterine device and maternal copper metabolism during lactation</TI>
<SO>Contraception</SO>
<YR>2001</YR>
<VL>63</VL>
<NO>1</NO>
<PG>37-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Seth-1977" NAME="Seth 1977" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Seth U, Yadava HS, Agarwal N, Laumas KR, Hingorani V</AU>
<TI>Effect of a subdermal silastic implant containing norethindrone acetate on human lactation</TI>
<SO>Contraception</SO>
<YR>1977</YR>
<VL>16</VL>
<PG>383-98</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shaaban-2013" MODIFIED="2015-03-02 21:55:21 +0100" MODIFIED_BY="[Empty name]" NAME="Shaaban 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-03-02 21:55:21 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shaaban OM, Hassen SG, Nour SA, Kames MA, Yones EM</AU>
<TI>Emergency contraceptive pills as a backup for lactational amenorrhea method (LAM) of contraception: a randomized controlled trial</TI>
<SO>Contraception</SO>
<YR>2013</YR>
<VL>87</VL>
<NO>3</NO>
<PG>363-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sinchai-1995" NAME="Sinchai 1995" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sinchai W, Sethavanich S, Asavpiriyanont S, Sittipiyasakul V, Sirikanchanakul R, Udomkiatsakul P, et al</AU>
<TI>Effects of a progestogen-only pill (Exluton) and an intrauterine device (Multiload Cu250) on breastfeeding</TI>
<SO>Advances in Contraception</SO>
<YR>1995</YR>
<VL>2</VL>
<PG>143-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Toaff-1969" NAME="Toaff 1969" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Toaff R, Ashkenazi H, Schwartz A, Herzberg M</AU>
<TI>Effects of oestrogen and progestagen on the composition of human milk</TI>
<SO>Journal of Reproduction and Fertility</SO>
<YR>1969</YR>
<VL>19</VL>
<PG>475-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Were-1997" MODIFIED="2014-07-14 20:30:24 +0200" MODIFIED_BY="[Empty name]" NAME="Were 1997" YEAR="">
<REFERENCE MODIFIED="2014-07-14 20:30:24 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Were EO, Nyongesa K, Nyongesa P</AU>
<TI>Randomized clinical trial to determine optimum initiation time of norgestrel-progestin only contraception in Eldoret teaching hospital, Kenya</TI>
<SO>East African Medical Journal</SO>
<YR>1997</YR>
<VL>74</VL>
<PG>103-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zanartu-1976" MODIFIED="2014-07-15 20:12:23 +0200" MODIFIED_BY="[Empty name]" NAME="Zanartu 1976" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zanartu J, Aguilera E, Munoz G, Peliowsky H</AU>
<TI>Effect of a long-acting contraceptive progestogen on lactation</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>1976</YR>
<VL>47</VL>
<PG>174-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2014-08-14 20:40:03 +0200" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2015-02-25 21:58:41 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Turok-2014" MODIFIED="2015-02-25 21:58:41 +0100" MODIFIED_BY="[Empty name]" NAME="Turok 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-02-25 21:58:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Turok D</AU>
<TI>BLIS - Breastfeeding Levonorgestrel IUD Study</TI>
<SO>http://clinicaltrials.gov/show/NCT01990703</SO>
<YR>(accessed 13 August 2014)</YR>
<IDENTIFIERS MODIFIED="2015-02-25 21:58:41 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2015-02-25 22:10:54 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2015-02-25 22:10:54 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-AAP-2012" MODIFIED="2015-02-25 21:54:01 +0100" MODIFIED_BY="[Empty name]" NAME="AAP 2012" TYPE="JOURNAL_ARTICLE">
<AU>American Academy of Pediatrics. Section on Breastfeeding</AU>
<TI>Policy Statement. Breastfeeding and the use of human milk</TI>
<SO>Pediatrics</SO>
<YR>2012</YR>
<VL>129</VL>
<NO>3</NO>
<PG>e827-41</PG>
<IDENTIFIERS MODIFIED="2014-08-26 17:55:34 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-08-26 17:55:34 +0200" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1542/peds.2011-3552"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bahamondes-2013" MODIFIED="2014-07-23 15:59:39 +0200" MODIFIED_BY="[Empty name]" NAME="Bahamondes 2013" TYPE="OTHER">
<AU>Bahamondes L, Bahamondes MV, Modesto W, Tilley IB, Magalhães A, Silva JLPe, et al</AU>
<TI>Effect of hormonal contraceptives during breastfeeding on infant's milk ingestion and growth</TI>
<SO>Fertility and Sterility</SO>
<YR>2013</YR>
<VL>100</VL>
<NO>2</NO>
<PG>445-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Balshem-2011" MODIFIED="2014-07-15 16:50:52 +0200" MODIFIED_BY="[Empty name]" NAME="Balshem 2011" TYPE="JOURNAL_ARTICLE">
<AU>Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al</AU>
<TI>GRADE guidelines: 3. Rating the quality of evidence</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2011</YR>
<VL>64</VL>
<NO>4</NO>
<PG>401-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bohler-1996" MODIFIED="2014-09-29 20:11:35 +0200" MODIFIED_BY="[Empty name]" NAME="Bohler 1996" TYPE="JOURNAL_ARTICLE">
<AU>Bohler E, Bergstrom S</AU>
<TI>Child growth during weaning depends on whether mother is pregnant again</TI>
<SO>Journal of Tropical Pediatrics</SO>
<YR>1996</YR>
<VL>42</VL>
<NO>2</NO>
<PG>104-9</PG>
<IDENTIFIERS MODIFIED="2014-09-29 20:11:35 +0200" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Brownell-2012" MODIFIED="2014-07-23 15:59:43 +0200" MODIFIED_BY="[Empty name]" NAME="Brownell 2012" TYPE="JOURNAL_ARTICLE">
<AU>Brownell EA, Fernandez ID, Howard CR, Fisher SG, Ternullo SR, Buckley RJ, et al</AU>
<TI>A systematic review of early postpartum medroxyprogesterone receipt and early breastfeeding cessation: evaluating the methodological rigor of the evidence</TI>
<SO>Breastfeeding Medicine</SO>
<YR>2012</YR>
<VL>7</VL>
<NO>1</NO>
<PG>10-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-CDC-2010" MODIFIED="2014-08-21 20:49:15 +0200" MODIFIED_BY="[Empty name]" NAME="CDC 2010" TYPE="JOURNAL_ARTICLE">
<AU>Centers for Disease Control and Prevention</AU>
<TI>U.S. Medical Eligibility Criteria for Contraceptive Use, 2010. Appendix A. Summary of Changes to the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th Edition, to Create the U.S. Medical Eligibility Criteria for Contraceptive Use, 2010</TI>
<SO>Morbidity and Mortality Weekly Report (MMWR)</SO>
<YR>2010</YR>
<VL>59</VL>
<NO>RR04</NO>
<PG>7-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-CDC-2011" MODIFIED="2014-08-20 19:49:59 +0200" MODIFIED_BY="[Empty name]" NAME="CDC 2011" TYPE="JOURNAL_ARTICLE">
<AU>Centers for Disease Control and Prevention</AU>
<TI>Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of contraceptive methods during the postpartum period</TI>
<SO>Morbidity and Mortality Weekly Report (MMWR)</SO>
<YR>2011</YR>
<VL>60</VL>
<NO>26</NO>
<PG>878-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Conde_x002d_Agudelo-2000" NAME="Conde-Agudelo 2000" TYPE="JOURNAL_ARTICLE">
<AU>Conde-Agudelo A, Belizan JM</AU>
<TI>Maternal morbidity and mortality associated with interpregnancy interval: cross sectional study</TI>
<SO>British Medical Journal</SO>
<YR>2000</YR>
<VL>321</VL>
<PG>1255-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Erwin-1994" NAME="Erwin 1994" TYPE="JOURNAL_ARTICLE">
<AU>Erwin PC</AU>
<TI>To use or not use combined hormonal oral contraceptives during lactation</TI>
<SO>Family Planning Perspectives</SO>
<YR>1994</YR>
<VL>26</VL>
<PG>26-30,33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2011" MODIFIED="2014-07-15 16:50:46 +0200" MODIFIED_BY="[Empty name]" NAME="Guyatt 2011" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al</AU>
<TI>GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2011</YR>
<VL>64</VL>
<NO>4</NO>
<PG>383-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hall-2012" MODIFIED="2014-08-19 16:55:46 +0200" MODIFIED_BY="[Empty name]" NAME="Hall 2012" NOTES="&lt;p&gt;Hall, Kelli Stidham&lt;br&gt;Trussell, James&lt;br&gt;Schwarz, Eleanor Bimla&lt;br&gt;R24 HD047879/HD/NICHD NIH HHS/United States&lt;br&gt;R24HD047879/HD/NICHD NIH HHS/United States&lt;br&gt;Research Support, N.I.H., Extramural&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;United States&lt;br&gt;Contraception. 2012 Dec;86(6):653-8. doi: 10.1016/j.contraception.2012.05.003. Epub 2012 Jun 6.&lt;/p&gt;" NOTES_MODIFIED="2014-08-19 16:55:46 +0200" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Hall KS, Trussell J, Schwarz EB</AU>
<TI>Progestin-only contraceptive pill use among women in the United States</TI>
<SO>Contraception</SO>
<YR>2012</YR>
<VL>86</VL>
<NO>6</NO>
<PG>653-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2015-02-25 21:59:02 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ip-2007" MODIFIED="2014-08-27 18:50:24 +0200" MODIFIED_BY="[Empty name]" NAME="Ip 2007" TYPE="JOURNAL_ARTICLE">
<AU>Ip S, Chung M, Raman G, Chew P, Magula N, DeVine D, et al</AU>
<TI>Breastfeeding and maternal and infant health outcomes in developed countries</TI>
<SO>Evidence Report/Technology Assessment</SO>
<YR>2007</YR>
<VL>Apr</VL>
<NO>153</NO>
<PG>1-186</PG>
<IDENTIFIERS MODIFIED="2014-08-26 18:12:15 +0200" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-K4-Health-2014" MODIFIED="2014-09-10 15:30:00 +0200" MODIFIED_BY="[Empty name]" NAME="K4 Health 2014" TYPE="OTHER">
<AU>K4 Health</AU>
<TI>Lactational Amenorrhea Method Toolkit</TI>
<SO>https://www.k4health.org/toolkits/lam</SO>
<YR>(accessed 20 August 2014)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kapp-2010a" MODIFIED="2014-08-12 20:37:39 +0200" MODIFIED_BY="[Empty name]" NAME="Kapp 2010a" TYPE="JOURNAL_ARTICLE">
<AU>Kapp N, Curtis K, Nanda K</AU>
<TI>Progestogen-only contraceptive use among breastfeeding women: a systematic review</TI>
<SO>Contraception</SO>
<YR>2010</YR>
<VL>82</VL>
<NO>1</NO>
<PG>17-37</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kapp-2010b" MODIFIED="2014-08-12 20:37:47 +0200" MODIFIED_BY="[Empty name]" NAME="Kapp 2010b" TYPE="JOURNAL_ARTICLE">
<AU>Kapp N, Curtis KM</AU>
<TI>Combined oral contraceptive use among breastfeeding women: a systematic review</TI>
<SO>Contraception</SO>
<YR>2010</YR>
<VL>82</VL>
<NO>1</NO>
<PG>10-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kennedy-2011" MODIFIED="2014-07-15 16:42:36 +0200" MODIFIED_BY="[Empty name]" NAME="Kennedy 2011" TYPE="BOOK_SECTION">
<AU>Kennedy KI, Trussell J</AU>
<TI>Postpartum contraception and lactation</TI>
<SO>Contraceptive Technology</SO>
<YR>2011</YR>
<PG>483-511</PG>
<EN>20th revised</EN>
<ED>Hatcher RA, Trussell J, Nelson AL, Cates W, Kowal D, Policar MS, et al</ED>
<PB>Ardent Media, Inc.</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Knijff-2000" NAME="Knijff 2000" NOTES="&lt;p&gt;LC Control Number: 99027096&lt;/p&gt;" TYPE="BOOK">
<AU>Knijff SCM, Goorissen EM, Velthuis-te Wierik EJM, Korver T, Grimes DA</AU>
<SO>Summary of Contraindications to Oral Contraceptives</SO>
<YR>2000</YR>
<PB>Parthenon Publishing Group, Inc.</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kramer-2012" MODIFIED="2014-10-01 19:40:47 +0200" MODIFIED_BY="[Empty name]" NAME="Kramer 2012" TYPE="COCHRANE_REVIEW">
<AU>Kramer MS, Kakuma R</AU>
<TI>Optimal duration of exclusive breastfeeding</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>8</NO>
<PG>CD003517</PG>
<IDENTIFIERS MODIFIED="2014-10-01 19:40:47 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-10-01 19:40:47 +0200" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003517.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pang-2007" MODIFIED="2014-09-29 20:02:38 +0200" MODIFIED_BY="[Empty name]" NAME="Pang 2007" TYPE="JOURNAL_ARTICLE">
<AU>Pang WW, Hartmann PE</AU>
<TI>Initiation of human lactation: secretory differentiation and secretory activation</TI>
<SO>Journal of Mammary Gland Biology and Neoplasia</SO>
<YR>2007</YR>
<VL>12</VL>
<NO>4</NO>
<PG>211-21</PG>
<IDENTIFIERS MODIFIED="2014-09-29 20:02:23 +0200" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-RamaRao-2013" MODIFIED="2014-08-19 16:55:16 +0200" MODIFIED_BY="[Empty name]" NAME="RamaRao 2013" NOTES="&lt;p&gt;RamaRao, Saumya&lt;br&gt;Clark, Heather&lt;br&gt;Merkatz, Ruth&lt;br&gt;Sussman, Heather&lt;br&gt;Sitruk-Ware, Regine&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;United States&lt;br&gt;Contraception. 2013 Nov;88(5):591-8. doi: 10.1016/j.contraception.2013.05.004. Epub 2013 May 16.&lt;/p&gt;" NOTES_MODIFIED="2014-08-19 16:55:16 +0200" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>RamaRao S, Clark H, Merkatz R, Sussman H, Sitruk-Ware R</AU>
<TI>Progesterone vaginal ring: introducing a contraceptive to meet the needs of breastfeeding women</TI>
<SO>Contraception</SO>
<YR>2013</YR>
<VL>88</VL>
<NO>5</NO>
<PG>591-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Raymond-2011" MODIFIED="2014-08-26 16:03:52 +0200" MODIFIED_BY="[Empty name]" NAME="Raymond 2011" TYPE="BOOK_SECTION">
<AU>Raymond EG</AU>
<TI>Progestin-only pills</TI>
<SO>Contraceptive Technology</SO>
<YR>2011</YR>
<PG>237-47</PG>
<EN>20th revised</EN>
<ED>Hatcher RA, Trussell J, Nelson AL, Cates W, Kowal D, Policar MS, et al</ED>
<PB>Ardent Media, Inc.</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2014-09-03 22:48:03 +0200" MODIFIED_BY="[Empty name]" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schulz-2010" MODIFIED="2014-07-28 22:01:50 +0200" MODIFIED_BY="[Empty name]" NAME="Schulz 2010" TYPE="OTHER">
<AU>Schulz KF, Altman DG, Moher D, for the CONSORT Group</AU>
<TI>CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials</TI>
<SO>BMJ</SO>
<YR>2010</YR>
<VL>340</VL>
<PG>c332</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Speroff-2004" MODIFIED="2015-02-25 22:05:13 +0100" MODIFIED_BY="[Empty name]" NAME="Speroff 2004" NOTES="&lt;p&gt;LC Control Number: 94006960&lt;/p&gt;" NOTES_MODIFIED="2015-02-25 22:05:13 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="BOOK">
<AU>Speroff L, Fritz MA</AU>
<SO>Clinical Gynecologic Endocrinology and Infertility</SO>
<YR>2004</YR>
<EN>7th</EN>
<PB>Lippincott Williams and Wilkins</PB>
<CY>Baltimore</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Strauss-2005" MODIFIED="2014-07-23 19:03:46 +0200" MODIFIED_BY="[Empty name]" NAME="Strauss 2005" TYPE="BOOK">
<AU>Strauss SE, Richardson WS, Glasziou P, Haynes RB</AU>
<SO>Evidence-based Medicine: How to Practice and Teach EBM</SO>
<YR>2005</YR>
<EN>Third</EN>
<PB>Churchill Livingstone</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tsui-1997" MODIFIED="2015-02-25 22:10:54 +0100" MODIFIED_BY="[Empty name]" NAME="Tsui 1997" NOTES="&lt;p&gt;LC Control Number: 97004867&lt;/p&gt;" NOTES_MODIFIED="2015-02-25 22:10:54 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="BOOK">
<AU>Tsui AO, Wasserheit JN, Haaga J, National Research Council (U.S.) Panel on Reproductive Health</AU>
<SO>Reproductive Health in Developing Countries: Expanding Dimensions, Building Solutions</SO>
<YR>1997</YR>
<PB>National Academy Press</PB>
<CY>Washington</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-USAID-2009" MODIFIED="2014-09-03 23:07:17 +0200" MODIFIED_BY="[Empty name]" NAME="USAID 2009" TYPE="OTHER">
<AU>USAID and ACCESS-FP</AU>
<TI>The Lactational Amenorrhea Method METHOD (LAM): A Postpartum Contraceptive Choice for Women Who Breastfeed; 2009</TI>
<SO>https://www.k4health.org/toolkits/lam/essential-knowledge</SO>
<YR>(accessed 20 August 2014)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Van-der-Wijden-2003" MODIFIED="2014-11-17 21:25:35 +0100" MODIFIED_BY="[Empty name]" NAME="Van der Wijden 2003" TYPE="COCHRANE_REVIEW">
<AU>Van der Wijden C, Brown J, Kleijnen J</AU>
<TI>Lactational amenorrhea for family planning</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2014-11-17 21:24:29 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-17 21:24:29 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001329"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Westhoff-2012" MODIFIED="2015-02-25 22:10:26 +0100" MODIFIED_BY="[Empty name]" NAME="Westhoff 2012" TYPE="OTHER">
<AU>Westhoff CF</AU>
<TI>Unmet Need for Modern Contraceptive Methods. DHS Analytical Studies No. 28</TI>
<SO>Princeton, NJ: Office of Population Research, Princeton University, 2012 September</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-1986" MODIFIED="2015-01-14 15:49:41 +0100" MODIFIED_BY="[Empty name]" NAME="WHO 1986" TYPE="OTHER">
<AU>World Health Organization</AU>
<TI>Protocols for the development and field testing of techniques for monitoring physical growth and psychosocial development</TI>
<SO>World Health Organization Division of Family Health and Division of Mental Health; 1986. WHO document: WHO/MCH/MNH</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-1994" MODIFIED="2015-01-14 15:37:19 +0100" MODIFIED_BY="[Empty name]" NAME="WHO 1994" TYPE="JOURNAL_ARTICLE">
<AU>World Health Organization</AU>
<TI>Progestogen-only contraceptives during lactation: II. Infant development. World Health Organization, Task Force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development, and Research Training in Human Reproduction</TI>
<SO>Contraception</SO>
<YR>1994</YR>
<VL>50</VL>
<NO>1</NO>
<PG>55-68</PG>
<IDENTIFIERS MODIFIED="2015-01-14 15:37:19 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2005" MODIFIED="2014-09-03 23:07:39 +0200" MODIFIED_BY="[Empty name]" NAME="WHO 2005" TYPE="OTHER">
<AU>World Health Organization</AU>
<TI>Report of a WHO Technical Consultation on Birth Spacing; 2005 Jun 13-15; Geneva</TI>
<SO>http://www.who.int/maternal_child_adolescent/documents/birth_spacing.pdf</SO>
<YR>(accessed 26 August 2014)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2009" MODIFIED="2014-09-03 23:09:32 +0200" MODIFIED_BY="[Empty name]" NAME="WHO 2009" TYPE="OTHER">
<AU>World Health Organization</AU>
<TI>Medical Eligibility Criteria for Contraceptive Use. Fourth Edition, 2009</TI>
<SO>http://www.who.int/reproductivehealth/publications/family_planning/9789241563888/en/</SO>
<YR>(accessed 23 July 2014)</YR>
<PG>16</PG>
<PB>World Health Organization</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2010" MODIFIED="2014-09-03 23:07:51 +0200" MODIFIED_BY="[Empty name]" NAME="WHO 2010" TYPE="OTHER">
<AU>World Health Organization</AU>
<TI>Combined hormonal contraceptive use during the postpartum period: 2010</TI>
<SO>http://www.who.int/reproductivehealth/publications/family_planning/rhr_10_15/en/</SO>
<YR>(accessed 21 August 2014)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2013" MODIFIED="2014-09-10 17:33:55 +0200" MODIFIED_BY="[Empty name]" NAME="WHO 2013" TYPE="OTHER">
<AU>World Health Organization</AU>
<TI>Statement for Collective Action for Postpartum Family Planning</TI>
<SO>http://www.who.int/reproductivehealth/publications/family_planning/statmt_ppfp/en/</SO>
<YR>(accessed 10 September 2014)</YR>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES>
<REFERENCE ID="REF-Truitt-2003" NAME="Truitt 2003" TYPE="JOURNAL_ARTICLE">
<AU>Truitt S, Fraser A, Grimes D, Gallo M, Schulz K</AU>
<TI>Hormonal contraception during lactation</TI>
<SO>Contraception</SO>
<YR>2003</YR>
<VL>68</VL>
<PG>233-8</PG>
<IDENTIFIERS/>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2014-07-23 16:00:02 +0200" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2015-03-05 15:36:23 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2015-03-05 15:36:23 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2015-03-04 19:23:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Brito-2009">
<CHAR_METHODS MODIFIED="2015-03-04 19:23:08 +0100" MODIFIED_BY="[Empty name]">
<P>Time frame and location: recruitment from September 2007 to July 2008; São Paulo, Brazil</P>
<P>Described as a pilot study. Further details on methods were provided in later publication (Brito 2012)</P>
<P>Sample size calculation and outcomes of focus: women's body weight and resistance to activated protein C (not outcomes for this review); difference of 1 SD in first 6 weeks; 20 per group due to potential loss during study; power not reported</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-03-04 18:51:28 +0100" MODIFIED_BY="[Empty name]">
<P>General with N and source: 40 women in prenatal care program</P>
<P>Inclusion criteria: 18 and 35 years old, exclusively breastfeeding and desires long-acting contraception after delivery</P>
<P>Exclusion criteria: smoker, alcoholic, or user of recreational drugs; body mass index (BMI) (kg/m<SUP>2</SUP>) &#8805; 30 or systemic disease (diabetes mellitus, cardiovascular disease, liver disease, thyroid disease, autoimmune disease); history (personal or family) of thromboembolic events; alterations in hepatic enzymes or allergy to local anesthetics (xylocaine)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-02-25 22:32:12 +0100" MODIFIED_BY="[Empty name]">
<P>Treatment: etonogestrel-releasing implant, early insertion (24 to 48 hours after delivery)</P>
<P>Comparison: no contraceptive for 6 weeks after delivery, then depot medroxyprogesterone acetate at week 6 postpartum</P>
<P>Timing: as noted above</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-02-25 22:32:12 +0100" MODIFIED_BY="[Empty name]">
<P>Measures: infant weight gain; maintenance of exclusive lactation to week 12 postpartum</P>
<P>Assessments: 6 and 12 weeks</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-02-25 23:24:31 +0100" MODIFIED_BY="[Empty name]">
<P>---</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-03-04 19:06:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dutta-2013">
<CHAR_METHODS MODIFIED="2015-03-04 19:06:26 +0100" MODIFIED_BY="[Empty name]">
<P>Time frame and location: conducted from January 2010 through June 2011 in Kalyani, Nadia, West Bengal (India)</P>
<P>Limited details about methods; published as a preliminary report</P>
<P>Sample size calculation and outcome of focus: no mention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-03-02 22:08:57 +0100" MODIFIED_BY="[Empty name]">
<P>General with N and source: 400 lactating women from clinic</P>
<P>Inclusion criteria: normal lipid profile, blood sugar levels, and thyroid stimulating hormone</P>
<P>Exclusion criteria: family history or past history of thromboembolism</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-02-25 23:24:45 +0100" MODIFIED_BY="[Empty name]">
<P>Treatment: oral contraceptive (OC) containing desogestrel 75 &#956;g for 6 months</P>
<P>Comparison: placebo</P>
<P>Timing: starting 6 weeks after delivery</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-02-25 22:40:35 +0100" MODIFIED_BY="[Empty name]">
<P>Measures: milk volume and composition, pregnancy, normal infant growth (see below); time frames and samples sizes for analysis not specified</P>
<P>(Normal infant growth defined as weight doubled by 4 months and tripled by 1 year, height 50 cm at birth increased to 62 cm by 6 months and 75 cm by 1 year, head circumference increased by 2 cm per month until l year.)</P>
<P>Assessments: 8, 12, 16, and 24 weeks; 1 year</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-03-02 21:40:35 +0100" MODIFIED_BY="[Empty name]">
<P>Investigator provided some design information; we were unable to obtain additional data for analysis and interpretation.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-03-05 15:36:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Espey-2012">
<CHAR_METHODS MODIFIED="2015-03-04 19:07:43 +0100" MODIFIED_BY="[Empty name]">
<P>Time frame and location: conducted from January 2005 to June 2008 in Albuquerque, New Mexico (USA)</P>
<P>Sample size calculation and outcome of focus: breastfeeding continuation at 8 weeks; 120 participants for 80% power to detect continuation difference of 35% in COC group versus 60% in POP group (hazard ratio = 2). Assumed 50% breastfeeding at 8 weeks. With potential 20% loss to follow-up, 150 needed; increased to 200 because of high loss between enrollment and randomization.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-02-25 22:35:50 +0100" MODIFIED_BY="[Empty name]">
<P>General with N and source: 197 postpartum women in hospital after delivery</P>
<P>Inclusion criteria: age 15 to 45 years; delivered at University of New Mexico Hospital; intended to breastfeed; planned to use oral contraceptives as family planning method</P>
<P>Exclusion criteria: medical contraindication to combined pills, including history of venous thromboembolism, uncontrolled hypertension, or complex migraine headaches; preterm birth (&lt; 37 weeks); newborn small for gestational age (&lt; 2500 g) or large for gestational age (&gt; 4500 g); newborn had major congenital anomaly</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-03-05 15:36:23 +0100" MODIFIED_BY="[Empty name]">
<P>Treatment: combined oral contraceptive (COC) containing norethindrone 1 mg plus ethinyl estradiol (EE) 35 &#956;g for 21 days and placebo for 7 days</P>
<P>Comparison: OC containing norethindrone 350 &#956;g daily</P>
<P>Timing: starting 2 weeks postpartum</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-03-04 17:16:36 +0100" MODIFIED_BY="[Empty name]">
<P>Measures: breastfeeding continuation; infant weight, length, and head circumference (in figures without actual numbers); self-reported pregnancy</P>
<P>Assessments: phone call 3 to 7 weeks postpartum and 4 to 6 months postpartum; hospital visit 2 months postpartum</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-03-02 21:40:42 +0100" MODIFIED_BY="[Empty name]">
<P>Investigator provided means and SD for change in infant weight and length.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-03-04 17:16:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Giner-Velazquez-1976">
<CHAR_METHODS MODIFIED="2015-03-02 21:40:52 +0100" MODIFIED_BY="[Empty name]">
<P>Time frame and location: no time frame; Mexico</P>
<P>Limited details about methods</P>
<P>Sample size calculation and outcome of focus: no mention; small sample size limits power</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-02-25 22:40:53 +0100" MODIFIED_BY="[Empty name]">
<P>General with N and source: 20 women selected immediately after birth</P>
<P>Inclusion criteria: age 18 to 36 years; adequate health and nutrition during pregnancy</P>
<P>Exclusion criteria: not specified</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-03-02 21:40:54 +0100" MODIFIED_BY="[Empty name]">
<P>Treatment: OC containing norethindrone 350 &#956;g</P>
<P>Comparison: placebo</P>
<P>Timing: starting 48 hours postpartum</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-03-04 17:16:37 +0100" MODIFIED_BY="[Empty name]">
<P>Measures: average milk production; biochemical composition of milk; infant weights; results primarily in figures without actual numbers</P>
<P>Assessments: 14 days</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-09-03 22:53:39 +0200" MODIFIED_BY="[Empty name]">
<P>Information from report translation</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-03-04 19:24:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gurtcheff-2011">
<CHAR_METHODS MODIFIED="2015-03-04 19:24:15 +0100" MODIFIED_BY="[Empty name]">
<P>Time frame and location: January to October 2009 in Salt Lake City, Utah (USA)</P>
<P>Described as non-inferiority trial</P>
<P>Sample size calculation and outcomes of focus: </P>
<UL>
<LI>lactation failure: assuming 5% failure in both groups, n = 27 per group for 80% power and 15% non-inferiority margin; </LI>
<LI>hours to lactogenesis II: assuming mean 54 ± 12, n = 34 per group for 80% power, and non-inferiority margin of 8 additional hours</LI>
</UL>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-03-04 19:17:06 +0100" MODIFIED_BY="[Empty name]">
<P>General with N and source: 69 healthy peripartum women</P>
<P>Inclusion criteria: healthy; intended to breastfeed</P>
<P>Exclusion criteria: onset of lactogenesis before randomization; hemorrhage requiring transfusion; severe pregnancy-induced hypertension; prolonged hospitalization; coagulopathy; liver disease; undiagnosed genital bleeding; other contraindication to etonogestrel implant insertion; taking inducers of hepatic enzymes</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-03-02 21:32:08 +0100" MODIFIED_BY="[Empty name]">
<P>Etonogestrel implant with different insertion times</P>
<P>Treatment: early insertion, 1 to 3 days postpartum</P>
<P>Comparison: standard insertion, 4 to 8 weeks postpartum</P>
<P>Timing: See above</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-03-04 19:18:10 +0100" MODIFIED_BY="[Empty name]">
<P>Measures: lactation failure (assessed 3 times daily in hospital and at least daily after discharge; diagnosed by 120 hours); time to lactogenesis stage II (copious milk secretion); breastfeeding, full or any (shown in figure without actual numbers); creamatocrit for fat and energy content of milk sample from 6-week visit</P>
<P>Assessments: 2 and 6 weeks, 3 and 6 months postpartum</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-03-02 21:41:20 +0100" MODIFIED_BY="[Empty name]">
<P>Investigator provided data for breastfeeding continuation (full or any).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-03-04 19:19:45 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Heikkil_x00e4_-1982">
<CHAR_METHODS MODIFIED="2015-03-04 19:18:44 +0100" MODIFIED_BY="[Empty name]">
<P>Time frame and location: no time frame; conducted in Helsinki, Finland</P>
<P>Some methods from secondary article</P>
<P>Sample size calculation and outcome of focus: not specified</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-08-06 15:01:18 +0200" MODIFIED_BY="[Empty name]">
<P>General with N and source: 80 women, delivered at State Maternity Hospital</P>
<P>Inclusion criteria: breastfeeding and amenorrheic</P>
<P>Exclusion criteria: not specified</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-03-04 17:00:30 +0100" MODIFIED_BY="[Empty name]">
<P>Treatment: levonorgestrel-releasing IUD (30 &#956;g)</P>
<P>Comparison: Nova T intrauterine device (IUD) (copper releasing)</P>
<P>Timing: inserted 6 weeks postpartum; range 29 to 56 days in one report, and 32 to 56 days in another</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-03-04 17:16:39 +0100" MODIFIED_BY="[Empty name]">
<P>Measures: breastfeeding duration (no sample sizes for analysis); infant growth measured outside of study and presented in figure without actual numbers</P>
<P>Assessment: unclear source and time frame; 75 days after insertion for analysis of breastfeeding data; secondary report notes recording of bleeding and spotting on cards and clinic visits at 3, 6, 12 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-03-04 19:19:45 +0100" MODIFIED_BY="[Empty name]">
<P>Third group was added later (not randomized); received levonorgestrel-releasing IUD (10 &#956;g)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-03-04 19:21:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Miller-1970">
<CHAR_METHODS MODIFIED="2014-09-03 22:56:13 +0200" MODIFIED_BY="[Empty name]">
<P>Time frame and location: September 1967 to June 1968 in Iowa City, Iowa (USA)</P>
<P>Limited detail about methods</P>
<P>Sample size calculation and outcome of focus: no mention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-03-02 21:42:00 +0100" MODIFIED_BY="[Empty name]">
<P>General with N and source: 50 women delivering healthy term infants at city hospital.</P>
<P>Inclusion criteria: desire to nurse for 3 months and use oral contraceptives while nursing</P>
<P>Exclusion criteria: none specified</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-02-25 22:44:58 +0100" MODIFIED_BY="[Empty name]">
<P>Treatment: COC containing norethindrone 1 mg plus mestranol 80 &#956;g daily for 21 days</P>
<P>Comparison: identically-labeled placebos for 21 days</P>
<P>Timing: postpartum day 14; all received COC starting 6 weeks postpartum</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-03-04 19:21:39 +0100" MODIFIED_BY="[Empty name]">
<P>Measures: lactation duration, milk volume production. Results presented in figures without actual numbers; graphic variations not identified.</P>
<P>Assessments: 3 weeks, 5 weeks, and 3 months postpartum</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-03-04 19:21:46 +0100" MODIFIED_BY="[Empty name]">
<P>---</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-03-04 17:18:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Semm-1966">
<CHAR_METHODS MODIFIED="2014-09-03 22:55:36 +0200" MODIFIED_BY="[Empty name]">
<P>Time frame and location: no time frame; Munich, Germany</P>
<P>Limited detail about methods</P>
<P>Sample size calculation and outcome of focus: no mention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-02-25 22:46:02 +0100" MODIFIED_BY="[Empty name]">
<P>General with N and source: 100 women delivering with a definite desire to lactate</P>
<P>Inclusion criteria: women in "child-bed"; with definite desire to lactate</P>
<P>Exclusion criteria: not specified</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-02-25 22:45:52 +0100" MODIFIED_BY="[Empty name]">
<P>Treatment: COC containing lynestrenol 2.5 mg plus mestranol 75 &#956;g daily</P>
<P>Comparison: identically labeled placebos</P>
<P>Timing: postpartum day 1</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-03-04 17:18:32 +0100" MODIFIED_BY="[Empty name]">
<P>Measures: lactation initiation and milk volume yield; results in figure without actual numbers</P>
<P>Assessments: daily for 10 days; women also weighed babies at home in following 3 weeks, but data not shown</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-02-25 22:45:30 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-03-04 19:22:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shaamash-2005">
<CHAR_METHODS MODIFIED="2015-03-04 19:22:46 +0100" MODIFIED_BY="[Empty name]">
<P>Time frame and location: conducted from June 2001 to June 2003 in Assiut, Egypt</P>
<P>Sample size calculation and outcomes of focus:</P>
<UL>
<LI>Breastfeeding rate: 151 per group for 80% power to detect difference of 15 per 100 women</LI>
<LI>Infant weight: 56 males and 56 females for 90% power to detect 400 gram difference at 12 months, assuming 20% attrition</LI>
</UL>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-03-02 21:43:42 +0100" MODIFIED_BY="[Empty name]">
<P>General with N and source: 320 exclusively breastfeeding women; university hospital clinic</P>
<P>Inclusion criteria: gave birth to healthy term baby with no health problem; had no contraindication to the use of LNG or copper IUD contraceptives; planning to breastfeed for at least 1 year</P>
<P>Exclusion criteria: not specified</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-03-02 21:32:11 +0100" MODIFIED_BY="[Empty name]">
<P>Treatment: levonorgestrel-releasing IUS (20 &#956;g)</P>
<P>Comparison: Copper T 380A IUD</P>
<P>Timing: inserted 6 to 8 weeks postpartum</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-03-02 21:43:45 +0100" MODIFIED_BY="[Empty name]">
<P>Measures: breastfeeding (full, partial); infant growth (weight, length, head circumference, mid-arm circumference, triceps skinfold); pregnancy (presumably self-reported)</P>
<P>No sample sizes for analysis</P>
<P>Assessments: 3, 6, 9, 12 months postpartum</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-07-09 18:37:00 +0200" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-03-02 21:46:35 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stuart-2014">
<CHAR_METHODS MODIFIED="2015-03-02 21:44:18 +0100" MODIFIED_BY="[Empty name]">
<P>Time frame and location: March 2012 to June 2013; Chapel Hill, NC (USA)</P>
<P>RCT, phase 4</P>
<P>Sample size calculation and outcome of focus: no information. Planned to enroll 190; randomized 35. Study stopped early; expulsion rate met a priori stopping rules.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-03-02 21:46:25 +0100" MODIFIED_BY="[Empty name]">
<P>General with N and source: 35 women, 18 to 45 years old; Women's Hospital of North Carolina</P>
<P>
<U>Inclusion criteria (for antepartum enrollment</U>):</P>
<P>Pregnant and &#8805; 24 weeks of estimated gestational age; intent to breastfeed for at least 6 months; plan to use LNG-IUS postpartum; anticipation of vaginal delivery; HIV negative; intention to stay in Chapel Hill area for at least 6 months after birth; no medical or personal conditions that in the judgment of study staff preclude participation; no allergies to any component of LNG-IUS; no known uterine anomalies; fluent in English<BR/>No history of ectopic pregnancy, carcinoma of the breast, acute liver disease or liver tumor (benign or malignant); uterine or cervical neoplasia or unresolved abnormal pap smear; active pelvic inflammatory disease; hypersensitivity to component of LNG-IUS; genital bleeding of unknown etiology; solid organ transplantation</P>
<P>
<U>Additional eligibility criteria for trial entry (assessed postpartum</U>):<BR/>No endometritis or chorioamnionitis; membranes ruptured &lt; 24 hours before delivery; no fever &#8805; 38°C during intrapartum or postpartum period; did not receive medication other than pitocin or misoprostol to control postpartum bleeding; did not have blood loss &gt; 750 mL intrapartum, blood transfusion for postpartum hemorrhage, third or fourth degree laceration at delivery; infant &gt; 35 weeks gestation as determined by physical exam; weight at least 2727 grams; singleton birth; not in intensive care nursery; not diagnosed with condition that precludes long-term feeding<BR/>
</P>
<P>
<U>Exclusion criteria</U>: no other mention</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-19 22:06:43 +0100" MODIFIED_BY="[Empty name]">
<P>Levonorgestrel-releasing IUS (20 &#956;g) with different insertion times</P>
<P>Treatment: inserted within 48 hours of delivery</P>
<P>Comparison: inserted 4 to 8 weeks after delivery</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-01-14 15:17:51 +0100" MODIFIED_BY="[Empty name]">
<P>Measures: any breastfeeding</P>
<P>Assessments: 6 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-03-02 21:46:35 +0100" MODIFIED_BY="[Empty name]">
<P>Information from published conference abstract, ClinicalTrials.gov listing, and communication with investigator</P>
<P>Full report to be submitted for publication by mid-September, according to investigator.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-03-04 19:27:56 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-WHO-1984">
<CHAR_METHODS MODIFIED="2015-03-02 21:31:40 +0100" MODIFIED_BY="[Empty name]">
<P>Time frame and location: no time frame; conducted in Szeged, Hungary; Bangkok, Thailand; Khon Kaen, Thailand</P>
<P>Multicenter trial</P>
<P>Sample size calculation and outcome of focus: no information</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-03-04 19:27:32 +0100" MODIFIED_BY="[Empty name]">
<P>General with N and source: 171 women delivering and chose to use OCs</P>
<P>Inclusion criteria: age 20 to 35 years; 2 to 4 live births; prior successful breastfeeding (3 months); hemoglobin 10 to 12 g/dL; normal gestation and uncomplicated singleton delivery (2700 g to 3700 g); no breast abnormalities; desiring to use hormonal contraception during lactation</P>
<P>Exclusion criteria: none specified</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-02-25 22:52:47 +0100" MODIFIED_BY="[Empty name]">
<P>Treatment: COC containing levonorgestrel 150 &#956;g plus ethinyl estradiol 30 &#956;g</P>
<P>Comparison: OC containing norgestrel 75 &#956;g</P>
<P>Timing: initiated at 6 weeks postpartum (± 3 days)</P>
<P>Study length: 24 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-03-02 21:46:39 +0100" MODIFIED_BY="[Empty name]">
<P>Measures:</P>
<UL>
<LI>1984 report (Tankeyoon): average breast milk volume; change in infant weight (no sample sizes for analysis); study withdrawal due to inadequate milk supply or infant growth (withdrawal by center, not total)</LI>
<LI>1986 report (Sas): milk composition (lipids and fatty acids); by center, not total</LI>
<LI>1988 report (WHO): milk composition (fat, nitrogen, caloric content, lactose, and osmolality) and infant weight; by center, not total</LI>
</UL>
<P>Assessments: 6 (baseline), 9, 12, 16, 20, 24 weeks postpartum</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-03-04 19:27:56 +0100" MODIFIED_BY="[Empty name]">
<P>341 women were recruited; only 171 women were randomized. Others chose depot medroxyprogesterone acetate (DMPA) or nonhormonal methods.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>COC: combined oral contraceptive</P>
<P>IUD: intrauterine device</P>
<P>LNG-IUS: levonorgestrel-releasing intrauterine system</P>
<P>OC: oral contraceptive</P>
<P>POP: progestin-only contraceptive</P>
<P>WHO: World Health Organization</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2015-03-05 14:59:30 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2014-09-03 22:59:48 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Abdel_x002d_Aleem-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-09-03 22:59:48 +0200" MODIFIED_BY="[Empty name]">
<P>Not a randomized controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-03-05 14:57:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barsivala-1973">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-03-05 14:57:42 +0100" MODIFIED_BY="[Empty name]">
<P>Unclear whether participant allocation was random</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-09-03 22:59:53 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bassol-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-09-03 22:59:53 +0200" MODIFIED_BY="[Empty name]">
<P>Outcomes not applicable for this review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-03-02 21:32:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Betrabet-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-03-02 21:32:57 +0100" MODIFIED_BY="[Empty name]">
<P>Per correspondence with the investigator (Betrabet), study participants received personal choice of intervention, not random allocation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-09-03 22:59:58 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bhatia-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-09-03 22:59:58 +0200" MODIFIED_BY="[Empty name]">
<P>Not a randomized controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-09-03 23:00:04 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Borglin-1971">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-09-03 23:00:04 +0200" MODIFIED_BY="[Empty name]">
<P>Study described as a "carefully controlled trial." No evidence of randomization</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-03-02 22:13:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-03-02 22:13:22 +0100" MODIFIED_BY="[Empty name]">
<P>Secondary analysis; trial of immediate versus delayed insertion of levonorgestrel-releasing intrauterine system (LNG-IUS)</P>
<P>Interim contraception varied for delayed-insertion group until LNG-IUS was inserted at 6 to 8 weeks postpartum; included condoms, depot medroxyprogesterone acetate (DMPA), abstinence, and none. Women were not randomized to specific method during those first few weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-03-02 21:46:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Croxatto-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-03-02 21:46:59 +0100" MODIFIED_BY="[Empty name]">
<P>Per correspondence with the investigator, study participants received personal choice of intervention, not random allocation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-03-02 21:47:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Croxatto-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-03-02 21:47:01 +0100" MODIFIED_BY="[Empty name]">
<P>Per correspondence with the investigator, study participants received personal choice of intervention, not random allocation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-03-02 21:47:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Diaz-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-03-02 21:47:03 +0100" MODIFIED_BY="[Empty name]">
<P>Per correspondence with the investigator, study participants received personal choice of intervention, not random allocation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-03-02 21:47:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Diaz-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-03-02 21:47:04 +0100" MODIFIED_BY="[Empty name]">
<P>Per correspondence with the investigator, study participants received personal choice of intervention, not random allocation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-09-03 23:00:17 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Diaz-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-09-03 23:00:17 +0200" MODIFIED_BY="[Empty name]">
<P>Not a randomized controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-09-03 23:00:31 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Drury-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-09-03 23:00:31 +0200" MODIFIED_BY="[Empty name]">
<P>Subgroup analysis of <LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-09-03 23:00:42 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gellen-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-09-03 23:00:42 +0200" MODIFIED_BY="[Empty name]">
<P>Subgroup analysis of <LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-09-03 23:00:47 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gupta-1974">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-09-03 23:00:47 +0200" MODIFIED_BY="[Empty name]">
<P>Not a randomized controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-25 22:56:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hefnawi-1970">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-25 22:56:53 +0100" MODIFIED_BY="[Empty name]">
<P>Unclear whether participant allocation was random</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-25 22:57:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kader-1969">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-25 22:57:11 +0100" MODIFIED_BY="[Empty name]">
<P>Unclear whether participant allocation was random</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-25 23:00:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kader-1975">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-25 23:00:02 +0100" MODIFIED_BY="[Empty name]">
<P>Unclear whether participant allocation was random</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-25 23:00:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kaern-1967">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-25 23:00:06 +0100" MODIFIED_BY="[Empty name]">
<P>Unclear whether participant allocation was random</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-25 23:00:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kamal-1969a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-25 23:00:10 +0100" MODIFIED_BY="[Empty name]">
<P>Unclear whether participant allocation was random</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-03-05 14:59:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kamal-1969b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-03-05 14:59:00 +0100" MODIFIED_BY="[Empty name]">
<P>Unclear whether participant allocation was random</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-03-05 14:59:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kamal-1970">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-03-05 14:59:03 +0100" MODIFIED_BY="[Empty name]">
<P>Unclear whether participant allocation was random</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-09-03 23:01:06 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Karim-1971">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-09-03 23:01:06 +0200" MODIFIED_BY="[Empty name]">
<P>Not a randomized controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-25 22:59:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Koetsawang-1972a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-25 22:59:39 +0100" MODIFIED_BY="[Empty name]">
<P>Unclear whether participant allocation was random</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-25 22:59:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Koetsawang-1972b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-25 22:59:42 +0100" MODIFIED_BY="[Empty name]">
<P>Unclear whether participant allocation was random</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-03-02 21:47:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Peralta-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-03-02 21:47:07 +0100" MODIFIED_BY="[Empty name]">
<P>Per correspondence with the investigator, all trials in the series were not randomized. Participants chose their intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-09-03 23:01:13 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rodrigues-da-Cunha-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-09-03 23:01:13 +0200" MODIFIED_BY="[Empty name]">
<P>Not an RCT; choice of contraceptive</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-03-05 14:59:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Seth-1977">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-03-05 14:59:30 +0100" MODIFIED_BY="[Empty name]">
<P>Unclear whether participant allocation was random</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-03-02 21:47:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shaaban-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-03-02 21:47:09 +0100" MODIFIED_BY="[Empty name]">
<P>Does not have any of our primary outcomes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-09-03 23:01:22 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sinchai-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-09-03 23:01:22 +0200" MODIFIED_BY="[Empty name]">
<P>Not a randomized controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-25 22:59:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Toaff-1969">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-25 22:59:19 +0100" MODIFIED_BY="[Empty name]">
<P>Trial does not include regularly marketed combined oral contraceptive. Intervention on postpartum days 1 to 5 further limited its usefulness.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-25 22:59:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Were-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-25 22:59:23 +0100" MODIFIED_BY="[Empty name]">
<P>No relevant outcome when outcomes were divided into primary and secondary in 2014; trial did not address lactation. Further, losses were &gt; 85% in each arm.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-09-03 23:01:43 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zanartu-1976">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-09-03 23:01:43 +0200" MODIFIED_BY="[Empty name]">
<P>Not a randomized controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2014-08-14 20:40:03 +0200" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2015-03-05 15:00:17 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2015-03-05 15:00:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Turok-2014">
<CHAR_STUDY_NAME MODIFIED="2014-08-19 21:23:41 +0200" MODIFIED_BY="[Empty name]">
<P>BLIS - Breastfeeding Levonorgestrel IUD Study</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-03-05 15:00:17 +0100" MODIFIED_BY="[Empty name]">
<P>Time frame and location: January 2014 to December 2015 in Albuquerque, NM, and Salt Lake City, UT (USA)</P>
<P>Randomized controlled trial, non-inferiority, phase 4; open label</P>
<P>Sample size calculation and outcome of focus: no mention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-03-02 22:14:32 +0100" MODIFIED_BY="[Empty name]">
<P>General with N: 317 pregnant women</P>
<P>Inclusion criteria: healthy; 18 to 40 years old; pregnant; intention to breastfeed; desire for LNG-IUD (levonorgestrel-releasing intrauterine device) as method of contraception; delivered healthy term infant (37 weeks gestation)<BR/>Exclusion criteria: chorioamnionitis; obstetric complications including transfusion, severe pregnancy-induced hypertension, prolonged hospitalization, coagulopathy, liver disease, undiagnosed genital bleeding, or other relative contraindication to LNG-IUD insertion (known or suspected pregnancy, uterine cavity; abnormality, known, suspected, or history of breast cancer; or hypersensitivity to any of the components in the LNG-IUD)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-09-30 17:57:27 +0200" MODIFIED_BY="[Empty name]">
<P>Levonorgestrel-releasing IUD</P>
<P>Treatment: immediately after delivery of baby and placenta (within 10 minutes)</P>
<P>Comparison: 4 to 6 weeks after delivery</P>
<P>Timing: as above</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-08-26 15:34:21 +0200" MODIFIED_BY="[Empty name]">
<P>Measures: breastfeeding continuation and exclusivity; lactogenesis stage 2 (first 5 days after birth)</P>
<P>Assessments: 5 days (lactogenesis stage 2); 8 and 26 weeks (breastfeeding)</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2014-09-03 23:02:14 +0200" MODIFIED_BY="[Empty name]">
<P>January 2014; estimated primary completion December 2015</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-02-23 03:45:49 +0100" MODIFIED_BY="[Empty name]">
<P>Contact: Maria Masters; maria.masters@hsc.utah.edu; 801-213-2286</P>
<P>PI: David K Turok, MD; University of Utah, Department of Obstetrics and Gynecology</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-02-25 22:58:56 +0100" MODIFIED_BY="[Empty name]">
<P>---</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2015-03-04 19:26:22 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2015-03-04 19:26:22 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-25 22:40:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brito-2009">
<DESCRIPTION>
<P>Computerized; 1:1 ratio</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-04 19:06:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dutta-2013">
<DESCRIPTION>
<P>Interventions were provided "in a random sequence." Communication with investigator indicated that this was an RCT.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-25 22:36:16 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Espey-2012">
<DESCRIPTION>
<P>Generated in randomly-permuted blocks of 6.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-04 19:10:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Giner-Velazquez-1976">
<DESCRIPTION>
<P>Divided randomly (12 treatment and 8 control)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-07-10 21:30:01 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gurtcheff-2011">
<DESCRIPTION>
<P>Computer-generated random numbers in varying blocks of 2, 4, 6</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-02 21:41:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Heikkil_x00e4_-1982">
<DESCRIPTION>
<P>"Divided at random" into 2 groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-07-09 16:35:52 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Miller-1970">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-25 22:46:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Semm-1966">
<DESCRIPTION>
<P>Distribution of 2 types of tablets was "purely random"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-02 21:43:55 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shaamash-2005">
<DESCRIPTION>
<P>Randomization scheme was computer generated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-04 19:26:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stuart-2014">
<DESCRIPTION>
<P>1:1 allocation</P>
<P>Computer generated by someone not involved with study activities, according to communication with investigator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-07-09 16:43:29 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-WHO-1984">
<DESCRIPTION>
<P>Computer-generated sequence from WHO</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2015-03-04 19:24:47 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-25 22:32:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Brito-2009">
<DESCRIPTION>
<P>According to communication with investigator, randomized groups were stored in sealed envelopes by one investigator and only opened by another investigator.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-07-14 18:36:39 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dutta-2013">
<DESCRIPTION>
<P>No mention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-25 22:36:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Espey-2012">
<DESCRIPTION>
<P>Pharmacy-blinded packages; pills placed in red capsules; identical monthly pill dispensers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-11-02 18:16:27 +0100" MODIFIED_BY="Laureen M Lopez" RESULT="UNKNOWN" STUDY_ID="STD-Giner-Velazquez-1976">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-25 22:44:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gurtcheff-2011">
<DESCRIPTION>
<P>Sequentially numbered, opaque, sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-08-06 14:26:17 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Heikkil_x00e4_-1982">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-11-02 18:17:02 +0100" MODIFIED_BY="Laureen M Lopez" RESULT="UNKNOWN" STUDY_ID="STD-Miller-1970">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-11-02 18:16:44 +0100" MODIFIED_BY="Laureen M Lopez" RESULT="UNKNOWN" STUDY_ID="STD-Semm-1966">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-04 19:24:47 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shaamash-2005">
<DESCRIPTION>
<P>Sealed opaque envelopes; opened in sequential order at time of enrollment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-09-03 22:58:54 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stuart-2014">
<DESCRIPTION>
<P>Sequentially numbered opaque envelopes, according to communication with investigator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-09-03 22:59:34 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-WHO-1984">
<DESCRIPTION>
<P>Sealed, opaque envelopes, according to communication with investigator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2015-03-04 17:00:36 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-09-25 20:16:28 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Brito-2009">
<DESCRIPTION>
<P>Open; ethical reasons</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-07-14 18:36:41 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dutta-2013">
<DESCRIPTION>
<P>No mention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-09-03 22:53:14 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Espey-2012">
<DESCRIPTION>
<P>Blinding of participants and study personnel</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-03-02 21:41:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Giner-Velazquez-1976">
<DESCRIPTION>
<P>Double blind; no detail</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-09-25 20:16:40 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gurtcheff-2011">
<DESCRIPTION>
<P>Not blinded; considered not feasible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-03-04 17:00:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Heikkil_x00e4_-1982">
<DESCRIPTION>
<P>Participants did not know which IUD they received (30 &#956;g/day LNG-IUD or Nova T).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-03-02 21:42:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Miller-1970">
<DESCRIPTION>
<P>Participants and investigators blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-07-14 17:45:57 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Semm-1966">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-07-14 19:49:11 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shaamash-2005">
<DESCRIPTION>
<P>No mention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-02-25 22:47:52 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Stuart-2014">
<DESCRIPTION>
<P>Open label</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-09-03 22:59:36 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-WHO-1984">
<DESCRIPTION>
<P>Double-blind; pills packaged identically</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2015-03-04 17:00:42 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-09-03 22:51:23 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brito-2009">
<DESCRIPTION>
<P>No losses or discontinuations, according to study flow chart</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-07-21 18:04:00 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dutta-2013">
<DESCRIPTION>
<P>No mention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-03-02 18:22:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Espey-2012">
<DESCRIPTION>
<P>Loss to follow-up: COC 23% (15/64); POP 22% (14/63)</P>
<P>Women who stopped breastfeeding before 8 weeks were discontinued from the study.</P>
<P>Infant growth was not obtained at 8 weeks: COC 12.5% (8/64); POP 14% (9/63).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-03-02 18:22:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Giner-Velazquez-1976">
<DESCRIPTION>
<P>No mention of discontinuation, loss to follow-up or exclusions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-03-02 18:22:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gurtcheff-2011">
<DESCRIPTION>
<P>Loss to follow-up: early insertion 17% (6/35); standard insertion 18% (6/34)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-03-04 17:00:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Heikkil_x00e4_-1982">
<DESCRIPTION>
<P>Loss to follow-up: none<BR/>Discontinuation (expulsion or removal): 4 LNG-IUD 30 &#956;g; 4 Nova T. Also, 2 excluded from study due to uterine perforation at insertion (group not specified).</P>
<P>Sample sizes for analysis not specified or inconsistent across reports.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-03-02 21:42:24 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Miller-1970">
<DESCRIPTION>
<P>Loss to follow-up: 1 in each arm; 1 discontinuation in placebo arm</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-03-02 21:43:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Semm-1966">
<DESCRIPTION>
<P>Loss to follow-up: no mention, nor any mention of discontinuation or exclusions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-09-03 22:56:58 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shaamash-2005">
<DESCRIPTION>
<P>No information on losses or sample sizes for analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-02-25 22:47:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stuart-2014">
<DESCRIPTION>
<P>Six-month analysis for LNG-IUS continuation included all women randomized.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-03-02 18:22:11 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-WHO-1984">
<DESCRIPTION>
<P>Loss to follow-up: unclear due to inconsistent reporting across and within reports</P>
<P>COC: 9% at 9 weeks, 22% at 16 weeks, 34% at 24 weeks</P>
<P>POP: 2% at 9 weeks, 14% at 16 weeks, 32% at 24 weeks</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2015-03-05 15:13:28 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2015-03-05 15:02:33 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2014-07-21 18:29:12 +0200" MODIFIED_BY="[Empty name]">Evidence quality</TITLE>
<TABLE COLS="7" ROWS="18">
<TR>
<TH>
<P>Study</P>
</TH>
<TH ALIGN="CENTER">
<P>Comparison groups</P>
</TH>
<TH ALIGN="CENTER">
<P>Inadequate<BR/>randomization<BR/>and allocation concealment</P>
</TH>
<TH ALIGN="CENTER">
<P>No blinding</P>
</TH>
<TH ALIGN="CENTER">
<P>Follow-up:<BR/>&lt; 8 weeks for infant growth;<BR/>&lt; 12 weeks for lactation</P>
</TH>
<TH ALIGN="CENTER">
<P>Loss to follow-up<BR/>&gt; 20%</P>
</TH>
<TH ALIGN="CENTER">
<P>Quality of evidence<SUP>a</SUP>
</P>
</TH>
</TR>
<TR>
<TD COLSPAN="7">
<P/>
<P>
<B>Progestin-only pills (POPs) versus placebo</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Giner-Velazquez-1976" TYPE="STUDY">Giner Velazquez 1976</LINK>
</P>
</TD>
<TD>
<UL>
<LI>POP norethindrone</LI>
<LI>Placebo</LI>
</UL>
<P/>
</TD>
<TD>
<P>-1</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>-1</P>
</TD>
<TD>
<P>No information</P>
</TD>
<TD>
<P>Low</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Dutta-2013" TYPE="STUDY">Dutta 2013</LINK>
</P>
</TD>
<TD>
<UL>
<LI>POP desogestrel</LI>
<LI>Placebo</LI>
</UL>
<P/>
</TD>
<TD>
<P>-1</P>
</TD>
<TD>
<P>No information</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>No information</P>
</TD>
<TD>
<P>Low</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P/>
<P>
<B>Levonorgestrel-releasing intrauterine system (LNG-IUS)</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Heikkil_x00e4_-1982" TYPE="STUDY">Heikkilä 1982</LINK>
</P>
</TD>
<TD>
<UL>
<LI>LNG-IUS (30 &#956;g)</LI>
<LI>Nova T IUD</LI>
</UL>
<P/>
</TD>
<TD>
<P>-1</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Shaamash-2005" TYPE="STUDY">Shaamash 2005</LINK>
</P>
</TD>
<TD>
<UL>
<LI>LNG-IUS (20 &#956;g)</LI>
<LI>CuT 380A IUD</LI>
</UL>
<P/>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>No information</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>No information</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Stuart-2014" TYPE="STUDY">Stuart 2014</LINK>
</P>
</TD>
<TD>
<P>LNG-IUS (20 &#956;g), insertion times</P>
<UL>
<LI>Within 48 hours</LI>
<LI>4 to 8 weeks</LI>
</UL>
<P/>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>-1</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P/>
<P>
<B>Etonogestrel-releasing (ETG) implant, early versus standard insertion</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Brito-2009" TYPE="STUDY">Brito 2009</LINK>
</P>
</TD>
<TD>
<UL>
<LI>ETG implant, early insertion (1 to 2 days)</LI>
<LI>No method 6 weeks, then DMPA</LI>
</UL>
<P/>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>-1</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Gurtcheff-2011" TYPE="STUDY">Gurtcheff 2011</LINK>
</P>
</TD>
<TD>
<P>ETG implant, postpartum insertion time</P>
<UL>
<LI>Early (1 to 3 days)</LI>
<LI>Standard (4 to 8 weeks)</LI>
</UL>
<P/>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>-1</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P/>
<P>
<B>Combined oral contraceptive (COC) versus placebo</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Semm-1966" TYPE="STUDY">Semm 1966</LINK>
</P>
</TD>
<TD>
<UL>
<LI>COC lynestrenol + mestranol</LI>
<LI>Placebo</LI>
</UL>
<P/>
</TD>
<TD>
<P>-1</P>
</TD>
<TD>
<P>No information</P>
</TD>
<TD>
<P>-1</P>
</TD>
<TD>
<P>No information</P>
</TD>
<TD>
<P>Very low</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Miller-1970" TYPE="STUDY">Miller 1970</LINK>
</P>
</TD>
<TD>
<UL>
<LI>COC norethindrone + mestranol</LI>
<LI>Placebo</LI>
</UL>
<P/>
</TD>
<TD>
<P>-1</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>----</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P/>
<P>
<B>Combined oral contraceptive versus progestin-only pill</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK>
</P>
</TD>
<TD>
<UL>
<LI>COC levonorgestrel + EE</LI>
<LI>POP norgestrel</LI>
</UL>
<P/>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>-1</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Espey-2012" TYPE="STUDY">Espey 2012</LINK>
</P>
</TD>
<TD>
<UL>
<LI>COC norethindrone + EE</LI>
<LI>POP norethindrone</LI>
</UL>
<P/>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>-1</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD COLSPAN="6">
<P/>
<P>
<B>
<I>Overall quality of evidence</I>
</B>
</P>
</TD>
<TD>
<P>
<B>
<I>Moderate</I>
</B>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP>Grade levels were high, moderate, low, or very low. RCTs were downgraded by one level for each of the following: (1) no information on randomization sequence generation or allocation concealment, or one was clearly inadequate; (2) no blinding; (3) follow-up &lt; 8 weeks for infant growth or &lt; 12 weeks for lactation; (4) loss to follow-up &gt; 20%; (5) information missing for both blinding and losses.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2015-03-05 15:06:06 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2014-08-04 16:05:39 +0200" MODIFIED_BY="[Empty name]">Outcome summary</TITLE>
<TABLE COLS="8" ROWS="17">
<TR>
<TH>
<P>Study</P>
</TH>
<TH ALIGN="CENTER">
<P>Comparison groups<SUP>a</SUP>
</P>
</TH>
<TH ALIGN="CENTER">
<P>N</P>
</TH>
<TH ALIGN="CENTER">
<P>Postpartum initiation</P>
</TH>
<TH ALIGN="CENTER">
<P>Lactation<SUP>b</SUP>
</P>
</TH>
<TH ALIGN="CENTER">
<P>Breast milk<SUP>c</SUP>
</P>
</TH>
<TH ALIGN="CENTER">
<P>Infant growth<SUP>d</SUP>
</P>
</TH>
<TH>
<P>Pregnancy</P>
</TH>
</TR>
<TR>
<TD COLSPAN="7">
<P/>
<P>
<B>Progestin-only pill (POP) versus placebo</B>
</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Giner-Velazquez-1976" TYPE="STUDY">Giner Velazquez 1976</LINK>
</P>
</TD>
<TD>
<UL>
<LI>POP norethindrone</LI>
<LI>Placebo</LI>
</UL>
<P/>
</TD>
<TD ALIGN="RIGHT">
<P>20</P>
</TD>
<TD>
<P>48 hours</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>NS<SUP>e</SUP>; not quantified</P>
</TD>
<TD>
<P>NS<SUP>e</SUP>; not quantified</P>
</TD>
<TD>
<P>---</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Dutta-2013" TYPE="STUDY">Dutta 2013</LINK>
</P>
</TD>
<TD>
<UL>
<LI>POP desogestrel</LI>
<LI>Placebo</LI>
</UL>
<P/>
</TD>
<TD ALIGN="RIGHT">
<P>400</P>
</TD>
<TD>
<P>6 weeks</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>NS<SUP>e</SUP>
</P>
</TD>
<TD>
<P>NS<SUP>e</SUP>
</P>
</TD>
<TD>
<P>POP &lt; placebo<SUP>e</SUP>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="8">
<P/>
<P>
<B>Levonorgestrel-releasing intrauterine system (LNG-IUS)</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Heikkil_x00e4_-1982" TYPE="STUDY">Heikkilä 1982</LINK>
</P>
</TD>
<TD>
<UL>
<LI>LNG-IUS (30 &#956;g)</LI>
<LI>Nova T IUD</LI>
</UL>
<P/>
</TD>
<TD ALIGN="RIGHT">
<P>80</P>
</TD>
<TD>
<P>6 weeks</P>
</TD>
<TD>
<P>BF<SUP>e</SUP>: LNG-IUS &lt; Nova T IUD</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>NS<SUP>e</SUP>; not quantified</P>
</TD>
<TD>
<P>None</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Shaamash-2005" TYPE="STUDY">Shaamash 2005</LINK>
</P>
</TD>
<TD>
<UL>
<LI>LNG-IUS (20 &#956;g)</LI>
<LI>CuT 380A IUD</LI>
</UL>
<P/>
</TD>
<TD ALIGN="RIGHT">
<P>320</P>
</TD>
<TD>
<P>6 to 8 weeks</P>
</TD>
<TD>
<P>NS<SUP>e</SUP>
</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>NS<SUP>e</SUP>
</P>
</TD>
<TD>
<P>None</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Stuart-2014" TYPE="STUDY">Stuart 2014</LINK>
</P>
</TD>
<TD>
<P>LNG-IUS (20 &#956;g), insertion times</P>
<UL>
<LI>&#8804; 48 hours</LI>
<LI>4 to 8 weeks</LI>
</UL>
<P/>
</TD>
<TD ALIGN="RIGHT">
<P>35</P>
</TD>
<TD>
<P>48 hours vs<BR/>4 to 8 weeks</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>---</P>
</TD>
</TR>
<TR>
<TD COLSPAN="8">
<P/>
<P>
<B>Etonogestrel-releasing (ETG) implant: early versus standard insertion</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Brito-2009" TYPE="STUDY">Brito 2009</LINK>
</P>
</TD>
<TD>
<UL>
<LI>ETG implant, early insertion (24 to 48 hours)</LI>
<LI>No method 6 weeks, then DMPA</LI>
</UL>
<P/>
</TD>
<TD ALIGN="RIGHT">
<P>40</P>
</TD>
<TD>
<P>24 to 48 hours vs 6 weeks</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>Weight:<BR/>6 weeks, implant &gt; no method; 12 weeks, DMPA &gt; implant<BR/>
</P>
</TD>
<TD>
<P>---</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Gurtcheff-2011" TYPE="STUDY">Gurtcheff 2011</LINK>
</P>
</TD>
<TD>
<P>ETG implant insertion</P>
<UL>
<LI>Early (1 to 3 days)</LI>
<LI>Standard (4 to 8 weeks)</LI>
</UL>
<P/>
</TD>
<TD ALIGN="RIGHT">
<P>69</P>
</TD>
<TD>
<P>1 to 3 days vs 4 to 8 weeks</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>---</P>
</TD>
</TR>
<TR>
<TD COLSPAN="8">
<P/>
<P>
<B>Combined oral contraceptive (COC) versus placebo</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Semm-1966" TYPE="STUDY">Semm 1966</LINK>
</P>
</TD>
<TD>
<UL>
<LI>COC lynestrenol + mestranol</LI>
<LI>Placebo</LI>
</UL>
<P/>
</TD>
<TD ALIGN="RIGHT">
<P>100</P>
</TD>
<TD>
<P>1 day</P>
</TD>
<TD>
<P>NS<SUP>e</SUP>; not quantified</P>
</TD>
<TD>
<P>NS<SUP>e</SUP>; not quantified</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>---</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Miller-1970" TYPE="STUDY">Miller 1970</LINK>
</P>
</TD>
<TD>
<UL>
<LI>COC norethindrone + mestranol</LI>
<LI>Placebo</LI>
</UL>
<P/>
</TD>
<TD ALIGN="RIGHT">
<P>50</P>
</TD>
<TD>
<P>14 days</P>
</TD>
<TD>
<P>BF<SUP>e</SUP>: COC &lt; placebo; unclear, not quantified</P>
</TD>
<TD>
<P>Volume<SUP>e</SUP>: COC &lt; placebo; unclear, not quantified,</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>---</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P/>
<P>
<B>Combined versus progestin-only oral contraceptive</B>
</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK>
</P>
</TD>
<TD>
<UL>
<LI>COC levonorgestrel + EE</LI>
<LI>POP norgestrel</LI>
</UL>
<P/>
</TD>
<TD ALIGN="RIGHT">
<P>171</P>
</TD>
<TD>
<P>6 weeks</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>Volume:</P>
<P>COC &lt; POP</P>
</TD>
<TD>
<P>NS<SUP>e</SUP>
</P>
</TD>
<TD>
<P>---</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Espey-2012" TYPE="STUDY">Espey 2012</LINK>
</P>
</TD>
<TD>
<UL>
<LI>COC norethindrone + EE</LI>
<LI>POP norethindrone</LI>
</UL>
<P/>
</TD>
<TD ALIGN="RIGHT">
<P>197</P>
</TD>
<TD>
<P>2 weeks</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>None</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP>Table shows direction of significant differences (reported or analyzed); NS = not significantly different.<BR/>
<SUP>b</SUP>Initiation, failure, breastfeeding (BF) fully or any.<BR/>
<SUP>c</SUP>Time to lactogenesis II, volume, composition.<BR/>
<SUP>d</SUP>Weight or length.<BR/>
<SUP>e</SUP>Reported; insufficient data for analysis in this review.<BR/>
</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2015-03-05 15:13:28 +0100" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2014-07-23 16:52:35 +0200" MODIFIED_BY="[Empty name]">Sensitivity analysis</TITLE>
<TABLE COLS="7" ROWS="10">
<TR>
<TH>
<P>Study<SUP>a</SUP>
</P>
</TH>
<TH ALIGN="CENTER">
<P>Comparison groups</P>
</TH>
<TH ALIGN="CENTER">
<P>N</P>
</TH>
<TH ALIGN="CENTER">
<P>Postpartum initiation</P>
</TH>
<TH ALIGN="CENTER">
<P>Lactation<SUP>b</SUP>
</P>
</TH>
<TH ALIGN="CENTER">
<P>Breast milk<SUP>c</SUP>
</P>
</TH>
<TH ALIGN="CENTER">
<P>Infant growth</P>
</TH>
</TR>
<TR>
<TD COLSPAN="7">
<P/>
<P>
<B>Levonorgestrel-releasing intrauterine system (LNG-IUS)</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Shaamash-2005" TYPE="STUDY">Shaamash 2005</LINK>
</P>
</TD>
<TD>
<UL>
<LI>LNG-IUS (20 &#956;g)</LI>
<LI>CuT 380A IUD</LI>
</UL>
<P/>
</TD>
<TD ALIGN="RIGHT">
<P>320</P>
</TD>
<TD>
<P>6 to 8 weeks</P>
</TD>
<TD>
<P>NS<SUP>d</SUP>:<BR/>full BF (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>)</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>NS<SUP>d</SUP>:</P>
<P>weight (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>) and length <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Stuart-2014" TYPE="STUDY">Stuart 2014</LINK>
</P>
</TD>
<TD>
<P>LNG-IUS (20 &#956;g) insertion times</P>
<UL>
<LI>&#8804; 48 hours</LI>
<LI>4 to 8 weeks</LI>
</UL>
<P/>
</TD>
<TD ALIGN="RIGHT">
<P>35</P>
</TD>
<TD>
<P>48 hours vs<BR/>4 to 8 weeks</P>
</TD>
<TD>
<P>NS:<BR/>any BF (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>)</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>---</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P/>
<P>
<B>Etonogestrel-releasing (ETG) implant: early versus standard insertion</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Brito-2009" TYPE="STUDY">Brito 2009</LINK>
</P>
</TD>
<TD>
<UL>
<LI>ETG implant, early insertion (1 to 2 days)</LI>
<LI>No method for 6 weeks, then DMPA</LI>
</UL>
<P/>
</TD>
<TD ALIGN="RIGHT">
<P>40</P>
</TD>
<TD>
<P>24 to 48 hours vs 6 weeks</P>
</TD>
<TD>
<P>NS:<BR/>full BF (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>)</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>Weight:<BR/>6 weeks, ETG implant &gt; no method (<LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>); 12 weeks, DMPA &gt; ETG implant (<LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Gurtcheff-2011" TYPE="STUDY">Gurtcheff 2011</LINK>
</P>
</TD>
<TD>
<P>ETG implant, postpartum insertion</P>
<UL>
<LI>Early (1 to 3 days)</LI>
<LI>Standard (4 to 8 weeks)</LI>
</UL>
<P/>
</TD>
<TD ALIGN="RIGHT">
<P>65</P>
</TD>
<TD>
<P>1 to 3 days vs 4 to 8 weeks</P>
</TD>
<TD>
<P>NS:<BR/>failure (<LINK REF="CMP-006.01" TYPE="ANALYSIS">Analysis 6.1</LINK>); full BF (<LINK REF="CMP-006.04" TYPE="ANALYSIS">Analysis 6.4</LINK>); any BF (<LINK REF="CMP-006.05" TYPE="ANALYSIS">Analysis 6.5</LINK>)</P>
</TD>
<TD>
<P>NS:<BR/>lactogenesis II (<LINK REF="CMP-006.02" TYPE="ANALYSIS">Analysis 6.2</LINK>); creamatocrit (<LINK REF="CMP-006.03" TYPE="ANALYSIS">Analysis 6.3</LINK>)</P>
</TD>
<TD>
<P>---</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P/>
<P>
<B>Combined (COC) versus progestin-only (POP) oral contraceptive</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-WHO-1984" TYPE="STUDY">WHO 1984</LINK>
</P>
</TD>
<TD>
<UL>
<LI>COC levonorgestrel + EE</LI>
<LI>POP norgestrel</LI>
</UL>
<P/>
</TD>
<TD ALIGN="RIGHT">
<P>171</P>
</TD>
<TD>
<P>6 weeks</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>Volume:<BR/>COC &lt; POP (<LINK REF="CMP-007.01" TYPE="ANALYSIS">Analysis 7.1</LINK>)</P>
</TD>
<TD>
<P>NS<SUP>d</SUP>:<BR/>weight (<LINK REF="CMP-008.03" TYPE="ANALYSIS">Analysis 8.3</LINK>)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Espey-2012" TYPE="STUDY">Espey 2012</LINK>
</P>
</TD>
<TD>
<UL>
<LI>COC norethindrone + EE</LI>
<LI>POP norethindrone</LI>
</UL>
<P/>
</TD>
<TD ALIGN="RIGHT">
<P>179</P>
</TD>
<TD>
<P>2 weeks</P>
</TD>
<TD>
<P>NS:<BR/>BF (<LINK REF="CMP-008.03" TYPE="ANALYSIS">Analysis 8.3</LINK>)</P>
</TD>
<TD>
<P>---</P>
</TD>
<TD>
<P>NS:<BR/>weight (<LINK REF="CMP-008.01" TYPE="ANALYSIS">Analysis 8.1</LINK>) and length (<LINK REF="CMP-008.02" TYPE="ANALYSIS">Analysis 8.2</LINK>)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP>Includes studies with moderate-quality evidence (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>) and sufficient outcome data (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>). Direction of significant differences shown (reported or analyzed); NS = not significantly different.<BR/>
<SUP>b</SUP>Initiation; failure; breastfeeding (BF) full, any, or discontinuation.<BR/>
<SUP>c</SUP>Time to lactogenesis II; milk volume or composition.<BR/>
<SUP>d</SUP>Reported; insufficient data for analysis in this review.<BR/>
</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2015-03-02 21:35:49 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2015-03-02 21:27:57 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>LNG-IUS (30 &#956;g) versus nonhormonal IUD (Nova T)</NAME>
<OTHER_OUTCOME COLS="3" ID="CMP-001.01" MODIFIED="2014-12-10 16:23:37 +0100" MODIFIED_BY="[Empty name]" NO="1" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Breastfeeding continuation at 75 days</NAME>
<TR>
<TH>
<P>LNG-IUS</P>
</TH>
<TH>
<P>Nova T</P>
</TH>
<TH>
<P>Reported P</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2014-11-17 19:50:43 +0100" MODIFIED_BY="[Empty name]" ORDER="1" STUDY_ID="STD-Heikkil_x00e4_-1982">
<TR>
<TD>
<P>56%</P>
</TD>
<TD>
<P>79%</P>
</TD>
<TD>
<P>&lt; .05</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="3" ID="CMP-001.02" MODIFIED="2014-12-10 16:23:47 +0100" MODIFIED_BY="[Empty name]" NO="2" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Mean days of breastfeeding (over 12 months)</NAME>
<TR>
<TH>
<P>LNG-IUS<BR/>(mean <U>+</U> SD)</P>
</TH>
<TH>
<P>Nova T<BR/>(mean <U>+</U> SD)</P>
</TH>
<TH>
<P>Reported P</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2014-11-19 15:32:48 +0100" MODIFIED_BY="[Empty name]" ORDER="2" STUDY_ID="STD-Heikkil_x00e4_-1982">
<TR>
<TD>
<P>197 <U>+</U> 141</P>
</TD>
<TD>
<P>208 <U>+</U> 104</P>
</TD>
<TD>
<P>not significant (NS)</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2015-03-02 21:28:12 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>LNG-IUS (20 &#956;g) versus nonhormonal IUD (CuT 380A)</NAME>
<OTHER_OUTCOME COLS="4" ID="CMP-002.01" MODIFIED="2014-11-19 15:42:42 +0100" MODIFIED_BY="[Empty name]" NO="1" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Reported mean infant weight (g)</NAME>
<TR>
<TH>
<P>Time frame</P>
</TH>
<TH>
<P>LNG-IUS<BR/>(mean <U>+</U> SD)</P>
</TH>
<TH>
<P>CuT 380A<BR/>(mean <U>+</U> SD)</P>
</TH>
<TH>
<P>Reported P</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2014-11-19 15:35:59 +0100" MODIFIED_BY="[Empty name]" ORDER="3" STUDY_ID="STD-Shaamash-2005">
<TR>
<TD>
<P>6 months</P>
</TD>
<TD>
<P>7225 <U>+</U> 810</P>
</TD>
<TD>
<P>7157 <U>+</U> 759</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>12 months</P>
</TD>
<TD>
<P>9284 <U>+</U> 423</P>
</TD>
<TD>
<P>9183 <U>+</U> 421</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="4" ID="CMP-002.02" MODIFIED="2014-11-19 15:42:36 +0100" MODIFIED_BY="[Empty name]" NO="2" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Reported mean infant length (cm)</NAME>
<TR>
<TH>
<P>Time frame</P>
</TH>
<TH>
<P>LNG-IUS<BR/>(mean <U>+</U> SD)</P>
</TH>
<TH>
<P>CuT 380A<BR/>(mean <U>+</U> SD)</P>
</TH>
<TH>
<P>Reported P</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2014-11-19 15:37:04 +0100" MODIFIED_BY="[Empty name]" ORDER="4" STUDY_ID="STD-Shaamash-2005">
<TR>
<TD>
<P>6 months</P>
</TD>
<TD>
<P>65.1 <U>+</U> 3.2</P>
</TD>
<TD>
<P>64.4 <U>+</U> 3.0</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>12 months</P>
</TD>
<TD>
<P>72.6 <U>+</U> 3.2</P>
</TD>
<TD>
<P>72.3 <U>+</U> 3.9</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="3" ID="CMP-002.03" MODIFIED="2014-11-19 15:42:14 +0100" MODIFIED_BY="[Empty name]" NO="3" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Reported net cumulative rate for full breastfeeding</NAME>
<TR>
<TH>
<P>Time frame</P>
</TH>
<TH>
<P>LNG-IUS<BR/>(mean <U>+</U> SE)</P>
</TH>
<TH>
<P>CuT 380A<BR/>(mean <U>+</U> SE)</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2014-11-19 15:37:52 +0100" MODIFIED_BY="[Empty name]" ORDER="5" STUDY_ID="STD-Shaamash-2005">
<TR>
<TD>
<P>6 months</P>
</TD>
<TD>
<P>16.5 <U>+</U> 3.4</P>
</TD>
<TD>
<P>19.9 <U>+</U> 3.6</P>
</TD>
</TR>
<TR>
<TD>
<P>12 months</P>
</TD>
<TD>
<P>0.3 <U>+</U> 0.4</P>
</TD>
<TD>
<P>0.0 <U>+</U> 0.0</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="3" ID="CMP-002.04" MODIFIED="2014-11-19 15:43:01 +0100" MODIFIED_BY="[Empty name]" NO="4" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Reported net cumulative rate for continuation of IUS or IUD</NAME>
<TR>
<TH>
<P>Time frame</P>
</TH>
<TH>
<P>LNG-IUS<BR/>(mean <U>+</U> SE)</P>
</TH>
<TH>
<P>CuT 380A<BR/>(mean <U>+</U> SE)</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2014-11-19 15:40:14 +0100" MODIFIED_BY="[Empty name]" ORDER="6" STUDY_ID="STD-Shaamash-2005">
<TR>
<TD>
<P>6 months</P>
</TD>
<TD>
<P>90.6 <U>+</U> 2.3</P>
</TD>
<TD>
<P>93.5 <U>+</U> 2.0</P>
</TD>
</TR>
<TR>
<TD>
<P>12 months</P>
</TD>
<TD>
<P>89.3 <U>+</U> 2.5</P>
</TD>
<TD>
<P>90.9 <U>+</U> 2.3</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2015-03-02 21:28:27 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>LNG-IUS insertion time after delivery: 48 hours versus 4 to 6 weeks</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="5.437428478119871" CI_START="0.3753274796611718" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.4285714285714286" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.7353935574547102" LOG_CI_START="-0.42558963748322387" LOG_EFFECT_SIZE="0.1549019599857432" METHOD="MH" MODIFIED="2014-08-20 16:11:04 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.6009680728802458" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="18" WEIGHT="100.0" Z="0.5230088842465145">
<NAME>Any breastfeeding at 6 months</NAME>
<GROUP_LABEL_1>48 hours</GROUP_LABEL_1>
<GROUP_LABEL_2>4 to 6 weeks</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors 4 to 6 weeks</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors 48 hours</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.437428478119871" CI_START="0.3753274796611718" EFFECT_SIZE="1.4285714285714286" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" LOG_CI_END="0.7353935574547102" LOG_CI_START="-0.42558963748322387" LOG_EFFECT_SIZE="0.1549019599857432" MODIFIED="2014-08-14 21:22:47 +0200" MODIFIED_BY="[Empty name]" ORDER="191" O_E="0.0" SE="0.6819672756660432" STUDY_ID="STD-Stuart-2014" TOTAL_1="17" TOTAL_2="18" VAR="0.46507936507936504" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2015-03-02 21:35:49 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Etonogestrel implant (at 24 to 48 hours) versus no method until 6 weeks</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="35.36426859205191" CI_START="0.31789755537029973" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="3.3529411764705883" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="1.5485646803819706" LOG_CI_START="-0.4977128117935357" LOG_EFFECT_SIZE="0.5254259342942175" METHOD="MH" MODIFIED="2014-09-29 19:16:30 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.31416255039697194" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="20" TOTAL_2="20" WEIGHT="100.0" Z="1.0065261546371438">
<NAME>Exclusive breastfeeding</NAME>
<GROUP_LABEL_1>ETG implant</GROUP_LABEL_1>
<GROUP_LABEL_2>No method</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors no method</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors ETG implant</GRAPH_LABEL_2>
<DICH_DATA CI_END="35.36426859205191" CI_START="0.31789755537029973" EFFECT_SIZE="3.3529411764705883" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="17" LOG_CI_END="1.5485646803819706" LOG_CI_START="-0.4977128117935357" LOG_EFFECT_SIZE="0.5254259342942175" MODIFIED="2014-09-29 19:03:56 +0200" MODIFIED_BY="[Empty name]" ORDER="91" O_E="0.0" SE="1.201993528140841" STUDY_ID="STD-Brito-2009" TOTAL_1="20" TOTAL_2="20" VAR="1.4447884416924663" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="793.0644181090438" CI_START="58.93558189095614" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="426.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.02" MODIFIED="2014-09-29 19:12:07 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.022926675919997537" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="20" TOTAL_2="20" UNITS="" WEIGHT="100.0" Z="2.2746543010497575">
<NAME>Mean change in infant weight (g)</NAME>
<GROUP_LABEL_1>ETG implant</GROUP_LABEL_1>
<GROUP_LABEL_2>No method</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors no method</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors ETG implant</GRAPH_LABEL_2>
<CONT_DATA CI_END="793.0644181090438" CI_START="58.93558189095614" EFFECT_SIZE="426.0" ESTIMABLE="YES" MEAN_1="1461.0" MEAN_2="1035.0" MODIFIED="2014-09-29 18:59:29 +0200" MODIFIED_BY="[Empty name]" ORDER="50" SD_1="621.0" SD_2="562.0" SE="187.2812056774518" STUDY_ID="STD-Brito-2009" TOTAL_1="20" TOTAL_2="20" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2015-03-02 21:28:44 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>ETG implant (at 24 to 48 hours) versus DMPA from 6 to 12 weeks</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="9.27062923153935" CI_START="0.3848607408901268" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.8888888888888888" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="15" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="0.9671092123010442" LOG_CI_START="-0.41469638842314605" LOG_EFFECT_SIZE="0.27620641193894907" METHOD="MH" MODIFIED="2014-09-29 19:15:43 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.43330613912770355" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="20" TOTAL_2="20" WEIGHT="100.0" Z="0.7835467151322238">
<NAME>Exclusive breastfeeding</NAME>
<GROUP_LABEL_1>ETG implant</GROUP_LABEL_1>
<GROUP_LABEL_2>DMPA (6 to 12 weeks)</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors DMPA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors ETG implant</GRAPH_LABEL_2>
<DICH_DATA CI_END="9.27062923153935" CI_START="0.3848607408901268" EFFECT_SIZE="1.8888888888888888" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="15" LOG_CI_END="0.9671092123010442" LOG_CI_START="-0.41469638842314605" LOG_EFFECT_SIZE="0.27620641193894907" MODIFIED="2014-09-29 19:05:50 +0200" MODIFIED_BY="[Empty name]" ORDER="91" O_E="0.0" SE="0.8116794499134278" STUDY_ID="STD-Brito-2009" TOTAL_1="20" TOTAL_2="20" VAR="0.6588235294117647" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-186.9029265560393" CI_START="-355.0970734439607" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-271.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.02" MODIFIED="2014-09-29 19:16:59 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="2.685620199447152E-10" Q="0.0" RANDOM="NO" SCALE="444.5583277178812" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="20" TOTAL_2="20" UNITS="" WEIGHT="99.99999999999999" Z="6.315918236611341">
<NAME>Mean change in infant weight (g)</NAME>
<GROUP_LABEL_1>ETG implant</GROUP_LABEL_1>
<GROUP_LABEL_2>DMPA (6 to 12 weeks)</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors DMPA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors ETG implant</GRAPH_LABEL_2>
<CONT_DATA CI_END="-186.9029265560393" CI_START="-355.0970734439607" EFFECT_SIZE="-271.0" ESTIMABLE="YES" MEAN_1="366.0" MEAN_2="637.0" MODIFIED="2014-09-29 19:03:11 +0200" MODIFIED_BY="[Empty name]" ORDER="50" SD_1="89.0" SD_2="170.0" SE="42.9074585590897" STUDY_ID="STD-Brito-2009" TOTAL_1="20" TOTAL_2="20" WEIGHT="99.99999999999999"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2015-03-02 21:29:03 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Etonogestrel implant: early versus standard insertion</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="80.78880803138077" CI_START="0.12510031433619542" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="3.1791044776119404" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="1.9073512005409665" LOG_CI_START="-0.9027415990651442" LOG_EFFECT_SIZE="0.5023048007379113" METHOD="MH" MODIFIED="2014-08-20 16:20:05 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.48349767730286175" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="34" TOTAL_2="35" WEIGHT="100.0" Z="0.7006881188022483">
<NAME>Lactation failure</NAME>
<GROUP_LABEL_1>Early</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors early</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="80.78880803138077" CI_START="0.12510031433619542" EFFECT_SIZE="3.1791044776119404" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9073512005409665" LOG_CI_START="-0.9027415990651442" LOG_EFFECT_SIZE="0.5023048007379113" MODIFIED="2014-07-16 23:00:05 +0200" MODIFIED_BY="[Empty name]" ORDER="108" O_E="0.0" SE="1.6506624206723282" STUDY_ID="STD-Gurtcheff-2011" TOTAL_1="34" TOTAL_2="35" VAR="2.7246864270198303" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="5.847948320297418E-34" CI_END="8.098218978142192" CI_START="-9.898218978142204" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.9000000000000056" ESTIMABLE="YES" I2="100.00000000000001" I2_Q="0.0" ID="CMP-006.02" MODIFIED="2014-08-20 16:20:27 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="1.0" P_Z="0.8445826211536703" Q="0.0" RANDOM="NO" SCALE="25.01" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="34" TOTAL_2="35" UNITS="" WEIGHT="100.00000000000001" Z="0.19603519211645748">
<NAME>Mean time to lactogenesis stage II</NAME>
<GROUP_LABEL_1>Early</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors early</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors standard</GRAPH_LABEL_2>
<CONT_DATA CI_END="8.098218978142192" CI_START="-9.898218978142204" EFFECT_SIZE="-0.9000000000000057" ESTIMABLE="YES" MEAN_1="64.3" MEAN_2="65.2" MODIFIED="2014-07-16 22:50:13 +0200" MODIFIED_BY="[Empty name]" ORDER="107" SD_1="19.6" SD_2="18.5" SE="4.591012411002958" STUDY_ID="STD-Gurtcheff-2011" TOTAL_1="34" TOTAL_2="35" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="2.163132885838851" CI_START="-0.7631328858388506" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.7000000000000002" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.03" MODIFIED="2014-08-20 16:20:42 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.34840034290249566" Q="0.0" RANDOM="NO" SCALE="6.47" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="34" TOTAL_2="35" UNITS="" WEIGHT="100.0" Z="0.9376966388062905">
<NAME>Mean creamatocrit of breast milk at 6 weeks</NAME>
<GROUP_LABEL_1>Early</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors standard</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors early</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.163132885838851" CI_START="-0.7631328858388506" EFFECT_SIZE="0.7000000000000002" ESTIMABLE="YES" MEAN_1="7.5" MEAN_2="6.8" MODIFIED="2014-07-14 22:35:22 +0200" MODIFIED_BY="[Empty name]" ORDER="69" SD_1="3.0" SD_2="3.2" SE="0.7465100876239851" STUDY_ID="STD-Gurtcheff-2011" TOTAL_1="34" TOTAL_2="35" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.25576263503808294" CI_END="2.0481950973527527" CI_START="0.6166921412550482" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="OR" EFFECT_SIZE="1.123879806871963" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="32" I2="0.0" I2_Q="0.0" ID="CMP-006.04" LOG_CI_END="0.31137132225897585" LOG_CI_START="-0.20993158591991512" LOG_EFFECT_SIZE="0.050719868169530356" METHOD="MH" MODIFIED="2014-09-02 15:46:48 +0200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.8799578139679407" P_Q="0.8799578193487206" P_Z="0.7029159963242781" Q="0.2557626228084479" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="98" TOTAL_2="91" WEIGHT="300.0" Z="0.3813871488274362">
<NAME>Breastfeeding fully</NAME>
<GROUP_LABEL_1>Early</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors standard</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors early</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.2827050328926917" CI_START="0.4614465461349909" DF="0" EFFECT_SIZE="1.2307692307692308" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="13" I2="0.0" ID="CMP-006.04.01" LOG_CI_END="0.5162318609985461" LOG_CI_START="-0.33587860030037" LOG_EFFECT_SIZE="0.09017663034908803" MODIFIED="2014-07-23 19:47:41 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.678262136515422" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="31" WEIGHT="100.0" Z="0.4148357654522296">
<NAME>At 6 weeks</NAME>
<DICH_DATA CI_END="3.2827050328926917" CI_START="0.4614465461349909" EFFECT_SIZE="1.2307692307692308" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="13" LOG_CI_END="0.5162318609985461" LOG_CI_START="-0.33587860030037" LOG_EFFECT_SIZE="0.09017663034908803" MODIFIED="2014-07-23 19:47:27 +0200" MODIFIED_BY="[Empty name]" ORDER="108" O_E="0.0" SE="0.500533902981794" STUDY_ID="STD-Gurtcheff-2011" TOTAL_1="34" TOTAL_2="31" VAR="0.25053418803418803" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.4474981011189563" CI_START="0.44890049891220307" DF="0" EFFECT_SIZE="1.244019138755981" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="11" I2="0.0" ID="CMP-006.04.02" LOG_CI_END="0.5375040356386673" LOG_CI_START="-0.34784991191913944" LOG_EFFECT_SIZE="0.09482706185976399" MODIFIED="2014-07-23 19:49:34 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.6745955345440058" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="31" WEIGHT="100.0" Z="0.41984931906062156">
<NAME>At 3 months</NAME>
<DICH_DATA CI_END="3.4474981011189563" CI_START="0.44890049891220307" EFFECT_SIZE="1.244019138755981" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="11" LOG_CI_END="0.5375040356386673" LOG_CI_START="-0.34784991191913944" LOG_EFFECT_SIZE="0.09482706185976399" MODIFIED="2014-07-23 19:49:34 +0200" MODIFIED_BY="[Empty name]" ORDER="108" O_E="0.0" SE="0.5200612913681774" STUDY_ID="STD-Gurtcheff-2011" TOTAL_1="32" TOTAL_2="31" VAR="0.2704637467795363" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.7404251678925005" CI_START="0.2793818305897391" DF="0" EFFECT_SIZE="0.875" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="8" I2="0.0" ID="CMP-006.04.03" LOG_CI_END="0.4378179473988866" LOG_CI_START="-0.5538018413542601" LOG_EFFECT_SIZE="-0.057991946977686754" MODIFIED="2014-07-23 19:49:33 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.8186782038857157" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="29" WEIGHT="100.0" Z="0.22924537964806083">
<NAME>At 6 months</NAME>
<DICH_DATA CI_END="2.7404251678925005" CI_START="0.2793818305897392" EFFECT_SIZE="0.875" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="8" LOG_CI_END="0.4378179473988866" LOG_CI_START="-0.55380184135426" LOG_EFFECT_SIZE="-0.057991946977686754" MODIFIED="2014-07-23 19:49:33 +0200" MODIFIED_BY="[Empty name]" ORDER="108" O_E="0.0" SE="0.5824823725107174" STUDY_ID="STD-Gurtcheff-2011" TOTAL_1="32" TOTAL_2="29" VAR="0.33928571428571425" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.1909883684674507" CI_END="4.394772696245459" CI_START="1.098187550495694" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="OR" EFFECT_SIZE="2.1968806663711065" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="57" I2="0.0" I2_Q="0.0" ID="CMP-006.05" LOG_CI_END="0.642936417676195" LOG_CI_START="0.04067651606096591" LOG_EFFECT_SIZE="0.3418064668685804" METHOD="MH" MODIFIED="2014-09-25 19:44:03 +0200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.5512902911018733" P_Q="0.5514001911442605" P_Z="0.026100366340786024" Q="1.1905897047664071" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="94" TOTAL_2="91" WEIGHT="300.0" Z="2.2247151535361684">
<NAME>Breastfeeding, any</NAME>
<GROUP_LABEL_1>Early</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors standard</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors early</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="17.175248918976656" CI_START="0.5512266905687366" DF="0" EFFECT_SIZE="3.076923076923077" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="26" I2="0.0" ID="CMP-006.05.01" LOG_CI_END="1.2349030399589318" LOG_CI_START="-0.25866976191668056" LOG_EFFECT_SIZE="0.4881166390211256" MODIFIED="2014-07-23 19:51:48 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.20016655075421147" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="31" WEIGHT="100.0" Z="1.2810772016399101">
<NAME>At 6 weeks</NAME>
<DICH_DATA CI_END="17.175248918976656" CI_START="0.5512266905687366" EFFECT_SIZE="3.076923076923077" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="26" LOG_CI_END="1.2349030399589318" LOG_CI_START="-0.25866976191668056" LOG_EFFECT_SIZE="0.4881166390211256" MODIFIED="2014-07-23 19:51:48 +0200" MODIFIED_BY="[Empty name]" ORDER="108" O_E="0.0" SE="0.8773320571263417" STUDY_ID="STD-Gurtcheff-2011" TOTAL_1="34" TOTAL_2="31" VAR="0.7697115384615385" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="9.774051381356005" CI_START="1.0021004838729262" DF="0" EFFECT_SIZE="3.1296296296296298" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="18" I2="0.0" ID="CMP-006.05.02" LOG_CI_END="0.9900746177472719" LOG_CI_START="9.112718341382068E-4" LOG_EFFECT_SIZE="0.49549294479070505" MODIFIED="2014-09-25 19:44:03 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.049579371295780425" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="31" WEIGHT="100.0" Z="1.9635752383990173">
<NAME>At 3 months</NAME>
<DICH_DATA CI_END="9.774051381356005" CI_START="1.0021004838729264" EFFECT_SIZE="3.1296296296296298" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="18" LOG_CI_END="0.9900746177472719" LOG_CI_START="9.112718341383031E-4" LOG_EFFECT_SIZE="0.49549294479070505" MODIFIED="2014-09-25 19:44:03 +0200" MODIFIED_BY="[Empty name]" ORDER="108" O_E="0.0" SE="0.5810394458269056" STUDY_ID="STD-Gurtcheff-2011" TOTAL_1="32" TOTAL_2="31" VAR="0.3376068376068376" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.028606177922937" CI_START="0.5006039358554163" DF="0" EFFECT_SIZE="1.4201183431952662" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="13" I2="0.0" ID="CMP-006.05.03" LOG_CI_END="0.6051548143939575" LOG_CI_START="-0.30050574019809256" LOG_EFFECT_SIZE="0.15232453709793245" MODIFIED="2014-07-23 19:52:12 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.5097037068088155" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="29" WEIGHT="100.0" Z="0.6592991273825844">
<NAME>At 6 months</NAME>
<DICH_DATA CI_END="4.028606177922937" CI_START="0.5006039358554163" EFFECT_SIZE="1.4201183431952662" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="13" LOG_CI_END="0.6051548143939575" LOG_CI_START="-0.30050574019809256" LOG_EFFECT_SIZE="0.15232453709793245" MODIFIED="2014-07-23 19:52:12 +0200" MODIFIED_BY="[Empty name]" ORDER="108" O_E="0.0" SE="0.5319894928594178" STUDY_ID="STD-Gurtcheff-2011" TOTAL_1="28" TOTAL_2="29" VAR="0.2830128205128205" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2015-03-02 21:34:11 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>COC (levonorgestrel 150 &#956;g + EE 30 &#956;g) versus POP (norgestrel 75 &#956;g)</NAME>
<CONT_OUTCOME CHI2="0.9537200602741944" CI_END="-15.99246319030431" CI_START="-28.543391416493908" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-22.26792730339911" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.01" MODIFIED="2015-03-02 21:34:11 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6207294500760483" P_Q="0.6207294500760483" P_Z="3.5316724184555488E-12" Q="0.9537200602741944" RANDOM="NO" SCALE="64.65" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="202" TOTAL_2="214" UNITS="" WEIGHT="300.0" Z="6.954758204089993">
<NAME>Mean breast milk volume (mL)</NAME>
<GROUP_LABEL_1>COC</GROUP_LABEL_1>
<GROUP_LABEL_2>POP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors POP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors COC</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-6.803510263976607" CI_START="-28.796489736023403" DF="0" EFFECT_SIZE="-17.800000000000004" ESTIMABLE="YES" I2="0.0" ID="CMP-007.01.01" MODIFIED="2014-07-22 21:31:34 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.0015108545983627186" STUDIES="1" TAU2="0.0" TOTAL_1="78" TOTAL_2="83" WEIGHT="100.0" Z="3.172590504997743">
<NAME>At 9 weeks</NAME>
<CONT_DATA CI_END="-6.803510263976607" CI_START="-28.796489736023403" EFFECT_SIZE="-17.800000000000004" ESTIMABLE="YES" MEAN_1="57.6" MEAN_2="75.4" MODIFIED="2014-07-22 21:31:34 +0200" MODIFIED_BY="[Empty name]" ORDER="90" SD_1="31.8" SD_2="39.2" SE="5.610557042252973" STUDY_ID="STD-WHO-1984" TOTAL_1="78" TOTAL_2="83" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-13.472186419187604" CI_START="-34.52781358081239" DF="0" EFFECT_SIZE="-24.0" ESTIMABLE="YES" I2="0.0" ID="CMP-007.01.02" MODIFIED="2014-07-23 18:29:24 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="7.892400914366775E-6" STUDIES="1" TAU2="0.0" TOTAL_1="67" TOTAL_2="73" WEIGHT="100.0" Z="4.468082120554746">
<NAME>At 16 weeks</NAME>
<CONT_DATA CI_END="-13.472186419187604" CI_START="-34.52781358081239" EFFECT_SIZE="-24.0" ESTIMABLE="YES" MEAN_1="46.5" MEAN_2="70.5" MODIFIED="2014-07-23 18:29:24 +0200" MODIFIED_BY="[Empty name]" ORDER="90" SD_1="21.28" SD_2="40.16" SE="5.371432160924612" STUDY_ID="STD-WHO-1984" TOTAL_1="67" TOTAL_2="73" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-13.789227536053975" CI_START="-36.01077246394604" DF="0" EFFECT_SIZE="-24.900000000000006" ESTIMABLE="YES" I2="0.0" ID="CMP-007.01.03" MODIFIED="2014-07-22 21:33:22 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="1.120994097457967E-5" STUDIES="1" TAU2="0.0" TOTAL_1="57" TOTAL_2="58" WEIGHT="100.0" Z="4.39241316239814">
<NAME>At 24 weeks</NAME>
<CONT_DATA CI_END="-13.789227536053975" CI_START="-36.01077246394604" EFFECT_SIZE="-24.900000000000006" ESTIMABLE="YES" MEAN_1="40.5" MEAN_2="65.4" MODIFIED="2014-07-22 21:33:22 +0200" MODIFIED_BY="[Empty name]" ORDER="90" SD_1="22.7" SD_2="36.6" SE="5.668865627933159" STUDY_ID="STD-WHO-1984" TOTAL_1="57" TOTAL_2="58" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<OTHER_OUTCOME COLS="3" ID="CMP-007.02" MODIFIED="2014-11-17 21:27:15 +0100" MODIFIED_BY="[Empty name]" NO="2" ROWS_PER_STUDY="4" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Mean change in infant weight (g)</NAME>
<TR>
<TH>
<P>
<B>Visit interval<BR/>(postpartum)</B>
</P>
</TH>
<TH>
<P>COC</P>
</TH>
<TH>
<P>POP</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2014-11-17 21:27:12 +0100" MODIFIED_BY="[Empty name]" ORDER="24" STUDY_ID="STD-WHO-1984">
<TR>
<TD/>
<TD>
<P>
<B>Mean <U>+</U> </B>
<BR/>
<B>standard error (SE)</B>
</P>
</TD>
<TD>
<P>
<B>Mean <U>+</U> SE</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>6 to 9 weeks</P>
</TD>
<TD>
<P>561.9 <U>+</U> 24.4</P>
</TD>
<TD>
<P>623.5 <U>+</U> 23.5</P>
</TD>
</TR>
<TR>
<TD>
<P>9 to 12 weeks</P>
</TD>
<TD>
<P>523.0 <U>+</U> 24.3</P>
</TD>
<TD>
<P>531.9 <U>+</U> 23.2</P>
</TD>
</TR>
<TR>
<TD>
<P>20 to 24 weeks</P>
</TD>
<TD>
<P>354.6 <U>+</U> 19.9</P>
</TD>
<TD>
<P>395.7 <U>+</U> 19.8</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" MODIFIED="2015-03-02 21:35:27 +0100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>COC (norethinodrone 1 mg + EE 35 &#956;g) versus POP (norethinodrone 350 &#956;g)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.09862236819490613" CI_START="-0.2986223681949063" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.10000000000000009" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.01" MODIFIED="2015-03-02 21:35:01 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.3237509637272449" Q="0.0" RANDOM="NO" SCALE="0.87" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="41" TOTAL_2="40" UNITS="" WEIGHT="100.0" Z="0.9867790835203225">
<NAME>Mean change in infant weight (kg) from week 2 to 8</NAME>
<GROUP_LABEL_1>COC</GROUP_LABEL_1>
<GROUP_LABEL_2>POP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors POP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors COC</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.09862236819490613" CI_START="-0.2986223681949063" EFFECT_SIZE="-0.10000000000000009" ESTIMABLE="YES" MEAN_1="1.42" MEAN_2="1.52" MODIFIED="2014-07-21 16:28:06 +0200" MODIFIED_BY="[Empty name]" ORDER="11" SD_1="0.43" SD_2="0.48" SE="0.10133980509928453" STUDY_ID="STD-Espey-2012" TOTAL_1="41" TOTAL_2="40" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.0234974973562476" CI_START="-0.4834974973562468" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.27000000000000046" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.02" MODIFIED="2015-03-02 21:35:27 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.4824846647036236" Q="0.0" RANDOM="NO" SCALE="1.89" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="41" TOTAL_2="40" UNITS="" WEIGHT="100.0" Z="0.7023119223123562">
<NAME>Mean change in infant length (cm) from week 2 to week 8</NAME>
<GROUP_LABEL_1>COC</GROUP_LABEL_1>
<GROUP_LABEL_2>POP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors POP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors COC</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.0234974973562476" CI_START="-0.4834974973562468" EFFECT_SIZE="0.27000000000000046" ESTIMABLE="YES" MEAN_1="5.61" MEAN_2="5.34" MODIFIED="2014-07-21 16:28:23 +0200" MODIFIED_BY="[Empty name]" ORDER="11" SD_1="1.75" SD_2="1.71" SE="0.3844445629102062" STUDY_ID="STD-Espey-2012" TOTAL_1="41" TOTAL_2="40" WEIGHT="100.0"/>
</CONT_OUTCOME>
<OTHER_OUTCOME COLS="4" ID="CMP-008.03" MODIFIED="2014-11-17 19:41:29 +0100" MODIFIED_BY="[Empty name]" NO="3" ROWS_PER_STUDY="3" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Breastfeeding discontinuation by 6 months</NAME>
<TR>
<TH>
<P>Variable</P>
</TH>
<TH>
<P>Reported<BR/>hazard ratio</P>
</TH>
<TH>
<P>Reported<BR/>95% CI</P>
</TH>
<TH>
<P>Reported<BR/>P value</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2014-11-17 19:41:29 +0100" MODIFIED_BY="[Empty name]" ORDER="27" STUDY_ID="STD-Espey-2012">
<TR>
<TD>
<P>Group: COC versus POP</P>
</TD>
<TD>
<P>1.42</P>
</TD>
<TD>
<P>0.76 to 2.65</P>
</TD>
<TD>
<P>.270</P>
</TD>
</TR>
<TR>
<TD>
<P>Supplementing: yes versus no</P>
</TD>
<TD>
<P>2.81</P>
</TD>
<TD>
<P>1.09 to 7.23</P>
</TD>
<TD>
<P>.033</P>
</TD>
</TR>
<TR>
<TD>
<P>Milk concerns: yes versus no</P>
</TD>
<TD>
<P>2.07</P>
</TD>
<TD>
<P>1.37 to 5.91</P>
</TD>
<TD>
<P>.005</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2015-03-04 19:26:23 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2015-03-03 21:25:53 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram (2014).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAmsAAAI0CAYAAABClG7GAABd80lEQVR42u29f2Qd2R///2attWpV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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2015-03-04 19:26:23 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAQgAAAKfCAIAAAAdH8HOAAAb0UlEQVR42u3dv24dxxXH8QsECFKw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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2015-03-04 19:26:23 +0100" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAl4AAAC1CAMAAAC54wHcAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2015-03-02 17:50:12 +0100" MODIFIED_BY="[Empty name]">
<FEEDBACK_ITEM ID="FBK-01" MODIFIED="2015-03-02 17:50:12 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2015-03-02 17:50:12 +0100" MODIFIED_BY="[Empty name]">Combined hormonal versus nonhormonal versus progestin-only contraception</TITLE>
<DATE_SUBMITTED>
<DATE DAY="" MONTH="" YEAR=""/>
</DATE_SUBMITTED>
<FEEDBACK_SUMMARY MODIFIED="2015-03-02 17:48:04 +0100" MODIFIED_BY="[Empty name]">
<P>The exclusion of the study by Diaz et al (Contraception 1983; 27: 1-11) is not justified. In the review it is stated: "Per correspondence with the author, study participants received personal choice of intervention, not random allocation". In the methods division of this study the authors wrote: "Women requesting an oral contraceptive were assigned at random to the contraceptive pill under study or to an oral placebo on a patient-blind basis. Both pills were offered as a low-dose O.C. with no demonstrated effects upon lactation". I wrote to dr Diaz and asked her why the Cochrane review could come to a different conclusion. She answered me that the person doing the Cochrane review asked her only in general about all the studies on breastfeeding and contraception. In all the other trials women had the free choice of contraceptive method. Because the reviewer did not ask in detail about every trial she forgot to mention that in one trial the treatment was randomized.</P>
<P>In the discussion of the review is stated: " No trial to date has documented an adverse effect of hormonal contraceptives on infant growth". This statement is wrong because in the trial by Diaz et al (1983) the oral contraceptive group showed a significantly lower average absolute weight at days 61 and 91 postpartum and a significantly lower average daily weight increase during the first month of treatment.</P>
<P>In the discussion of the Cochrane review, the review authors criticized several trials because the putative effects of hormonal contraceptives on lactation could have been masked by the influence of supplemental foods. The review authors apparently did not realize that it is impossible to do a month long trial on breastfeeding and forbid the mothers to give supplements to their babies if they consider that the babies get insufficient food.</P>
<P>In the implications for research, the authors of the review suggest that investigators should do a trial of contraceptives versus placebo: "such a trial might enroll women who are not at risk of pregnancy because of a sterilization procedure (i.e. postpartum sterilization or partner vasectomy)."This proposal would imply that researchers would have to ask mothers who were planning to breastfeed their infants during several months to take a pill that could potentially deteriorate their lactation, while this medication could not offer her or her baby any advantage. Is there any ethical committee that would approve such a proposal?</P>
<P>I certify that I have no affiliations with or involvement in any organization or entity with a direct financial interest in the subject matter of my criticisms.</P>
<P>February, 2004.</P>
</FEEDBACK_SUMMARY>
<FEEDBACK_REPLY MODIFIED="2015-03-02 17:48:46 +0100" MODIFIED_BY="[Empty name]">
<P>Response to Treffers re:<BR/>Dr. Treffers suggests that we incorrectly excluded the report by Diaz et al. (Contraception 1983;27:1-11) and thus reached the wrong conclusion about the effect of combined oral contraceptives on infant growth. We stand by our exclusion for several reasons. First, we contacted Dr. Diaz and were advised by her in writing on April 1, 2002, that randomization had not been used in her study. Second, the report appears to describe a cohort study, with another group (not randomized) having received an intramuscular placebo. Third, the disparity in sample size between the ostensibly randomized groups (oral contraceptive, 103 participants; oral placebo, 79 participants) is unlikely to have resulted from simple randomization. By binomial theorem, the likelihood of getting a difference this large or larger due to chance is 4%. Stated alternatively, one can be 96% sure that randomization did not yield this result. Hence, we conclude that the Diaz 1983 study was not a randomized controlled trial, and our interpretation of the literature stands.</P>
<P>Given the absence of any demonstrable adverse effect of oral contraceptives on infant growth, the age and limited quality of existing studies, and the public health importance of the question, we believe a proper trial is both appropriate and ethical.</P>
</FEEDBACK_REPLY>
<FEEDBACK_CONTRIBUTORS>
<P>Treffers, Pieter </P>
</FEEDBACK_CONTRIBUTORS>
</FEEDBACK_ITEM>
</FEEDBACK>
<APPENDICES MODIFIED="2015-03-04 15:12:13 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2015-03-04 15:12:13 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2015-03-03 21:28:24 +0100" MODIFIED_BY="[Empty name]">Search 2015</TITLE>
<APPENDIX_BODY MODIFIED="2015-03-04 15:12:13 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">PubMed (1 September 2001 to 6 January 2015)</HEADING>
<P>((breastfeeding OR lactation) AND (contraceptive devices, female OR contraceptive agents, female)) NOT (cancer OR cows)<BR/>Article types: Clinical Trial</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">CENTRAL (2015, Issue 2 (on 2 March 2015))</HEADING>
<P>Title, Abstract, Keywords: lactat* or breastfeed* OR breast-feed*<BR/>AND Title, Abstract, Keywords: contracept*<BR/>Publication Date from 2001 to 2015<BR/>Limited to Trials<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">POPLINE (2001 to 8 July 2014)</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Two strategies:</HEADING>
<P>Keyword: Contraception<BR/>AND Keyword: Lactation<BR/>Filter by Keyword: Research report<BR/>Years: 2001 to 2014</P>
<P>Keyword: Contraception<BR/>AND Keyword: Breastfeeding<BR/>AND Keyword: Clinical research<BR/>Years: 2001 to 2014</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Web of Science (11 December 2014)</HEADING>
<P>TOPIC: (contracept*)<BR/>
<I>AND</I> TOPIC: (lactat*)</P>
<P>Refined by: WEB OF SCIENCE CATEGORIES:<BR/>( OBSTETRICS GYNECOLOGY<BR/>OR PUBLIC ENVIRONMENTAL OCCUPATIONAL HEALTH<BR/>OR PUBLIC ENVIRONMENTAL OCCUPATIONAL HEALTH SSCI )</P>
<P>AND DOCUMENT TYPES: ( ARTICLE OR MEETING ABSTRACT OR REVIEW )</P>
<P>Timespan: 2001-2014</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">LILACS (4 March 2015)</HEADING>
<P>contraceptive agents, female or agentes anticonceptivos femeninos or anticoncepcionais femeninos [Words]<BR/>and ("LACTATION" ) or "BREASTFEEDING" [Words]</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">ClinicalTrials.gov (14 January 2015)</HEADING>
<P>Condition: breastfeeding OR lactation<BR/>Intervention: contraception OR contraceptive<BR/>Study type: Interventional studies<BR/>First received: from 01 June 2010</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">ICTRP (14 January 2015)</HEADING>
<P>Title: breast-feed* OR breastfeed* OR lactat*<BR/>Condition: contraception OR contraceptive<BR/>Recruitment status: All</P>
<P>Date of registration: from 01 June 2010 to 14 January 2015<BR/>
</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2015-03-02 17:49:37 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2014-09-10 18:14:17 +0200" MODIFIED_BY="[Empty name]">Prior searches</TITLE>
<APPENDIX_BODY MODIFIED="2015-03-02 17:49:37 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">2010 update</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">MEDLINE (via PubMed) (to 29 October 2014)</HEADING>
<P>((breastfeeding OR lactation) AND (contraceptive devices, female OR contraceptive agents, female)) AND (randomized controlled trial [pt] OR controlled clinical trial [pt] OR random allocation [mh] OR double-blind method [mh] OR single-blind method [mh] OR clinical trial [pt] OR ("clinical trial" [tw]) OR ((singl* [tw] OR doubl* [tw] OR trebl* [tw] OR tripl* [tw]) AND (mask* [tw] OR blind* [tw])) OR ("latin square" [tw]) OR placebos [mh] OR placebo* [tw] OR random* [tw] OR research design [mh:noexp] OR follow-up studies [mh] OR prospective studies [mh] OR cross-over studies [mh] OR control* [tw] OR prospectiv* [tw] OR volunteer* [tw]) NOT (cancer OR cows)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">POPLINE (2006 to 1 November 2010)</HEADING>
<P>(lactating / lactation / breastfed / breastfeed / breastfeeding / breastfeeding / breastfeeders / breastmilk) &amp; contraception &amp; clinical trials</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">CENTRAL (2008 to 29 October 2010)</HEADING>
<P>lactat* or breastfeed* in Title, Abstract, or Keywords AND contracept* in Title, Abstract, or Keywords</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">ClinicalTrials.gov (to 1 November 2010)</HEADING>
<P>(lactat* or breastfeed*) AND contracept*</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">ICTRP (to 1 November 2010)</HEADING>
<P>Condition: lactating OR lactation OR breastfeed OR breastfeeding<BR/>Intervention: contraception OR contraceptive</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Initial review and updates in 2005 and 2008</HEADING>
<P>Strategies for MEDLINE, POPLINE, and CENTRAL were those listed above for 2010. In addition, EMBASE and LILACS were searched as shown below. The 2005 searches were run to 5 April 2005, and the 2008 searches were run to 6 May 2008.</P>
<SUBSECTION>
<HEADING LEVEL="4">EMBASE</HEADING>
<P>1. contracep?<BR/>2. contraception!<BR/>3. 1 or 2<BR/>4. breast(W)milk OR breastmilk<BR/>5. breastfeed? OR breast(W)feed?<BR/>6. lactation<BR/>7. 4 OR 5 OR 6<BR/>8. clinical trial!<BR/>9. controlled study!<BR/>10. 8 OR 9<BR/>11. 3 AND 7 AND 10<BR/>12. 11/human</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">LILACS</HEADING>
<P>lactation, breastfeeding, contraception/contraceptives, clinical trials</P>
</SUBSECTION>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2015-03-02 17:50:51 +0100" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2015-03-02 17:50:39 +0100" MODIFIED_BY="[Empty name]">Non-randomized studies (previously listed as excluded)</TITLE>
<APPENDIX_BODY MODIFIED="2015-03-02 17:50:51 +0100" MODIFIED_BY="[Empty name]">
<P>Full-text review was not needed to determine that these studies were not eligible. In 2014, we classified them as 'discarded' to shorten the list of <LINK TAG="EXCLUDED_STUDIES" TYPE="SECTION">Excluded studies</LINK>.</P>
<P>1. Bjarnadottir RI, Gottfredsdottir H, Sigurdardottir K, Geirsson RT, Dieben TO. Comparative study of the effects of a progestogen-only pill containing desogestrel and an intrauterine contraceptive device in lactating women. British Journal of Obstetrics and Gynaecology 2001;108:1174-80.</P>
<P>2. Chen JH, Wu SC, Shao WQ, Zou MH, Hu J, Cong L, et al. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women. Contraception 1998;57:371-9.</P>
<P>3. Coutinho EM, Athayde C, Dantas C, Hirsch C, Barbosa I. Use of a single implant of elcometrine (ST-1435), a nonorally active progestin, as a long acting contraceptive for postpartum nursing women. Contraception 1999;59:115-22.</P>
<P>4. Danli S, Qingxiang S, Guowei S. A multicentered clinical trial of the long-acting injectable contraceptive Depo Provera in Chinese women. Contraception 2000;62:15-8.</P>
<P>5. Dunson TR, McLaurin VL, Grubb GS, Rosman AW. A multicenter clinical trial of a progestin-only oral contraceptive in lactating women. Contraception 1993;47:23-35.</P>
<P>6. Hannon PR, Duggan AK, Serwint JR, Vogelhut JW, Witter F, DeAngelis C. The influence of medroxyprogesterone on the duration of breast-feeding in mothers in an urban community. Archives of Pediatrics &amp; Adolescent Medicine 1997;151:490-6.</P>
<P>7. Lönnerdal B, Forsum E, Hambraeus L. Effect of oral contraceptives on composition and volume of breast milk. American Journal of Clinical Nutriton 1980;33:816-24.</P>
<P>8. Massai MR, Diaz S, Quinteros E, Reyes MV, Herreros C, Zepeda A, et al. Contraceptive efficacy and clinical performance of Nestorone implants in postpartum women. Contraception 2001;64:369-76.</P>
<P>9. McCann MF, Moggia AV, Higgins JE, Potts M, Becker C. The effects of a progestin-only oral contraceptive (levonorgestrel 0.03 mg) on breast-feeding. Contraception 1989;40:635-48.</P>
<P>10. Reinprayoon D, Taneepanichskul S, Bunyavejchevin S, Thaithumyanon P, Punnahitananda S, Tosukhowong P, et al. Effects of the etonogestrel-releasing contraceptive implant (Implanon) on parameters of breastfeeding compared to those of an intrauterine device. Contraception 2000;62:239-46.</P>
<P>11. Virutamasen P, Leepipatpaiboon S, Kriengsinyot R, Vichaidith P, Muia PN, Sekadde-Kigondu CB, et al. Pharmacodynamic effects of depot-medroxyprogesterone acetate (DMPA) administered to lactating women and their male infants. Contraception 1996;54:153-7.</P>
<P>12. World Health Organization Task Force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development, and Research Training in Human Reproduction. Progestogen-only contraceptives during lactation: I. infant growth. Contraception 1994;50:35-53.</P>
<P>13. Zacharias S, Aguilera E, Assenzo JR, Zanartu J. Effects of hormonal and nonhormonal contraceptives on lactation and incidence of pregnancy. Contraception 1986;33:203-12.</P>
<P>14. Zanartu J, Aguilera E, Munoz-Pinto G. Maintenance of lactation by means of continuous low-dose progestogen given post-partum as a contraceptive. Contraception 1976;13:313-8.</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;11 trials included in quantitative synthesis&lt;br&gt;(11 primary reports and 4 secondary articles)&lt;/p&gt;" WIDTH="153">
<FLOWCHARTBOX TEXT="&lt;p&gt;4 trials from initial review (4 primary reports and 2 secondary articles)&lt;/p&gt;" WIDTH="131"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;9 items included&lt;br&gt;(7 primary reports and 2 secondary articles)&lt;/p&gt;" WIDTH="147">
<FLOWCHARTBOX TEXT="&lt;p&gt;14 full-text items assessed for eligibility&lt;/p&gt;" WIDTH="108">
<FLOWCHARTBOX TEXT="&lt;p&gt;219 unduplicated records screened&lt;/p&gt;" WIDTH="113">
<FLOWCHARTBOX TEXT="&lt;p&gt;320 records identified through database searching&lt;/p&gt;" WIDTH="127">
<OUT TEXT="&lt;p&gt;109 duplicates removed&lt;/p&gt;" WIDTH="68"/>
</FLOWCHARTBOX>
<FLOWCHARTBOX TEXT="&lt;p&gt;4 records identified through other sources&lt;/p&gt;" WIDTH="126"/>
<OUT TEXT="&lt;p&gt;205 records discarded&lt;/p&gt;" WIDTH="85"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;3 full-text items excluded, with reasons; 2 more discarded&lt;/p&gt;" WIDTH="98"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>